0 Acquired Biotech Companies

159 Solutions	Acquired by IQVIA, May 2018
23andMe	Acquired by nonprofit, Jul 2025; Bankruptcy, Mar 2025
2seventy Bio	Acquired by BMS, May 2025, $286M; bluebird bio spinout
3-Dimensional Pharmaceuticals	Acquired by J&J, Jan 2003, $88M
3Clinical Research	Acquired by Parexel, Mar 2004
3F Therapeutics	Acquired by ATS Medical, Jan 2006
4-Antibody	Bought by Agenus, Jan 2014, $10M
454 Life Sciences	Bought by Roche, Mar 2007, $454M
4C Biotech	Acquired by Henogen, Jul 2003
4Clinics	Acquired by P95, Jul 2024
4P Therapeutics	Acquired by Nutriband, Apr 2018
4SC-Discovery	Sold to BioNTech Small Molecules, Apr 2016
510 Kardiac Devices	Acquired by Keystone Heart, Jun 2020
7D Surgical	Part of Orthofix; Acquired by SeaSpine, Mar 2021, $82.5M
A&E Medical	Acquired by Zimmer Biomet, Dec 2020, $250M
Aaren Scientific	Bought by Zeiss, Jan 2014
AavantiBio	Acquired by Solid Biosciences, Dec 2022
Ab Initio Biotherapeutics	Acquired by Ligand Pharmaceuticals, Jul 2019, $12M
Abaxis	Bought by Zoetis, Jul 2018
Abceutics	Acquired by Merck, Apr 2024, $208M
AbCheck	Acquired by Ampersand Biosciences, Jan 2024
Abcore	Acquired by Fortis Life Sciences, Mar 2022
abCRO	Acquired by PPD, Apr 2009
AbD Serotec	Acquired from MorphoSys by Bio-Rad, Jan 2013, €53M
Abeta	Assets bought by The Genetics Company, Jun 2003
Abexxa Biologics	Acquired by Boehringer-Ingelheim, Sep 2021
ABF Pharmaceutical Services	Acquired by GBF Group Pharma, 2017
AbFero Pharmaceuticals	Acquired by Pharmacosmos, Nov 2021, $225M
ABgene	Bought by Apogent, Dec 2001
Abgenix	Bought by Amgen 2006
Abide Therapeutics	Acquired by Lundbeck, May 2019, $250M
Ability Biomedical	Acquired by Medarex, $4.7M, Jul 2004
Abiomed	Acquired by J&J, Dec 2022, $16.6B
Ablation Frontiers	Acquired by Medtronic, Jan 2009, $225M
Ablynx	Acquired by Sanofi, Jun 2018, $4.8B
Abmaxis	Acquired by Merck, May 2006, $80M
Abound Bio	Acquired by Galapagos Jun 2022, $14M
Abraxis Bioscience	Bought by Celgene, Jun 2010, $2.9B
Abrika Pharmaceuticals	Acquired by Actavis, Apr 2007
Absalus	Acquired by EvoGenix, Apr 2005
Absorption Systems	Acquired by Pharmaron, Oct 2020
Abt Bio-Pharma Solutions	Acquired by United Biosource, May 2010
Abveris	Acquired by Twist Bioscience, Nov 2021, $150M + $40M milestones; fka AbX Biologics
AbVitro	Bought by Juno Therapeutics, Jan 2016, $125M
Acacia Biosciences	Acquired by Rosetta Inpharmatics, Feb 1999
Acacia Pharma	Acquired by Eagle Pharmaceuticals, Jun 2022, $100M
Acambis	Bought by Sanofi Pasteur, $276M, Sep 2008
Accel Biotech	Acquired by Ximedica, Jul 2016
Acceleron Pharma	Acquired by Merck, Nov 2021, $11.5B
AccelLAB	Acquired by Charles River, Apr 2019
Accellent	Acquired Lake Region Medical $390M Mar 2014, took on their name
Accelrys	Bought by Dassault, 2014
Acceptys	Assets acquired by Patrys, Oct 2008
Access Biologicals	Acquired by Grifols, Jun 2022, $140M for remaining 50% it did not own
ACCESS Oncology	Acquired by Keryx Biopharmaceuticals, Jan 2004
Access Scientific	Acquired by Smiths Medical, May 2020
AccessClosure	Bought by Cardinal Health, May 2014
Acclarent	Acquired by Integra LifeSciences, Mar 2024; Bought by J&J, Dec 2009, $785M
Accovion	Acquired by Clinipace, Apr 2015
Accriva Diagnostics	Acquired by Werfen/Instrumentation Laboratory, Jan 2017; fka ITC
Accugenix	Bought by Charles River, Aug 2012
Accuimage Diagnostics	Acquired by Merge eFilm, Jan 2005
Accuri Cytometers	Acquired by BD, Mar 2011
Ace Biosciences	Acquired by Zymenex, Nov 2009
ACEA Biosciences	Acquired by Agilent, Nov 2018
ACell	Acquired by Integra LifeSciences, Jan 2021, $300M
Acer Therapeutics	Acquired by Zevra Therapeutics, Nov 2023, $15M
Acessa Health	Acquired by Hologic, Aug 2020, $80M + Milestones
Acetylon Pharmaceuticals	Acquired by Celgene, Dec 2016
Achillion Pharmaceuticals	Acquired by Alexion, Jan 2020, $930M
ACI Clinical	Acquired by WCG, Mar 2018
Aciex Therapeutics	Acquired by Nicox, Oct 2014, $120M
Aclara Biosciences	Bought by ViroLogics, Dec 2004, $160M
ACMI	Acquired by Gyrus, 2005, $500M
Acolyte Biomedica	Acquired by 3M, Feb 2007
Acris Antibodies	Acquired by OriGene Technologies, Sep 2015, became OriGene Europe
AcroMetrix	Acquired by Life Technologies Jan 2010
Acrymed	Bought by Halyard (Halyard fka Kimberly-Clark Healthcare)
AcSentient	Main assets acquired by Ista Pharmaceuticals, May 2002
ACT Oncology	Acquired by Precision for Medicine, Mar 2016, renamed Precision Oncology
Acta Vascular	Acquired by CardioVasc, Apr 2007
Actagene Oncology	Acquired by Ignyta May 2013
Actavis	Acquired Allergan, $70B, Took Allergan name
Actelion Pharmaceuticals	Acquired by J&J, Jun 2017, $30B
Actient Pharmaceuticals	Acquired by Auxilium Pharmaceuticals, Apr 2013
Actimis Pharmaceuticals	Acquired by Boehringer Ingelheim 2008
Activaero	Bought by Vectura, €130M, Mar 2014
ActivaTek	Acquired by North Coast Medical
ActiViews	Acquired by Stryker, Oct 2013, $30M
Activiomics	Acquired by Retroscreen Virology Group, Mar 2014
Activus Pharma	Acquired by Sosei Group, Jun 2010, $5.6M
ActoGeniX	Acquired by Intrexon, $60M, Feb 2015
Acton Pharmaceuticals	Acquired by Meda, Aug 2013
AcuFocus	Acquired by Bausch + Lomb, Jan 2023
Acuity Bio	Acquired by Cook Biotech, May 2021
Acuson	Acquired by Siemens, Sep 2000, $700M
Acute Innovations	Acquired by Acumed, Mar 2020
Adamas Pharmaceuticals	Acquired by Supernus, Nov 2021
Adams Respiratory Therapeutics	Acquired by Reckitt Benckiser, Dec 2007, $2.3B
Adapt Pharma	Bought by Emergent Biosolutions, Oct 2018, $635M + $100M milestones
Adaptate Biotherapeutics	Acquired by Takeda, Jan 2022; Spun out of Gammadelta Therapeutics, Oct 2019
Adaptive Phage Therapeutics	Acquired by BiomX, Mar 2024
ADC Biotechnology	Acquired by Sterling Pharma Solutions, Apr 2021; aka ADCBIO
Additive Orthopaedics	Acquired by Paragon 28, Jun 2021
Addrenex	Bought by Shionogi subsidiary Sciele, Nov 2009, $29M
Adello Biologics	Acquired by Kashiv Pharma, Jan 2019
Adenosine Therapeutics	Bought by Clinical Data, Aug 2008, $11M
AdeptBio	Bought by Asterand Bioscience, Aug 2015
Aderis Pharmaceuticals	Acquired by Schwarz Pharma, Jul 2005
Adeza Biomedical	Acquired by Cytyc, Apr 2007
Adheron Therapeutics	Bought by Roche, Oct 2015, $105M + $475 Milestones
Adhesys Medical	Bought by Grunenthal, Apr 2017; fka Medical Adhesive Revolution
Adhezion Biomedical	Acquired by HB Fuller, Jul 2023
ADL Biopharma	Acquired by Wacker, May 2023; Kartesia bought 100% of stock Mar 2021
Admune Therapeutics	Acquired by Novartis, Oct 2015
Adnexus Therapeutics	Bought by BMS, Sep 2007, $415M
Adolor	Acquired by Cubist, Oct 2011, $415M
AdProtech	Acquired by Inflazyme Pharmaceuticals, Apr 2004
Adrestia Therapeutics	Acquired by Insmed, Jul 2023
ADSM-Synchro Medical	Acquired by Tyber Medical, Feb 2023
Aduro Biotech	Acquiring Chinook Therapeutics, Jun 2020, taking name
Advalytix	Acquired by Beckman Coulter, 2009
Advanced Accelerator Applications	Bought by Novartis, Nov 2017, $3.9B
Advanced Analytical Technologies	Acquired by Agilent, Mar 2018
Advanced Biohealing	Bought by Shire 2011, Now Shire Regenerative Medicine
Advanced Biomatrix	Acquired by BICO, Aug 2021, $15M
Advanced Biotherapy	Acquired for cash assets by energy company, Mar 2009
Advanced Circulatory	Bought by Zoll Medical, Mar 2015
Advanced Circulatory Systems	Acquired by Zoll, Dec 2014
Advanced Clinical Research	Acquired by Velocity Clinical, Jun 2019
Advanced Influenza Technologies	Acquired by CytoDyn, Jul 2006
Advanced Inhalation Research	Acquired by Alkermes, Feb 1999
Advanced Memory Institute of NJ	Acquired by Cenexel, Aug 2021
Advanced Ocular Systems	Acquired by scaffolding company, Dec 2008
Advanced Stent Technologies	Acquired by Boston Scientific Dec 2004
Advanced Technology and Regenerative Medicine	Bought by DePuy
Advanced Therapies	Acquired by Altaris, Mar 2025
AdvancedCath	Acquired by TE Connectivity, Feb 2015, $190M
AdvanDx	Acquired by OpGen, Jul 2015
Advangen	Acquired by Cellmid, May 2013
Advantar Laboratories	Acquired by Eurofins, Mar 2016
Advion Bioanalytical	Bought by Quintiles, Nov 2011
ADViSYS	Acquired by VGX Pharmaceuticals, 2007
ADx NeuroSciences	Acquired by Fujirebio, 2022
Aegea Biotechnologies
AEGEA Medical	Acquired by CooperSurgical, Feb 2021
Aegera Therapeutics	Acquired by PharmaScience, May 2011
Aegis Therapeutics	Acquired by Neurelis, Dec 2018
Aelian Biotechnology	Renamed Myllia, Apr 2022
Aequus Biopharma	Owned by CTI Biopharma, no news since 2012, no employees on LinkedIn
Aerie Pharmaceuticals	Acquired by Alcon, Nov 2022, $770M
Aero Pharmaceuticals	Acquired by Cocrystal Pharma, May 2011
Aerocrine	Bought by Circassia Pharmaceuticals, May 2015, $219M
AES Chemunex	Bought by bioMerieux, May 2011
Aesgen	Acquired by MGI Pharma, Sep 2004
Aesica Pharmaceuticals	Bought by Consort Medical for $374M, Sep 2014
AesRx	Bought by Baxter, Jul 2014
Aesthera	Acquired by Solta Medical, Feb 2010
Aevi Genomic Medicine	Acquired by Cerecor, Feb 2020, $15.6M + $6.5M Milestones
AexeRNA	Acquired by BioNTech, Nov 2023
Afexa Life Sciences	Acquired by Valeant Oct 2011
Affera	Acquired by Medtronic, Sep 2022, $1B
Afferent Pharmaceuticals	Bought by Merck, Jul 2016, $1.25B
Affinity BioReagents	Acquired by Thermo Fisher, Jul 2008
Affinium Pharmaceuticals	Assets acquired by Debiopharm, Feb 2014
Affinivax	Acquired by GSK, Aug 2022
Affomix	Acquired by Illumina, Jul 2010
Affymetrix	Acquired by Thermo Fisher, Apr 2016, $1.3B
Afmedica	Acquired by Angiotech, Sep 2005
AGA Medical	Acquired by St. Jude Medical, Oct 2010, $1.3B
Agalimmune	Acquired by BioLineRx, Mar 2017, $6M
Agenovir	Acquired by Vir Biotechnology, May 2018
Agensys	Acquired by Astellas Pharma, Nov 2007, $387M + $150M milestones
Agere Pharmaceuticals	Acquired by Patheon, Mar 2015
AGI Dermatics	Acquired by Estee Lauder, Sep 2008
AGI Therapeutics	Bought by Videra
Agilis Biotherapeutics	Bought by PTC Therapeutics, Aug 2018, $50M cash + $150M stock
Agility Clinical	Acquired by Precision for Medicine, Sep 2017
Agilix	Acquired by Perkin-Elmer, Feb 2006
Agilux Laboratories	Acquired by Charles River, Oct 2016, $64M
Agouron Pharmaceuticals	Acquired by Warner-Lambert, Jan 1999, $2.1B stock
AGTC	Acquired by Syncona, Dec 2022, $23.5M + $50M milestones
Ahura Scientific	Acquired by Thermo Fisher
AI Biomed	Acquired by Medtronic, Oct 2020
Aimmune Therapeutics
Aiolos Bio	Acquired by GSK, Feb 2024, $1B + $400M milestones
Aires Pharmaceuticals	Acquired by Mast Therapeutics, Apr 2014
AIT Bioscience	Acquired by Nexelis, Jul 2020
Ajinomoto Althea	Sold to PCI Pharma Services, Apr 2025; Merged with OmniChem to become Ajinomoto Bio-Pharma Services, Oct 2018
Akarna Therapeutics	Acquired by Allergan, Sep 2016, $50M + milestones
AkaRx	Acquired by Eisai, Dec 2009
Akcea Therapeutics	Spun out of Ionis Pharmaceuticals, fully reacquired Aug 2020
Akers Biosciences	Acquired by MyMD Pharmaceuticals via Reverse Merger, Nov 2020
AKESOgen	Acquired by Tempus, Dec 2019
Akouos
Akoya Biosciences	Acquired by Quanterix, Jul 2025, $127M
AKRN Scientific Consulting	Acquired by NAMSA, Mar 2022
Alanex	Acquired by Agouron, Apr 1997
Alantos Pharmaceuticals	Bought by Amgen 2007
Alaris Medical	Acquired by Cardinal Health, May 2004
Alaven Pharmaceutical	Bought by Meda, $350M, Oct 2010
ALBiotek	Acquired by Vaxcell Bio, Jan 2025
Albireo Pharma	Acquired by Ipsen, Mar 2023; Merged with Biodel Nov 2016; Spun out of AstraZeneca in 2008
Albumedix	Acquired by Sartorius, Sep 2022, £415M
Alcobra Pharma	Acquired by Arcturus, Sep 2017 via reverse merger
Aldagen	Bought by Cytomedix Feb 2012
Alder BioPharmaceuticals	Acquired by Lundbeck, Oct 2019, $1.95B
Alere	Acquired by Abbott, Oct 2017, $4.6B
Alexion Pharmaceuticals	Acquired by AstraZeneca, Jul 2021, $39B
Alexza Pharmaceuticals	Acquired by Gruppo Ferrer, Jun 2016
Alfigen	Acquired by Genzyme, Feb 2004
Algeta	Acquired by Bayer, Mar 2014
AlgoNomics	Acquired by Lonza, Nov 2009
Algorx Pharmaceuticals	Acquired by Corgentech in reverse merger, Dec 2005
Algynomics	Acquired by Proove Biosciences, May 2016
Aliada Therapeutics	Acquired by AbbVie, Dec 2024
Align Pharmaceuticals	Acquired by Cyclacel, Oct 2007
Alimera Sciences	Acquired by ANI Pharmaceuticals, Sep 2024, $381M
Alimetrix	Acquired by Spectrum Solutions, Mar 2023
Alios Biopharma	Acquired by J&J Nov 2014, $1.75B
Alivio Therapeutics	Fully absorbed into PureTech, Jun 2021
Alize Pharma	Acquired by Millendo Therapeutics, Dec 2017
Alize Pharma II	Acquired by Jazz Pharmaceuticals, Jun 2016, €8M + €10M milestones
Alkan Pharma	Acquired by Hikma, Apr 2011, $60.5M
Allakos	Acquired by Concentra, May 2025, $35M
Allcyte	Acquired by Exscientia, Jun 2021
Allegro Diagnostics	Acquired by Veracyte, late 2014
Allendale Pharmaceuticals	Acquired by Synova Healthcare, Feb 2007, $16M stock
Allenex	Bought by CareDx, Apri 2016
Allergan	Acquired by AbbVie, May 2020, $63M
Allergy Immuno Technologies	Acquired by rubber company, 2003
Allergy Laboratories	Likely acquired by ALK-Abello, Dec 2016
Allevi	Acquired by 3D Systems, May 2021
Alliance Biosciences	Acquired by WIRB-Copernicus Group, Jul 2014
Alliance Contract Pharma	Acquired by Altasciences, Feb 2020
Alliance Medical Products	Acquired by Siegfried, May 2012
Alliance Protein Laboratories	Acquired by KBI Biopharma, Jun 2017
Alliant Pharmaceuticals	Acquired by Sciele Pharma, Jun 2007
AlliedPath	Acquired by IRIS International, Aug 2010
Allomek Therapeutics	Acquired by Pasithea Therapeutics, Oct 2022
Allon Therapeutics	Assets acquired by Paladin Labs, Jun 2013
Allos Therapeutics	Acquired by Spectrum Pharmaceuticals Sep 2012
Allotrope Medical	Acquired by Northgate Technologies, Apr 2023
AlloVir	Acquired by Kolaris Therapeutics, Nov 2024
Alltracel Pharmaceuticals	Bought by HemCon, 2008
Allylix	Acquired by Evolva, Nov 2014, $59M stock
AlmataBio	Acquired by Avalo Therapeutics, Mar 2024, $22M
Almedica	Acquired by Aptuit, Sep 2005
Alnara Pharmaceuticals	Bought by Eli Lilly, Jul 2010, $380M
Aloka	Acquired by Hitachi Medical, Jun 2011
Alpha Innotech	Acquired by Cell Biosciences, Sep 2009
Alpha-5 integrin	Acquired by Pasithea Therapeutics, Jun 2022
AlphaCore Pharma	Bought by MedImmune, Apr 2013
AlphaPharm	Acquired by Mylan, 2007
Alpharma	Bought by King Pharmaceuticals, now part of Zoetis
Alphazyme	Acquired by Maravai Life Sciences, Jan 2023
Alphora Research	Acquired by eurofins, Jun 2017
Alpine Biomed	Acquired by Natus, Sep 2009
Alpine Biosciences	Acquired by Oncothyreon Aug 2014, $27M in stock
Alpine Immune Sciences	Acquired by Vertex Pharmaceuticals, May 2024, $4.9B
Alsius	Assets purchased by Zoll Medical, May 2009, $12M
Altacor	Acquired by Fidia Pharma, Sep 2025
Altair Clinical	Bought by Accelovance, Feb 2015
Alteris Therapeutics	Bought by Celldex Oct 2005, $1.5M plus stock/milestones
Alternative BioMedical Solutions	Acquired by Ligthouse Lab Services
Althea Technologies	Acquired by Ajinomoto, Mar 2013
AltheaDx	Acquired by Castle Biosciences, Apr 2022
Altiva	Acquired by Exactech, Jan 2008
Altor Bioscience	Bought by NantCell, Aug 2017, $360M
Altura Medical	Bought by Lombard Medical Aug 2015, though it was closed Aug 2013 according to Crunchbase
ALung Technologies	Acquired by LivaNova, Jul 2022
Alveolus	Assets acquired by Merit Medical, Mar 2009
Alverix	Acquired by BD, Jan 2014
Alvine Pharmaceuticals	Assets acquired by ImmunogenX, Mar 2016
Alvos Therapeutics	Bought by Arrowhead Research, Apr 2012, $23.5M stock
Alydia Health	Acquired by Organon Jun 2021; fka InPress Technologies
ALZA	Bought by J&J, Jun 2001, $11.8B stock
AMAG Pharmaceuticals	Acquired by Covis Pharma, Nov 2020
AMAL Therapeutics	Acquired by Boehringer Ingelheim, Jul 2019, €225M + €100M Milestones
Amalyte Pharmaceuticals	Acquired by Kemin Jun 2009
Amaryllis Nucleics	Acquired by Active Motif, Jan 2022
amaxa	Acquired by Lonza, Jul 2008
Ambest Pharmaceuticals	Bought by Sihuan Pharmaceutical, Mar 2017, $160M
AMBI Pharmaceuticals	Acquired by Neuro-Hitech, Nov 2008
Ambion	Bought by Applied Biosystems 2006
Ambit Biosciences	Bought by Daiichi Sankyo, Nov 2014
Amblyotech	Acquired by Novartis, Apr 2020
Ambrx	Acquired by J&J, Mar 2024, $2B; Bought by joint venture of 4 Chinese pharma companies
Ambys Medicines	Acquired by Cytotheryx, Feb 2023
AmCell	Seems to have been subsumed into Miltenyi
AmCyte	Acquired by ReNeuron, Aug 2007, $4M
Amdipharm	Acquired by Concordia Healthcare, Sep 2015
Amedis Pharmaceuticals	Acquired by Takeda, Jan 2005
Amedra Pharmaceuticals	Acquired by Impax Laboratories, Mar 2015
Amendia	Acquired Spinal Elements, Apr 2017, took their name
American Bionostica	Acquired by Ott Scientific, May 2021
American Peptide Company	Acquired by Bachem, Feb 2015
AMF Medical	Acquired by Tandem Diabetes, Jan 2023
Amide Pharmaceutical	Acquired by Actavis, Jul 2005
Amira Medical	Acquired by Roche, Nov 2001
Amira Pharmaceuticals	Acquired by BMS, Jul 2011, $325M
Amnestix	Acquired by SYGNIS, Jun 2008, $6M
Amnis	Acquired by EMD Millipore, Aug 2011
Amolyt Pharma	Acquired by AstraZeneca, Jul 2024, $800M + $250M milestones
Amomed Pharma	Acquired by AOP, Jan 2022
Amorcyte	Acquired by Neostem, Oct 2011
Amorsa Therapeutics	Acquired, 2022
Amplimmune	Bought by MedImmune Oct 2013, $225M
Amplion	Acquired by Science & Medicine Group, Sep 2022
Amplyx Pharmaceuticals	Acquired by Pfizer Apr 2021
AmpTec	Acquired by Merck KGaA, Jan 2021
Amresco	Acquired by VWR, Feb 2011
Amring Pharmaceuticals	Acquired by Nordic Pharma, Mar 2024
Amryt Pharma	Acquired by Chiesi, Apr 2023
Amsterdam Molecular Therapeutics	Acquired by UniQure
Amunix Pharmaceuticals	Acquired by Sanofi, Feb 2022, $1B + $225 milestones
AMUR Pharmaceuticals	Bought by SuperGen
Amylin Pharmaceuticals	Bought by BMS Aug 2012
ANA Therapeutics	Acquired by NeuroBo Pharmaceuticals, Dec 2020
Anaconda Pharma	Acquired by Biota, Feb 2015
Anacor Pharmaceuticals	Bought by Pfizer, Jun 2016, $5.2B
Anadys Pharmaceuticals	Acquired by Roche 2011
Anagnostics	Assets acquired by CubeDx, Jul 2015
Anagram	Acquired by Avania, Oct 2024
Anakuria Therapeutics	Acquired by Janssen, Feb 2022
Analgesic Solutions	Acquired by WCG, Apr 2019
Analytical Bio-Chemistry Laboratories	Acquired by EAG, Jul 2015
Analytical Lab Group	Acquired by Element, now Element Life Sciences
Anaphore	Acquired RuiYi, rebranded as RuiYi
Anayaderm	Acquired by Alexar Therapeutics, 2014
Anchen	Bought by Par Pharmaceutical
Anchen Pharmaceuticals	Acquired by Par Pharmaceutical, Aug 2011
Ancile Pharmaceuticals	Acquired by Mera Pharmaceuticals, Jan 2003
Ancora Pharmaceuticals	Assets Acquired by Corden Pharm, Oct 2013
Andara Life Science	Acquired by CyberKinetics, Feb 2006
Andromeda Biotech	Acquired by Hyperion, Jun 2014
Andrx Pharmaceuticals	Acquired by Watson Pharmaceuticals, Nov 2006, $1.9B
Anelixis Therapeutics	Acquired by Novus Therapeutics, Sep 2020; fka Anelixis Pharmaceuticals
Angioblast Systems	Acquired by Mesoblast, May 2010
Angiolink	Acquired by Medtronic, Nov 2004
Angion Biomedica	Acquired by Elicio Therapeutics, Jun 2023
AngioScore	Acquired by Spectranetics, May 2014, $230M+
AngioSense	Acquired by MicroHeart, Sep 2001
Angiosyn	Acquired by Pfizer 2005
Angstrom Medica	Acquired by Pioneer Surgical, Oct 2007
AnHeart Therapeutics	Acquired by Nuvation Bio, Apr 2024
Annovation Biopharma	Acquired by The Medicines Company, Feb 2015
Annovis	Acquired by Transgenomic, May 2001
AnorMED	Acquired by Genzyme, Oct 2006
Anosys	Acquired by Chromos Molecular Systems, Dec 2001
Ansan Pharmaceuticals	Acquired by Discovery Labs, Jul 1997
Antares Pharma	Acquired by Halozyme, May 2022, $960M
Anteco Pharma	Acquired by Attwill Vascular, Nov 2017
Anterios Therapeutics	Acquired by Allergan, Jan 2016, $90M
Antex Biologics	Bought by BioPort, Jun 2003
Anthos Therapeutics	Acquired by Novartis, Apr 2025, $3.1B
Anthrogenesis	Acquired by Celegene, Jan 2003, $45M
Anvil Biosciences	Assets acquired 2017-2018
Anza Therapeutics	Closed Feb 2009, assets bought by Aduro Biotech
AorTech	Acquired RUA Medical, Mar 2020,, took name
Aortica	Acquired by Terumo, Nov 2019
AorTx	Acquired by Hansen Medical, Nov 2007, $4.5M
Apama Medical	Acquired by Boston Scientific, Oct 2017, $175M + $125 Milestones
ApaTech	Acquired by Baxter, Mar 2010, $330M
apceth	Acquired by Hitachi Chemical, Apr 2019
ApcinteX	Centessa Company
Apex Bioscience	Acquired by CuraCyte, fka Strohtech
Apexigen	Acquired by Pyxis Oncology, Aug 2023, $16M
Apica Cardiovascular	Acquired by Thoratec, Jul 2014
Apitope	Acquired by Worg Pharmaceuticals, Aug 2021
ApoCell	Acquired by Precision for Medicine, Jul 2019
Apogent	Acquired by Fisher, Aug 2004
Apollo Biopharmaceutics	Acquired by MitoKor, May 2001
Apollo Cytokine Research	Acquired by Symansis, Jun 2008
Apollo Endosurgery	Acquired by Boston Scientific, Apr 2023, $615M
Apoptos	Acquired by Receptos
APP Pharma	Bought by Fresenius Kabi, Jul 2008, $4.6B
Applied Biology	All assets purchased by Jupiter Wellness, Jun 2022
Applied BioMath	Acquired by Certara, Dec 2023
Applied Biosystems	Bought by Thermo Fisher, Jun 2008, $6.7B
Applied Immune Technologies	Bought by Adicet Bio, Jan 2016
Applied Immunology	Acquired by Precision for Medicine, May 2016
Applied Molecular Evolution	Bought by Eli Lilly, Feb 2004
Applied Proteomics	Assets bought by DiscernDx, Feb 2018, $1.85M
Applikon Biotechnology	Acquired by Getinge, Jan 2020
Aptalis	Acquired by Forest Labs, Jan 2014, $2.9B
Aptiv Solutions	Bought by ICON plc, May 2014
Apton Biosystems	Acquired by Pacific Biosciences, Sep 2023, $85M + $25M milestones
Aptuit	Bought by Evotec, Aug 2017, $300M
Aptus Endosystems	Acquired by Medtronic, Jul 2015, $110M
Aqua Pharmaceuticals	Acquired by Almirall, up to $400M
Aquapharm Biodiscovery	Acquired by Lallemand Dec 2013
Aquarius Biotechnologies	Acquired by Matinas Biopharma, Jan 2015
Aquatrove BioSciences	Bought by SASMAR, Aug 2016
AqueSys	Acquired by Allergan, Oct 2015, $300M
Aquila Biopharmaceuticals	Acquired by Antigenics, Aug 2000, $40M
Aquinox Pharmaceuticals	Acquired via Reverse Merger by Neoleukin Therapeutics Aug 2019; Stopped all RD Jul 2018
Aragon Pharmaceuticals	Bought by J&J, Jun 2013, $1B
Aran Biomedical	Acquired by Integer, Apr 2022; fka Proxy Biomedical
Arana Therapeutics	Acquired by Cephalon, Aug 2009
Aratinga Bio	Acquired by Ixaka, Jan 2021, $54M
Arbor Pharmaceuticals	Acquired by Azurity, Sep 2021
ARC Medical	Acquired by Typenex Medical
ARC Medical Design	Acquired by Olympus, Aug 2020
ARCA Biopharma	Acquired by Oruka Therapeutics, Aug 2024; Merged with Nuvelo, 2009
ArcherDx	Acquired by Invitae, Oct 2020, $1.4B; Spun out of Enzymatics after Qiagen acquired
Archimedes Pharma	Acquired by ProStakan, Jul 2014, $394M
Arcinova	Acquired by Quotient Sciences, Feb 2021
Ardea Biosciences	Bought by AstraZeneca, Jun 2012, $1.26B; Closed 2018
Ardian	Acquired by Medtronic, Nov 2010, $800M
Arena Pharmaceuticals	Acquired by Pfizer, Dec 2021, $6.7B
Argene	Acquired by bioMérieux, Jul 2011, $60M
Argenta Discovery	Bought by Charles River Labs, Mar 2014
Ariad Pharmaceuticals	Acquired by Takeda, Feb 2017, $5.2B
Aribex	Acquired by Danaher, Nov 2012
Ariosa Diagnostics	Bought by Roche, Dec 2014, $400M+$225M contingent
Arista Biologicals	Acquired by Fortis Life Sciences, Feb 2022
Aristos Pharmaceuticals	Owned by Cornerstone Therapeutics
Arius Pharmaceuticals	Acquired by BioDelivery Sciences, Aug 2004
Arixa Pharmaceuticals	Acquired by Pfizer, Oct 2020
Arkis Biosciences	Acquired by Integra LifeSciences, Jul 2019
ArmaGen	Acquired by JCR Pharmaceuticals, Apr 2020
ARMO BioSciences	Acquired by Lilly, Jul 2018, $1.6B
Armune Bioscience	Acquired by Exact Sciences, Dec 2017
Aronex Pharmaceuticals	Acquired by Antigenics, Apr 2001
Aros Applied Biotechnology	Acquired by eurofins
Arpida	Acquired by Evolva, Sep 2009
ArQule	Bought by Merck, Jan 2020, $2.7B
Arranta Bio	Acquired by Recipharm, Apr 2022
Array Biopharma	Bought by Pfizer, Jul 2019, $11.4B
Arrayon Biotechnology	Acquired by Endetec@Veolia, 2011
Arresto Biosciences	Bought by Gilead, Jan 2011, $225M
Arrevus	Acquired by Aceragen, Nov 2021
Arrow Therapeutics	Bought by AstraZeneca, Feb 2007
Arsanis Biosciences	Acquired by X4 Pharmaceuticals via reverse merger, Mar 2019
Arsia Therapeutics	Bought by Eagle Pharmaceuticals, Nov 2016, $30M + $48M milestones
Artedrone	Acquired by Affluent Medical, Feb 2026
Artegraft	Acquired by Lemaitre Vascular, Jun 2020, $72.5M
Arterys	Acquired by Tempus, Feb 2023, became Tempus Radiology
Arthrocare	Acquired by Smith & Nephew, May 2014
Arthrosurface	Acquired by Anika Therapeutics, Feb 2020, $100M
Artisan Pharma	Acquired by Asahi Kasei Pharma, Nov 2011
Artu Biologicals	Sold by Fornix Biosciences to ALK-Abello
Arvelle Therapeutics	Acquired by Angelini Pharma, Jan 2021
Asante Solutions	Assets acquired by Bigfoot Biomedical, May 2015
Ascendance Biotechnology	Acquired by BioIVT, Mar 2018
Ascent Development Services	Acquired by PharmaLex, Feb 2022
Ascyrus Medical	Bought by CryoLife Medical, Sep 2020
Asentral IRB	Acquired by Brany, Dec 2019
Ash Stevens	Acquired by Piramal, Aug 2016, $53M
Aspreva	Acquired by Vifor Pharma
Assurex Health	Acquired by Myriad Genetics, Sep 2016, $200M, renamed GeneSight
Asterand	Bought by Stemgent, Aug 2012, Some assets sold on to ReproCELL, then company renamed Asterand Bioscience
Asterand Bioscience	Bought by BioreclamationIVT, Aug 2017; Bought by Stemgent, Aug 2012
Asterias Biotherapeutics	Fully absorbed into BioTime Mar 2019; Technology acquired from Geron
Astero Bio	Acquired by BioLife Solutions, Apr 2019, $8M; Bought all assets of MedCision, May 2018
Asthmatx	Bought by Boston Scientific, Sep 2010, $194M + milestones
Astion Pharma	Products acquired by Cipher Pharmaceuticals, Feb 2015
ASTrego Diagnostics	Acquired by Sysmex, May 2022
Astria Therapeutics	Acquired by BioCryst, Jan 2026, $700M; fka Catabasis Pharmaceuticals
Astute Medical	Acquired by bioMérieux, Apr 2018, $90M
Asymptote	Acquired by GE Healthcare, Apr 2017
Ataxion Therapeutics	Bought by Clal Biotech, Mar 2017, became Luc Therapeutics
Athena Diagnostics	Acquired by Fisher Diagnostics, Mar 2006
Athena Neurosciences	Acquired by Elan, 1996
Atheromed	Acquired by Volcano, May 2014, $115M
Atlab Pharma	Bought by Telix Pharmaceuticals, Jan 2017
Atlanta Biologicals	Acquired by Bio-Techne, 2018
Atlantic Therapeutics	Acquired by Caldera Medical, Sep 2023
Atlas Chemical Industries	Acquired by ICI, 1972
ATMI - Life Sciences	Life Science business acquired by Pall, Feb 2014
Atoll	Acquired by Repligen, Apr 2016, $9.1M cash + stock
Atopix Therapeutics	Bought by Chiesi, 2016
Atreus Pharmaceuticals	Acquired by Advanced Accelerator Applications, Jan 2015
Atrin Pharmaceuticals	Acquired by Aprea Therapeutics, May 2022
Atrion Medical	Acquired by Nordson, Aug 2024
Atritech	Bought by Boston Scientific, Mar 2011, $100M + $275 milestones
ATS Medical	Bought by Medtronic, Apr 2010, $370M
Attenua	Acquired by CODA Biotherapeutics, Feb 2020
Attune Medical	Acquired by Haemontics, Mar 2024, $160M; fka Advanced Cooling Therapy
Atugen	Acquired by SR Pharma 2005
ATXCo	Acquired by Blade Therapeutics, Sep 2019
Audentes Therapeutics	Acquired by Astellas, Jan 2020, $3B
Augmenix	Acquired by Boston Scientific, Oct 2018, $500M + $100M milestones
Aurelia Bioscience	Acquired by Chernwood Molecular, Jun 2021
Aurex Laboratories	Acquired by APNAR Pharma, Jul 2022
Auris Health	Acquired by J&J, Apr 2019, $3.4B; fka Auris Surgical Robots
AurKa Pharma	Acquired by Lilly, May 2018
Aurora Biosciences	Acquired by Vertex Pharmaceuticals, 2001
Aushon Biosystems	Acquired by Quanterix, Jan 2018
Auspex Pharmaceuticals	Bought by Teva Mar 2015, $3.2B
Auxilium Pharmaceuticals	Acquired by Endo Oct 2014, $2.6B
Avalon	Acquired by Nordson Medical, Aug 2014
Avalon Pharmaceuticals	Bought by Clinical Data
Avanir Pharmaceuticals	Website down Jan 2023 - Mar 2023; Bought by Otsuka, Jan 2015, $3.5B
Avant Diagnostics	Assets acquired by OncBioMune, Jun 2020
Avecia	Bought by Nitto Denko
Avedro	Acquired by Glaukos, Nov 2019
Avema Pharma	Bought by PL Developments
Avenu Medical	Acquired by Medtronic, Oct 2020
Averitas Pharma	Acquired by Grunenthal Nov 2018
Aves Labs	Now part of Antibodies Inc
Aveva Drug Delivery Systems	Acquired by DifGen Pharmaceuticals, Apr 2023; Acquired by Apotex, Mar 2012
AveXis	Acquired by Novartis, Apr 2018, $8.7B
Avia Biosystems	Acquired by Unchained Labs, Jun 2015
Avid Radiopharmaceuticals	Bought by Lilly, Nov 2010, $800M
Avida Biomed	Acquired by Agilent, Jan 2023
Avidea Technologies	Acquired by Vaccitech, Dec 2021
Avidex	Bought by MediGene, Aug 2006, $62.4M
Avidia	Bought by Amgen 2006, Sep 2006, $380M
Avigen	Bought by Medicinova, Dec 2009, $37M
Avila Therapeutics	Bought by Celgene, Jan 2012, $350M
Aviragen Therapeutics	Acquired by reverse merger by Vaxart, Jan 2018; fka Biota Pharmaceuticals
Aviron	Acquired by Medimmune, Dec 2001, $1.5B
Avista Pharma Solutions	Bought by Cambrex, Jan 2019, $252M; Formed from the CMC business of Array BioPharma and contract services business of Scynexis
Avitus Orthopaedics	Acquired by Zimmer Biomet, Mar 2025
Avizorex Pharma	Acquired by Aerie Pharmaceuticals, Nov 2019; aka AVX Pharma
Avolynt	Acquired by AstraZeneca, Mar 2024, $1.05B; fka BHV Pharma
Avomeen	Acquired by Element, Mar 2021
Avrio Biopharma	Company was consolidated into Irvine Pharmaceutical Services
Axcellerate Pharma	Acquired by Generic Specialties, May 2016
Axela	Acquired by Angle plc, Oct 2017, $6M
Axenis	Acquired by genOway, Sep 2018
Axio Research	Acquired by Cytel, Jun 2019
Axiom Real-Time Metrics	Acquired by Sitero, Jul 2025
AxioMx	Acquired by Abcam, Nov 2015, $20M + $25 milestones
Axis-Shield	Acquired by Alere, Aug 2011
Axonics	Acquired by Boston Scientific, Nov 2024, $3.7B
Axsun	Acquired by Excelitas Technologies Jan 2019; Spun back out by Philips, Oct 2015; Acquired by Volcano Jan 2009
Axys Pharmaceuticals	Acquired by Celera, Nov 2001, $174M
Azanta	Acquired by Norgine, Mar 2020
Azur Pharma	Acquired by Jazz Pharmaceuticals, Sep 2011
B.R.A.H.M.S.	Acquired by Thermo Fisher, Sep 2009, €330M
Bacchus Vascular	Bought by Covidien, Jun 2009, undisclosed terms
Baccinex	Acquired by Adragos Pharma, Nov 2024
Baergic Bio	Acquired by Avenue Therapeutics, Nov 2022
Bako Diagnostics	Acquired by Fulgent Genetics, Mar 2026
Baliopharm AG	Acquired by Promethera Biosciences, Apr 2018
Baliopharm GmbH	Bought by Alvotech, May 2016
Bamboo Therapeutics	Bought by Pfizer, Jul 2016, $150M + milestones
Banner Life Sciences	Acquired by Cycle Pharma, Jan 2025
Banner Pharmacaps	Acquired by Patheon, Dec 2012, Renamed Banner Life Sciences
Bardy Diagnostics	Acquired by Hillrom, Sep 2021
Barofold	Assets Acquired by Pressure Biosciences, Dec 2017
Barr Pharmaceuticals	Acquired by Teva, Jul 2008, $7.46B
Barrier Therapeutics	Bought by Stiefel
Barrx Medical	Acquired by Covidien, Nov 2011, $325M
Base Genomics	Acquired by Exact Sciences, Oct 2020
BaseHealth	Acquired by Genalyte, Apr 2020
Bausch & Lomb	Acquired by Valeant, rebranded as Bausch Health
Baxa	Acquired by Baxter, Nov 2011, $380M
Baxalta	Bought by Shire, $32B, Jun 2016
Bay Bioanalytical	Acquired by Pacific BioLabs
Bayhill Therapeutics	Wound Down and Assets acquired by new-incarnation of Tolerion
Baylis Medical	Acquired by Boston Scientific, Feb 2022, $1.75B
Baylis Medical	Acquired by Boston Scientific, Feb 2022, $1.75B
Bayon Therapeutics	Acquired by EyeGate Pharmaceuticals, Oct 2021
Bazell Pharma	Acquired by Amzell, Mar 2021
BC Technical	Acquired by AlphaSource, Nov 2017
Beacon Discovery Inc	Acquired by Eurofins Scientfiic, Feb 2021; Spun out of Arena Pharmaceuticals, Sep 2016
Beardsworth	Bought by TFS International 2013
Beckley Canopy Therapeutics	Acquired by Canopy Growth, Oct 2019
Beckman Coulter Genomics	Bought by Genewiz, Dec 2015
Belkin Vision	Acquired by Alcon, Jul 2024, $81M
Bellus Health	Acquired by GSK, Jun 2023, $2B
Bellwether Bio	Acquired by Guardant Health, Apr 2019, $10M + $20M milestones
Benchmark Biolabs	Parent acquired by Huvepharma, Jan 2018
Benchmark Research	Acquired by IQVIA
Benchmark Research	Acquired by IQVIA
Benchmark Research	Acquired by IQVIA
Benchmark Research	Acquired by IQVIA
Benchmark Research	Acquired by IQVIA
Benchmark Research	Acquired by IQVIA
Bend Research	Acquired by Capsugel, Sep 2013
BeneChill	Assets purchase by BrainCool, Oct 2016
BeneVir Biopharm	Acquired by J&J, May 2018, $140M + $900M milestones
BennuBio	Acquired by Precision CellSystems, Nov 2025
Benten BioServices	Acquired by Deltagen, Dec 2009
Bentley Pharmaceuticals	Bought by Teva, Mar 2008, $360M
Benvenue Medical	Assets acquired by Spinal Elements, Dec 2020
Beogenomics	Acquired by APIS Assay Technologies, Sep 2020
Berg	Acquired, Jan 2023
Berkshire Sterile Manufacturing	Acquired by Sharp, Oct 2023
Berry Oncology	Website down Feb 2025 - Jun 2025
Bertek	Acquired by Mylan, Apr 1993, $39M
Beryllium	Acquired by UCB Pharma, Jun 2017
BetaLogics	Absorbed by ViaCyte, Feb 2016
Bethyl Laboratories	Acquired by Fortis Life Sciences, Mar 2021
Bexel Pharmaceuticals	Bought by Orchid Pharma, Aug 2006, $3M
BHV Pharma	Acquired by Avolynt, Mar 2016
Biacore	Acquired by GE, Jun 2006, $390M
Bigfoot Biomedical	Acquired by Abbott, Sep 2023
Bikam	Acquired by Shire, Aug 2015, $92M
Bina Technologies	Acquired by Roche, Dec 2014
Binax	Acquired by Alere, Feb 2005, $9M
Bio Elpida	Acquired by Sartorius, Dec 2022
Bio Processing	Bought by Bio-rad
Bio-Concept Laboratories	Acquired by Pace Analytical, Dec 2020
BioAnalytix	Acquired by Protagen Protein Services, Apr 2019
BioArra	Bought by VWR Nov 2016
BioAxoneTherapeutic	Founded 2000, all assets acquired by BioAxone Biosciences
Biobase	Bought by Qiagen, May 2014
BioBehavioral Diagnostics Company	Assets acquired by Pearson, Aug 2013
Bioceros	Bought by Epirus Biopharmaceuticals, Sep 2015, $14M
Biochrom GmbH	Bought by Millipore, Nov 2012
BioCision	Acquired by Brooks, Nov 2016
BioDelivery Sciences International	Acquired by Collegium Pharmaceuticals, Mar 2022, $604M
Biodiscovery	Acquired by Bionano Genomics, Oct 2021
Bioelectron	Assets bought by PTC Therapeutics; fka Edison Pharmaceuticals
BioElectron Technology	Assets Acquired by PTC Therapeutics, Oct 2019
Bioenvision	Acquired by Genzyme, Oct 2007, $345M
Biofocus	Bought by Charles River Labs, Mar 2014, $179M
Biogazelle	Acquired by CellCarta, Dec 2021
BioHelix	Acquired by Quidel, $10+milestones, May 2013
Bioinduction	Acquired by Amber Tx, Sep 2023
Bioject	Assets acquired by Inovio, Mar 2016, $5.5M
Biolipox	Bought by Orexo, €94M, Oct 2007
Biological Industries	Acquired by Sartorius, Dec 2019, $50M
Biologics Process Development	Acquired by ViroPro, 2010
BioLogo	Acquired by Nordic MUbio, Mar 2018
Biomage	Acquired by Parse Biosciences, Jan 2024
Biomatrica	Acquired by Exact Sciences, Oct 2018
Biomax Informatics	Acquired by Labvantage
BioMedical Enterprises	Bought by DePuy Synthes, May 2016
Biomedical Systems	Acquired by ERT, Sep 2017
Biomediq	Acquired by ScreenPoint Medical, Jan 2025
Biomet	Bought by Zimmer, Apr 2014, $13.4B - combined company renamed Zimmer Biomet
Biomeva Manufacturing	Acquired by Asahi Glass, Nov 2016; Now part of AGC Biologics
BioMimetic	Acquired by Wright Medical, Mar 2013, $190M cash + $190M milestones
Biomimetic Therapeutics	Acquired by Wright Medical group Apr 2013
Bion Enterprises	Acquired by MBL International, 2008
Bioness	Acquired by Bioventus, Mar 2021, $45M + $65M milestones
Bioniche Pharma	Acquired by Mylan, Sep 2010, $550M
Bionix Implants	Bought by CONMED, Mar 2003
Bioniz Therapeutics	Acquired by Equillium, Feb 2022, $329M
Bionomics	Renamed Neuphoria Therapeutics, Dec 2024
Bionor Pharma	No news 2019 - Jan 2026; Acquired by Immunor, Dec 2017
Bionostics	Bought by Techne, Jun 2013 $104M
BioNovion	Bought by Aduro Biotech, Sep 2015, $32.5M
BionX Medical	Acquired by Ottobock
Bioo Scientific	Acquired by Perkin Elmer, Aug 2016
BioPharma Global	Acquired by Pace Life Sciences, Sep 2022
BioPharmX	Acquired via Reverse Merger by Timber Pharmaceuticals, May 2020
BioProcess Technology Consultants	Acquired by BDO USA, Apr 2019
Bioprocessing Inc.	Bought by Bio-Rad
Biopta	Acquired by ReproCELL, combined with Reinnervate to become ReproCELL Europe, Jul 2016
Biopure	Assets bought by OPK Biotech, Aug 2009
BioReliance	Bought by Sigma-Aldrich, Jan 2012, $350M
BioRelix	Acquired by Pfizer, Sep 2005
BioRexis	Acquired by Pfizer, Feb 2007
Biorez	Acquired by CONMED, Aug 2022; fka Soft Tissue Regeneration
BioScreen Testing Services	Acquired by ALS Group USA, Feb 2019
Bioseek	Bought by Asterand Nov 2009, Sold to DiscoveRx Nov 2012
Bioserve	Acquired by ReproCell, 2014
BioSolutia	Acquired by CareMetx, Oct 2018
BioStable	Acquired by Corcym, Apr 2023
BioStorage Technologies	Acquired by Brooks Life Sciences, Nov 2015
Biostrand	Acquired by ImmunoPrecise, Apr 2022, €20M
BioSyntech	Bought by Piramal
BioTechLogic	Acquired by Dark Horse Consulting, Oct 2024
Biotectix	Acquired by Heraeus Medical Components, Aug 2017
Biotek	Acquired by Agilent, Aug 2019
Biotel	Acquired by CardioNet, 2010
BioTelemetry	Acquired by Philips, Feb 2021; fka CardioNet
Biotest Labs	Acquired by/Merged with Steris
Biotez	Acquired by BBI Solutions, Jan 2022
Biothera Pharmaceuticals	Acquired by Hibercell, Jul 2020
bioTheranostics	Acquired by Hologic, Feb 2021, $230M; bought by bioMérieux 2008, spun out again Jan 2016
Biotheus	Acquired by BioNTech, Feb 2025
Biotie Therapies	Bought by Acorda Therapeutics, Jan 2016, $363M
Biotrace Medical	Acquired by Merit Medical, Oct 2022
Biotronic	Bought by NuVasive, Jul 2016, $98M
BioTrove	Acquired by Life Technologies, Dec 2009
Bioverativ	Acquired by Sanofi, Jan 2018, $11.6B; Biogen's spinout hemophilia group
Biovertis	Acquired by Deinove, May 2018
BioVex	Bought by Amgen, Jan 2011, $425M + $575M milestones
BioVision	Acquired by Abcam, Oct 2021, $340M
Bioxalis	Bought by Procyon Biopharma, Jun 2005, $3.5M
BioXell	Acquired by Cosmo Pharmaceuticals, Nov 2009
Bipar Sciences	Bought by Sanofi-Aventis, Apr 2009, $500M
Bird Rock Bio	Acquired by Skye Bioscience, Aug 2023
BISC Global	Acquired by Excelra, Apr 2023
Biscayne Neurotherapeutics	Acquired by Supernus, Oct 2018, $15M + $168M milestones
Bitome	Acquired by Ginkgo Bioworks, Jun 2022
BK Ultrasound	Acquired by GE Healthcare, 2021, $1.45B
BlackThorn Therapeutics	Acquired by Neumora, Oct 2021
BLIRT	Acquired by Qiagen, May 2022
Blockade Medical	Acquired by BALT, Sep 2016
Blu Pharmaceuticals	Acquired by PuraCap, Mar 2016
Blue Heron Biotech	Acquired by eurofins, Aug 2019; Bought by OriGene Aug 2010
Blue Sky Bioservices	Acquired by LakePharm Mar 2016
Blue Stream Laboratories	Acquired by Charles River, Jun 2016
Blue Stream Labs	Acquired by Charles River Labs, Jun 2016
BlueJay Therapeutics	Acquired by Mirum Pharmaceuticals, Jan 2026
BlueReg	Acquired by Pharmalex, Nov 2022
Blueshift Biotechnologies	Acquired by MDS Analytical, Jun 2008, $13M
BN-ImmunoTherapeutics	Absorbed into Bavarian Nordic, 2010?
Boca Pharmacal	Bought by Qualitest
Boehringer Ingelheim Vetmedica	Acquired by Elanco, Oct 2016, $885M
Boehringer Mannheim	Bought by Roche, May 1997, $11B
Bolder Surgical	Acquired by Hologic, Nov 2021, $160M
Bolt Medical	Acquired by Boston Scientific, Apr 2025, $664M
Bonti	Bought by Allergan, Sep 2018, $195M
Boost Neuroscience	Acquired by Gate Neurosciences, Feb 2025
Boston Biochem	Acquired by Techne, Apr 2011
Boston Biomedical	Renamed Sumitomo Dainippon Pharma Oncology, Jun 2020; Bought by Dainippon Sumitomo Pharma, Feb 2012, $200M plus milestones up to $2.4B
Boston Genetics	Acquired by Genomenon, Jun 2023
Boulder Diagnostics	Assets purchased by Oxford Immunotec, Aug 2014
Brabant Pharma	Acquired by Zogenix, Oct 2014, $20M cash, $15M stock
Brainbits	Acquired by Transnetyx, Feb 2021
Brains On-Line	Acquired by Charles River, Aug 2017
Braintree Labs	Bought by Sebela Pharmaceuticals, May 2018
Brainvectis	Acquired by AskBio, Apr 2020
Brammer Bio	Bought by Thermo Fisher, May 2019, $1.7B
Brandwood Biomedical	Acquired by PharmaLex
Breath Therapeutics	Bought by Zambon, Jul 2019, $160M + $405 Milestones
Breathe Technologies	Acquired by Hillrom, Aug 2019, $130M
Brecon Pharmaceutical	Acquired by AmerisourceBergen Mar 2006 $28M, Merged with Anderson Packaging Jun 2012, Acquired by Frazier Apr 2013 and merged with Packaging Coordinators Inc. (Frazier)
Breethe	Acquired by Abiomed, Apr 2020
BRI Biopharmaceutical Research	Acquired by Frontage, Dec 2019
BrickBuilt Therapeutics	Acquired by DermBiont
Bridge Design	Acquired by Ximedica, Aug 2015
Bridgehead International	Bought by Gfk, Mar 2012
BrightWater Medical	Acquired by Merit Medical, Sep 2019, $50M
Brivant Medical Engineering	Bought by Lake Region Medical, Aug 2009
Brogan Pharma	Acquired by IMS Health, 2010
BSN Medical	Acquired by Essity, Apr 2017
BTG plc	Acquired by Boston Scientific, Aug 2019, $4.3B
BTG Specialty Pharmaceuticals	Acquired by SERB, Mar 2021
C.R. Bard	Acquired by BD, Dec 2017, $24B
C1 Consulting	Acquired by Charles River, Jan 2017
C2 Therapeutics	Acquired by Pentax Medical, Jan 2017
C2i Genomics	Acquired by Veracyte, Feb 2024, $70M +$25M milestones
C3 Research Associates	Acquired by Avance Clinical, Sep 2022
Cabrellis Pharmaceuticals	Acquired by Pharmion, Nov 2006
Cadence Pharmaceuticals	Acquired by Mallinckrodt, Mar 2014, $1.4B
Cadent Therapeutics	Acquired by Novartis, Dec 2020, $210M + $560M milestones; fka Luc Therapeutics
Caelum Biosciences	Acquired by AstraZeneca, Sep 2021, $150M + $350M milestones
Calibra Medical	Acquired by JNJ 2012
California Peptide Research	Acquired by Echelon Biosciences, Apr 2014
California Stem Cell	Bought by NeoStem, renamed NeoStem Oncology May 2014
CALiMMUNE	Acquired by CSL Behring, Aug 2017
Caliper Life Sciences	Bought by Perkin Elmer, Sep 2011, $600M
Calistoga Pharmaceuticals	Bought by Gilead, Feb 2011, $375M + $125Milestones
Calixa Therapeutics	Acquired by Cubist, Dec 2009, $92.5M + $310 milestones
CallistoGen	Assets acquired by The Genetics Company, Mar 2003
Calporta Therapeutics	Acquired by Merck, Nov 2019, $576M
Calvert Laboratories	Acquired by Altasciences, May 2021
Calydon	Acquired by Cell Genesys Aug 2001, $17.4M stock
Calypso Biotech	Acquired by Novartis, Jan 2024, $250M; Spun out of Merck-Serono
Calypso Medical Technologies	Acquired by Varian Medical Systems, Sep 2011, $10M
Camargo Pharmaceutical Services	Acquired by Premier Research, May 2021
Cambridge Biomedical	Acquired by Bioagilytix, Nov 2019
Cambridge Biotechnology	Acquired by Biovitrum, Mar 2005
Cambridge Cancer Genomics	Acquired by Dante Labs, Oct 2021
Cambridge Research Biochemicals	Acquired by Biosynth, May 2023
Cancer Prevention Pharmaceuticals	Acquired by Panbela Therapeutics, Jun 2022
Cancervax	Acquired by Micromet, May 2006
Cangene	Acquired by Emergent Biosolutions, Dec 2013, $222M
Canopy Biosciences	Acquired by Bruker, Sep 2020
CAPP Medical	Acquired by Roche, Apr 2015
caprotec bioanalytics	Company or Technology Acquired by Charles River
Capstan Therapeutics	Acquired by AbbVie, Aug 2025
Capsugel	Bought by Lonza, Dec 2016, $5.5B
Captozyme	Acquired by Arrant Bio, Nov 2019
Capua BioServices	Acquired by Olon, Jan 2019
Cara Therapeutics	Acquired by Tvardi, Apr 2025
Caraco Pharmaceutical Labs	Bought by Sun Pharma
Caranx Medical	Acquired by Affluent Medical, Feb 2026
Caraway Therapeutics	Acquired by Merck, Nov 2023, $610M; fka Rheostat Therapeutics
Cardea Bio	Acquired by Paragraf, May 2023; fka Nanomedical Diagnostics
Cardiac Science	Acquired by Zoll, Aug 2019
CardiAQ Valve Technologies	Acquired by Edwards Life Sciences, Jul 2015, $350M + $50M milestones
Cardiogen Sciences	Acquired by Audentes Therapeutics, Sep 2015
Cardioinsight Technologies	Acquired by Medtronic, Jul 2015
Cardiokine	Acquired by Cornerstone Therapeutics 2011
CardioLabs	Acquired by AliveCor, Jun 2021
Cardiome Pharma	Acquired Correvio, took name years later
CardioMEMS	Acquired by St. Jude Medical, Jun 2015, $455M
CardioPep Pharma	Acquired by and converted to Cardiorentis
CardioProlific	Bought by Philips, Jun 2017
Cardiovalve	Acquired by Venus Medtech, Dec 2021
Cardiovascular Systems Inc	Acquired by Abbott, Apr 2023, $890M
Cardioxyl Therapeutics	Bought by BMS, Nov 2015, $300M
Cardiva Medical	Acquired by Haemonetics, Jan 2021, $510M
Carefusion	Bought by BD, Mar 2015, $12.2B; Spun out of Cardinal Health Sep 2009
CARGO Therapeutics	Acquired by Concentra Biosciences, Aug 2025
Carmel Biosciences	Acquired by Nutriband, Sep 2018, $2.7M
Carmenta Bio	Acquired by Progenity, Apr 2015
Carmot Therapeutics	Acquired by Roche, Jan 2024, $2.7B + $400M milestones
Cartana	Bought by 10X Genomics, Oct 2020
CartiHeal	Acquired by Smith + Nephew, Jan 2024; Acquired by Bioventus, Jul 2022, $315M+
Cartiva	Acquired by Stryker as part of Wirght Medical, Nov 2019
Cascade Chemistry	Acquired by Aceto, Jun 2021
Cascadian Therapeutics	Bought by Seattle Genetics, Feb 2018, $614m stock
Catalytica Pharmaceuticals	Acquired by DSM
Catherex	Spun out of Medigene, sold to Amgen, Dec 2015, $10.5M
CATLab - Accredited Calibration Laboratories	Acquired by Trescal, Jan 2022
Cavion	Acquired by Jazz Pharmaceuticals, Aug 2019, $52.5M + $260M milestones; Formed out of Merger of Tau Therapeutics & Xdynia, Aug 2014
cCAM Biotherapeutics	Acquired by Merck, Aug 2015, $605M
CDD	Acquired by Biofocus, Jun 2001
Cedarburg Hauser Pharmaceuticals	Acquired by AMRI, Mar 2014
Cedilla Therapeutics	Shut down May 2023
CeeTox	Acquired by Cyprotex, Jan 2014
Ceiba Solutions	Bought by Perkin-Elmer, Mar 2015
Celares	Acquired by Biosynth, Jul 2023
Celator Pharmaceuticals	Bought by Jazz Pharmaceuticals, Jul 2016, $1.5B
Celenex	Bought by Amicus Therapeutics, Sep 2018, $100M
Celera	Acquired by Quest Diagnostics, Mar 2011, $671M
Celgene	Bought by BMS, Nov 2019, $74B
Celixir	Shell acquired Dec 2023
Cell Culture Service	Acquired by Evotec, Jan 2013
Cell Design Labs	Acquired by Gilead, Dec 2017, up to $567M
Cell IDx	Acquired by Leica Biosystems, Nov 2022
Cell Matrix	Acquired by Cancervax
Cell Pathways	Acquired by OSI Pharmaceuticals, Feb 2003, $32M
Cell Targeting Inc	Bought by Biotime
CellAct Pharma	Tech acquired by Mundipharma, 2017
Cellartis	Acquired by Takara Bio Jul 2014
CellASIC	Bought by Millipore, May 2012
Cellective Therapeutics	Acquired by MedImmune 2005, Up to $175M
Cellegy Pharmaceuticals	Acquired by Adamis, Feb 2008
Celleration	Acquired by Alliqua Biomedical, Jun 2015, $30.4M
Cellerix	Acquired by TiGenix Mar 2011
Cellero	Acquired by Charles River, Aug 2020, $38M; fka Astarte Biologics; Merged with Key Biologics, Aug 2018
Cellesce	Website down Apr 2025 - Jul 2025; Acquired by Molecular Devices, Jul 2023
Cellestis	Acquired by Qiagen Aug 2011
CellforCure	Acquired by Novartis, Feb 2019
Cellgate	Acquired by ProGen, Feb 2008, $2.5M
CellGenix	Sartorius acquired majority stake, Jul 2021
Cellomics	Acquired by Fisher Scientific, Aug 2005, $49M
CELLphenomics	Acquired by GSK, Feb 2025
CellPoint	Acquired by Galapagos, Jun 2022, €125M + €100M milestones
CellRight Technologies	Acquired by Tissue Regnix, Aug 2017
Celltech	Acquired by UCB, May 2004, $2.7B
Cellular Dynamics	Bought by Fujifilm, Mar 2015, $307M
Cellular Research	Acquired by BD, Aug 2015
Cellumen	Acquired by Apredica, Aug 2010, £2.7M
CellzDirect	Acquired by Life Technologies, Jan 2008
Cellzome	Acquired by GSK Mar 2012
Celmatix	Portfolio acquired by Gedeon Richter, Mar 2026
Celmed BioSciences	Acquired by Kiadis Pharma, Dec 2006
Celsee Diagnostics	Acquired by Bio-Rad, Apr 2020
Celsius Therapeutics	Acquired by AbbVie, Jun 2024, $250M; fka Cellular Ecosystems Therapeutics
Celtrix Pharmaceuticals	Acquired by Insmed in reverse merger, May 2000
Celula	Acquired by NeoSeq
Cenetron Diagnostics	Acquired by Versiti Blood Center, Jul 2019
Censa Pharmaceuticals	Acquired by PTC Therapeutics, Jun 2020
Center for Breakthrough Medicines	Acquired by SK Pharmteco, Sep 2023
CenterVue	Merged into iCare, Apr 2020
Cephalogics	Assets acquired by Invisio Medical, Feb 2018
Cephalon	Acquired by Teva, Oct 2011, $6.8B
Cephea Valve Technologies	Acquired by Abbott, Jan 2019
Ceptaris Therapeutics	Bought by Actelion, Sep 2013, $250M
Ception	Bought by Cephalon, Jan 2009, $250M
Ception Therapeutics	Acquired by Cephalon, 2010
Cerebrus CNS Drug Discovery	Acquired by Vernalis
Ceregene	Acquired by Sangamo, Aug 2013
Cereius	Acquired by Solve Therapeutics, Jun 2023
Cerep	Acquired by eurofins, Dec 2012
Cerevel Therapeutics	Acquired by AbbVie, Aug 2024, $8.7B; Went public via SPACquisition Oct 2020
Cerexa	Acquired by Forest Labs Dec 2006
Cergentis	Acquired by Solvias, Jul 2022
Cerilliant	Acquired by Millipore, Dec 2010
Cernostics	Acquired by Castle Bioscience, Dec 2021, up to $30M + $50M Milestones
Ceros Pharmaceuticals	Acquired by Auxeris Therapeutics, Jan 2004
CerSci Therapeutics	Acquired by Acadia Pharmaceutical, Aug 2020, $52.5M stock
Cerulean Pharma	Bought by Dare Bioscience, Mar 2017
Cerus Endovascular	Acquired by Stryker, May 2023
Cerus Endovascular	Acquired by Stryker, May 2023
Cerveau Technologies	Acquired by Lantheus, Feb 2023
Ceterix Orthopaedics	Acquired by Smith & Nephew, Jan 2019, $50M + $55M Milestones
CEVEC Pharmaceuticals	Acquired by Cytiva, Oct 2022
CGI Pharmaceuticals	Bought by Gilead 2010
Chamow & Associates	Acquired by Alira Health, Jan 2021
ChanTest	Acquired by Charles River, Oct 2014, $52M + $2M milestones
Chase Pharmaceuticals	Acquired by Allergan, Nov 2016, $125M
Chatham Therapeutics	Acquired by Baxter, Apr 2014, $70M+
Chattem	Bought by Sanofi, Dec 2009, $1.9B
Checkmate Pharmaceuticals	Acquired by Regeneron, May 2022, $250M
Checkpoint Therapeutics	Acquired by Sun Pharma, May 2025
Cheetah Medical	Bought by Baxter, Oct 2019, $190M + $40 Milestones
Chelsea Therapeutics	Acquired by Lundbeck, Jun 2014, up to $658M
Chem-Tech	Bought by Neogen, Jan 2014
ChemAxon	Acquired by Certara, Oct 2024
ChemGen	Bought by Elanco (Lilly) Jan 2012
ChemGenex	Bought by Cephalon Mar 2011
Chemgenics Pharmaceuticals	Acquired by Millennium Pharmaceuticals, Feb 1997, $89M
Chemic Laboratories	Acquired by Solvias, Jun 2021
Chemir Analytical Services	Acquired by EAG, 2011
ChemoCentryx	Acquired by Amgen, $3.7B, Oct 2022
Cherokee Pharmaceuticals	Bought by Merck Aug 2010?
Chester Valley Pharmaceuticals	Bought by Graceway
Chiasma Pharma	Acquired by Amryt Pharma, Aug 2021
Chicago Research Center	Acquired by IMA Group, Oct 2025
Chikujee Therapeutics	Acquired by Investors, Website Gone, CEO gone Aug 2016
Chiltern	Acquired by LabCorp, $1.2B, Jul 2017
Chimagen Biosciences	Lead program acquired by GSK, Oct 2024. No info prior to then
Chimerix	Acquired by Jazz Pharmaceuticals, Apr 2025
Chinook Therapeutics	Acquired by Novartis, Aug 2023, $3.2B; Acquired Aduro Biotech, Oct 2020, for ticker
Chinook Therapeutics	Acquired by Novartis, Aug 2023, $3.2B; Acquired Aduro Biotech, Oct 2020, for ticker
Chiron	Bought by Novartis
Chiron Behring Vaccines	Bought by Bharat Biotech, Feb 2019
Chord Therapeutics	Acquired by Merck KgAA, Dec 2021
ChromoTek	Acquired by Proteintech, Oct 2020
Chronos Therapeutics	Acquired by Evgen, Mar 2024
Cianna Medical	Acquired by Merit Medical, Nov 2018, $200M
Ciba Vision	Bought by Alcon, bought by Novartis
Ciclofilin Pharmaceuticals	Acquired by ContraVir, Jun 2016, $17M + stock
Cidara Therapeutics	Acquired by Merck, Jan 2026, $9.2B; Formerly K2 Therapeutics. Relocated from Boston to San Diego
Ciel Medical	Acquired by Vyaire Medical, Apr 2017
CIMA Labs	Acquired by Teva, May 2011
CIMEX Pharma	Acquired by Acino, 2004
CinCor Pharma	Acquired by AstraZeneca, Feb 2023
Cinfa Biotech	Acquired by Mundipharma, Oct 2018
Circe Biomedical	Acquired by ICN Pharmaceuticals, Oct 2002
Circularis	Acquired by Ginkgo Bioworks, Oct 2022
CircuLite	Bought by HeartWare, Dec 2013, $30M+$320Milestones
Circulomics	Acquired by Pacific Biosciences, Aug 2021
Cirrus Bio	Acquired by Maverix Medical, Mar 2024
Cirrus Pharmaceuticals	Acquired by Kemwell, Jul 2013
Cisbio	Acquired by PerkinElmer, Apr 2019
Cistron Biotechnology	Acquired by Celltech Group, Nov 2000
CiToxLAB	Acquired by Charles River, Apr 2019, €448M
CITrials	Acquired by Cenexel Clinical Research, Mar 2021
Citron Pharma	Assets acquired by Rising Pharmaceuticals, Dec 2016
CiVentiChem	Acquired by Sterling Pharma
Civitas Therapeutics	Acquired by Acorda, Sep 2014, $525M. Formerly an Alkermes spinout.
Clade Therapeutics	Acquired by Century Therapeutics, Apr 2024
Clairvoyant Therapeutics	Acquired by Psyence, Sep 2024
Claret Medical	Acquired by Boston Scientific, Jul 2018, $220M + milestone
Clarient	Acquired from GE Healthcare by NeoGenomics, Oct 2015, $265M
Claris Lifesciences	Bought by Baxter, Jul 2017
Claritas Pharmaceuticals	Website down Jul 2022 - Mar 2023; fka Kalytera; Acquiring Salzman Group Feb 2021
Claros Diagnostics	Acquired by Opko Health, Oct 2011
CLCbio	Acquired by Qiagen, 2013
Clear Genetics	Being Acquired by Invitae, Nov 2019, $50M
Clementia Pharmaceuticals	Bought by Ipsen, Apr 2019, $1.31B
Cleveland Biolabs	Acquired by Cytocom via Reverse Merger, Oct 2020
ClinArt MENA	Acquired by CTI Facts, Sep 2020
Clinical Data	Bought by Forest Labs Feb 2011
Clinical Network Services (Cns)	Acquired by Novotech
Clinical Research Advantage	Bought by Radiant Research, Nov 2012
Clinical Research Laboratories	Acquired by eurofins, Sep 2018
Clinical Trial Center North (CTC North & KG)	Acquired by Agenus, Feb 2022
ClinicalRM	Acquired by Icon plc, Sep 2016; aka Clinical Resource Management
Clinimetrics	Acquired by Omnicare Dec 2004; Now Theorem Clinical Research
Clinlogix	Bought by NAMSA, Aug 2021
Clintec	Acquired by IQVIA, Dec 2018
Clintrax Global	Acquired by WCG, Mar 2016
Co-Formulate	Acquired by Quotient Clinical, Feb 2017
Coastal Genomics	Acquired by Yourgene, Aug 2020, up to $5.5M + $8M milestones
Cobra Biologics	Bought by Cognate BioServices, Nov 2019
Codman Neurosurgery	Bought by Integra Life Sciences, Oct 2017, $1.045B
Cody Laboratories	Bought by Lannett, 2007
Coefficient Bio	Acquired by Anthropic, Apr 2026, $400M
Cogentix Medical	Acquired by Laborie, Apr 2018
Cognate Bioservices	Acquired by Charles River, Mar 2021; $875M
Cognis Corp	Acquired by BASF 2010
Coherex Medical	Acquired by Biosense Webster, Nov 2015
Coldstream Laboratories	Bought by Piramal
Coley Pharma	Acquired by Pfizer
Collagen Solutions	Acquired by RTI Surgical , Nov 2024
CollaGenex	Acquired by Galderma, Feb 2008, $420M
Collateral Therapeutics	Acquired by Schering, Mar 2002, $140M stock
CoLucid Pharmaceuticals	Acquired by Lilly, Jan 2017, $960M
Combangio	Acquired by Kala Pharmaceuticals, Nov 2021
CombiMatrix	Acquired by Invitae, Nov 2017
Combinati	Acquired by Thermo Fisher, Oct 2021
Comet Therapeutics	Acquired by VectIvBio, Aug 2021
Companion Medical	Acquired by Medtronic, Aug 2020
Compendia Bioscience	Acquired by Life Technologies, Oct 2012
Complement Pharma	Acquired by Graviton Bioscience, Dec 2022
Comprehend Systems	Acquired by Saama Technologies, Aug 2019
Conatus Pharmaceuticals	Acquired by Histogen via Reverse Merger, Jun 2020
Concentric Medical	Acquired by Stryker, Oct 2011
Concept Inc	Bought by BMS, 1990; sold to CONMED Dec 1997
Conceptus	Bought by Bayer Apr 2013
Concert Pharmaceuticals	Acquired by Sun Pharma, Mar 2023
Concord Biosciences	Acquired by Frontage Labs, Apr 2018
Concortis Biosystems	Acquired by Sorrento Therapeutics, Dec 2013
Conexio Genomics	Acquired by Illumina, Jan 2016
Confab Laboratories	Bought by Mylan, Jun 2016
Confluence Life Sciences	Acquired by Aclaris Therapeutics, Aug 2017, $10M cash + $10M shares
Conforma Therapeutics	Acquired by Biogen Idec, May 2006, $150M stock + $00M Milestones
Conformis
Conor Medsystems	Acquired by Johnson & Johnson, Nov 2006, $1.4B
Consort Medical	Acquired by Recipharm, Apr 2020
Constellation Pharmaceuticals	Acquired by MorphpSys, Jul 2021
Contura	Acquired by Axonics, Feb 2021, $200M
Conventus Orthopaedics	Acquired Flower Orthopedics, May 2020, took name
Convergence Pharmaceuticals	Bought by Biogen Idec, Jan 2015, $200M +$475 Milestones
Cook Biotech	Acquired by RTI Surgical, Feb 2024
Cook Pharmica	Bought by Catalent, Oct 2017
CoreLab Partners	Bought by JLL then merged with Bioclinica, 2013
CorePharma (1)	Acquired by Impax Laboratories, Mar 2015
Corevalve	Acquired by Medtronic, Feb 2009, $700M + milestones
CorEvitas	Acquired by Thermo Fisher, Jul 2023
Coriell Life Sciences	Acquired by InformedDNA, Mar 2025
Corimmun	Acquired by Janssen, Jun 2012
Corindus Vascular Robotics	Acquired by Siemens Healthineers, Oct 2019
Corinthian Ophthalmic	Assets bought by Eyenovia, Oct 2014
Corixa	Bought by GSK, 2005; closed 2006
Corlieve Therapeutics	Acquired by uniQure, Jun 2021, $55M + $240M milestones
CorMatrix Cardiovascular	Bought by Aziyo Biologics, May 2017
Cormorant Pharmaceuticals	Acquired by BMS, Jul 2016, $95M + $425M milestones
Cornerstone Therapeutics	Acquired by Chiesi Farmaceutici, Feb 2014
CORPAK MedSystems	Acquired by Avanos Medical, Apr 2016, $174M
Correlogic	Assets bought by Vermillion 2011
Correvio	Acquired by Advanz Pharma, May 2020, $76M
Correvio (1)	Acquired by Cardiome, Nov 2013, name resurrected and taken by Cardiome, May 2018
Cortex	Acquired by Boston Scientific, Jan 2025
Corthera	Acquired by Novartis 2010, $120M + $500M milestones
Corticrine	Bought by Actinogen, Aug 2014, $5.75M
Corus Pharma	Bought by Gilead, Aug 2006
Corvas International	Acquired by Dendreon Pharmaceuticals, Nov 2003
Corvidia Therapeutics	Acquired by Novo Nordisk, Aug 2020, $725M
Cosman Medical	Bought by Boston Scientific, Jul 2016
CoStim Pharmaceuticals	Acquired by Novartis, Feb 2014
Coté Orphan	Acquired by Quintiles, Jun 2017
Cougar Biotechnology	Bought by J&J
Coulter Pharmaceutical	Bought by Corixa, Oct 2000
Counsyl	Acquired by Myriad Genetics, Aug 2018
County Line Pharmaceuticals	Acquired by Alvogen, Mar 2016, $300M
Courier Therapeutics	Acquired by Valo Health, Jul 2021
Covagen	Acquired by Janssen Pharmaceutical, Aug 2014
Covance	Acquired by LabCorp, Feb 2015, $5.7B
Covidien	Bought by Medtronic, Jan 2015, $42.9B
Covis Pharma	Acquired by Azurity Pharmaceuticals, Mar 2025
CovX Research	Bought by Pfizer
CPEX Pharmaceuticals	Bought by FCB I Holdings, Apr 2011. Not sure what they did with the company/assets. Originally was a spinout from Bentley Pharmaceuticals when it was acquired by Teva in 2008
Creabilis	Acquired by Sienna Biopharmaceuticals, Dec 2016, up to $150M
Crealta Pharmaceuticals	Acquired by Horizon Pharma, Dec 2015, $510M
Creganna Medical	Acquired by TE Connectivity, Apr 2016, $895M
Creoptix	Acquired by Malvern Panalytical, Jan 2022
Crescendo Bioscience	Bought by Myriad Genetics, Mar 2014
CRISI Medical Systems	Acquired by BD, Mar 2015
CrossRoads Extremity Systems	Acquired by DePuy, Feb 2022
CRS Clinical Research Services	Acquired by hVIVO, Jan 2025
Crucell	Acquired by J&J, Mar 2011, $2.3B
Crux Biomedical	Acquired by Volcano, Dec 2012, $36M
CryoLife	Renamed Artivion, Jan 2022
CryoVascular	Bought by Boston Scientific, 2005
Crystal Bioscience	Acquired by Ligand Pharmaceuticals, Oct 2017, $25M
Crystal Laboratory	Acquired by ALK-Abello, Dec 2016
Crystax Pharmaceuticals	Acquired by Oryzon Genomics, Mar 2009
Cryterion Medical	Boston Scientific acquired remaining 65% stake, Jul 2018, $202M
CTI BioPharma	Acquired by Sobi, Jun 2023, $1.7B
Cubist Pharmaceuticals	Bought by Merck Jan 2015
Curacyte Discovery	Acquired by The Medicines Company, Aug 2008
CuraGen	Bought by Celldex 2009, $94.5M
Curative Medical	Acquired by ResMed, Oct 2015
CureDM	Acquired by Boston Scientific, Feb 2018
CureVac	Acquired by BioNTech, Dec 2025, $1.2B
Curiosity Diagnostics	Acquired by Bio-Rad, Aug 2022, $100M + $70M Milestones
CURNA	Acquired by Opko Health, Feb 2011
Curoverse	Bought by Veritas Genetics, Aug 2017
CustomArray	Acquired by GenScript, Dec 2017
Custopharm	Acquired by Hikma, Apr 2022, $375M + $50M milestones
Cutanea Life Sciences	Acquired by Biofrontera, Mar 2019
CV Therapeutics	Acquired by Gilead Apr 2009, $1.4B
CXR Biosciences	Acquired by Concept Life Sciences, Aug 2015
CyberHeart	Acquired by Varian, May 2019
Cyclica	Acquired by Recursion, May 2023, $40M
CyDex Pharmaceuticals	Acquired by Ligand Jan 2011
Cylex	Bought by Viracor-IBT Feb 2013
CymaBay Therapeutics	Acquired by Gilead, Mar 2024, $4.3B
CymoGen Dx	Acquired by Biocare Medical, Mar 2015
CynapseDx	Acquired by Pharmakure, Apr 2021
Cynapsus Therapeutics	Acquired by Sunovion, Oct 2016, $635M
Cypher Genomics	Acquired by Human Longevity, Dec 2015
Cypress Bioscience	Acquired by Royalty Pharma
Cypress Pharmaceuticals	Acquired by Pernix
Cyprotex	Acquired by Evotec, Dec 2016, £ 55.7M
Cytapex Bioinformatics	Acquired by Insightful Science, May 2020
Cytes Biotechnologies	Renamed BeCytes Biotechnologies, Jul 2023
CytoBioscience	Acquired in Reverse Merger, entity renamed Inventa Biotech
Cytocell	Acquired by Oxford Gene Technology, Mar 2014
Cytochroma	Acquired by Opko Health
Cytogenesis	Acquired by BresaGen, Nov 2000
Cytomed	Operations acquired by UCB Pharma, Feb 1999
Cytomyx	Acquired by Origene, fka Cambridge Bioscience
Cytonet	Key Assets acquired by Prometera Biosciences, Apr 2016
Cytopeia	Acquired by BD, May 2008
Cytopia	Acquired by YM Biosciences, Oct 2009, $14M
CytoSen Therapeutics	Acquired by Kiadis Pharma, Jun 2019
CytoTherapeutics	Acquired and took on StemCells Inc name
Cytune Pharma	Bought by SOTIO, Aug 2018
Cytyc	Acquired by Hologic, May 2007, $6.2B
CyVek	Acquired by Bio-Techne, 2014
Dako	Bought by Agilent, May 2012, $2.2B
Damora Therapeutics	Acquired by Galecto, Nov 2025
DanDrit Biotechnology	Acquired Enochian Biopharma, Feb 2018, took name Enochian Biosciences
Darwin Molecular	Acquired by Chiroscience, Nov 1996, $120M stock
Dascena	Acquired by CirrusDx, Aug 2022
Dasgip	Acquired by Eppendorf, Jan 2012
Davol	Acquired by Bard, 1980
Day Zero Diagnostics	Website down Jan 2026; Acquired by bioMérieux, Jun 2025
DCPrime	Acquired by Immunicum, Dec 2020
Decibel Therapeutics	Acquired by Regeneron, Sep 2023, $109M + $104M milestones
Decipher Biosciences	Bought by Veracyte, Mar 2021, $600M
Deep Lens	Acquired by Paradigm Health, Jan 2023
deepCDR Biologics	Acquired by Alloy Therapeutics, Dec 2021
Definiens	Acquired by MedImmune, Nov 2014
Degge Group	Acquired by PharmaLex, Apr 2014
Delenex Therapeutics	Bought by Cell Medica, Jul 2016
Delinia	Bought by Celgene, Jan 2017, $300M + $475 milestones
Delivra	Bought by Harvest One Cannabis, Mar 2019
Delphi Genetics	Acquired by Catalent, Feb 2021
Dendritic Nanotechnologies	Acquired by starpharma, Oct 2006
Denovium	Acquired by AbSci, Jan 2021
Derma Sciences	Acquired by Integra, Feb 2017, $240M
Dermavant Sciences	Acquired by Organon, Oct 2024
Dermavant Sciences	Acquired by Organon, Oct 2024
Dermik Laboratories	Owned by Sanofi, Acquired by Valeant Jul 2011
Dermira	Bought by Eli Lilly, Feb 2020, $1.1B
Destiny Pharma	Acquired by PE, assets repackaged into AMR Bio, Feb 2026
Devgen	Bought by Syngenta, Sep 2012
Devoro Medical	Acquired by Boston Scientific, Sep 2021, $320M + $80M Milestones
Dey LP	Bought by Mylan 2007
Dezima Pharma	Acquired by Amgen Sep 2015, $300M+$1.2B milestones
Dfine	Acquired by Merit Medical, Jul 2016, $98M
DFS Pharma	Acquired by Medrio, Apr 2021?; fka DataFlex Solutions
Dharmacon	Bought by Horizon Discovery, Jul7 2017, $85M
Diagnoplex	Assets acquired by Novigenix, Feb 2015
Diagnostic Hybrids	Acquired by Quidel, Nov 2013, $130M
DiaKine Therapeutics	Acquired by Islet Sciences Mar 2012
Diamed	Bought by Bio-rad
DiaMex	Acquired by LGC, Dec 2024
Diartis Pharmaceuticals	Bought out by investors, Mar 2013. Not sure what will happen
Diatherix Laboratories	Acquired by eurofins, $50M
DICE Therapeutics	Acquired by Eli Lilly, Aug 2023, $2.4B; fka DiCE Molecules
Dicerna Pharmaceuticals	Acquired by Novo Nordisk, Dec 2021, $3.3B
Diffinity Genomics	Acquired by Chiral Technologies, Aug 2015
Dilyx Biotechnologies	Acquired by Soluble Therapeutics, Oct 2014
Dimension Therapeutics	Bought by Ultragenyx, Nov 2017
Dionex	Bought by Thermo Fisher, Dec 2010, $2.1B
Diopsys	Acquired by LumiThera, Mar 2022
Diosynth	Bought by Organon, Jan 2005
Disarm Therapeutics	Acquired by Eli Lilly, Oct 2020, $135M + $1.225B milestones
Discovery BioMed	Acquired by eurofins, Jun 2022
Discovery Genomics	Acquired by Immusoft, Mar 2016
DiscoveryBioMed	Acquired by eurofins, Jul 2022
Discuva	Acquired by Summit Therapeutics, Dec 2017, £10M
Distributed Bio	Acquired by Charles River, Jan 2021, $83M + $21M milestones
Diteba Research Laboratories	Acquired by Nutrasource Diagnostics
Diurnal	Acquired by Neurocrine, Nov 2022, £48M
Divergence	Bought by Monsanto
DNA Therapeutics	Acquired by Onxeo, Mar 2016, €1.7M
DNAprint Genomics	Acquired by Nanobac Pharmaceuticals, Feb 2008
DNAx	Acquired by Schering-Plough, Apr 1982
Dogma Therapeutics	Product acquired by AstraZeneca, Sep 2020; Residential address
Dokumeds	Acquired by Rho, Dec 2021
Dolomite Bio	Acquired by Unchained Labs, Jul 2023
Dorian Therapeutics	Acquired by Altos Labs, May 2025
DOV Pharmaceuticals	Acquired by Euthymics
Dova Pharmaceuticals	Acquired by Swedish Orphan Biovitrum, Nov 2019, up to $915M
Dow Pharmaceutical Sciences	Bought by Valeant Dec 2008, Wound down late 2013
Draxis Pharma	Bought by Jubilant 2008
Dream Pharma	Acquired by Alvogen $186M, Jun 2014
Dropprint Genomics	Acquired by Immunai, Mar 2021
Dropworks	Acquired by Bio-rad, 2021
Drug Delivery Experts	Acquired by Pace Analytical, Jul 2021
Drug Development Solutions	Acquired by Alliance Pharma, Jul 2022
DTx Pharma	Acquired by Novartis, Jul 2023, $500M + $500M milestones
Dualogics	Platform acquired by AbCellera, Aug 2020
Ducentis BioTherapeutics	Acquired by Arcutis Biotherapeutics, Sep 2022, $30M + $370M milestones
Dune Medical Devices	Acquired by Dilon Technologies, Apr 2020
DuPont Pharmaceuticals	Bought by BMS, Oct 2001, $7.8B
Duramed	Acquired by Barr Labs 2001
Durata Therapeutics	Acquired by Actavis, Nov 2014, $675M
Durect	Acquired by Bausch Health, Sep 2025, $63M
DUSA Pharmaceuticals	Part of Sun Pharmaceuticals
DVS Sciences	Acquired by Fluidigm, Jan 2014, $207M
Dyax	Bought by Shire, Jan 2016, $5.9B
Dynacare	Bought by LabCorp 2002
E-MSion	Acquired by Agilent, Mar 2023
EastCoast Bio	Acquired by Medic Biochemica, Jun 2020
EastHORN Clinical Services	Acquired by Novotech, Jan 2023
eBioscience	Acquired by Affymetrix, Nov 2011, $330M
Eclipse Therapeutics	Bought by Bionomics, Sep 2012, $10M
Eden Biodesign	Bought by Watson
Eden Biologics	Acquired by Bora Pharmaceuticals, May 2022; fka JHL Biotech
Edge Therapeutics	Acquired by PDS biotechnology, reverse merger, Mar 2019
Edico Genome	Acquired by Illumina, May 2018
EEL transcriptomics	Assets acquired by Rebus Biosystems, Dec 2021
EganLee - Trial Focus	Acquired by Precision for Medicine
EGEN	Acquired by Celsion, Jun 2014
Egenix	Assets acquired by Bantam Pharmaceutical, Aug 2015
EKG Labs	Acquired by Infinity Life Sciences, Jun 2022
EKR Therapeutics	Bought by Cornerstone Therapeutics 2012
Elan	Bought by Perrigo, Dec 2013
Elastagen	Acquired by Allergan, Feb 2018, $95M
Element Genomics	Acquired by UCB, Apr 2018, up to $30M
Eleusis	Acquired by Beckley PsyTech, Oct 2022
Elevation Oncology	Acquired by Concentra Biosciences, Jul 2025; Strategic Alternatives, Apr 2025
Elevation Pharmaceuticals	Bought by Sunovion, $430M, Aug 2012
Elion Labs	Acquired by KBI Biopharma, Jan 2018
ELITech Group	Acquired by Bruker, May 2024, €870M
Ellex	Acquired by Lumibird, Jun 2020
Ellipse Technologies	Bought by NuVasive, Jan 2016, $380M
Elsie Biotechnologies	Acquired by GSK, Jun 2024, up to $50M
Elto Pharma	Bought by Coeptis Pharmaceuticals, Nov 2018
Elucigene Diagnostics	Bought by Yourgene Health, Apr 2019
Elusys Therapeutics	Acquired by Heat Biologics, Apr 2022
Emas Pharma	Sold to PE Dec 2024; Acquired by Bionical, Nov 2016
Embark Biotech	Acquired by Novo Nordisk, Aug 2023, €15M
Embla Systems	Acquired by Natus Medical, Sep 2011
Emerald Biostructures	Acquired and renamed Beryllium
Emergence Therapeutics	Acquired by Eli Lilly, Aug 2023, $470M + $335M milestones
Emglev Therapeutics	Acquired by Valerio Therapeutics, Sep 2024
Emisphere	Acquired by Novo Nordisk, Dec 2020, $1.8B
Emphasys Medical	Assets acquired by Pulmonx, May 2009
Empirica Therapeutics	Acquired by Century Therapeutics, Jun 2020
Empirical Bioscience	Acquired by Fortis Life Sciences, Oct 2021; fka Syzygy Biotech
Enantigen Therapeutics	Acquired by OnCore Biopharma Oct 2014
EnBiotix	Acquired by Polyphor, Oct 2021
Encore Vision	Bought by Novartis, Dec 2016
Encycle Therapeutics	Acquired by Zealand Pharma, Oct 2019, up to $80M
Encysive Pharmaceuticals	Bought by Pfizer 2008; fka Texas Biotechnology Corp
EndoChoice	Acquired by Boston Scientific, Nov 2016, $210M
Endoclear	Acquired by Avanos, Nov 2019
Endocyte	Bought by Novartis, Dec 2018, $2.1B
EndoGastric Solutions	Acquired by Merit Medical, Jul 2024, $105M
enEvolv	Acquired by Zymergen, Mar 2020
Engage Surgical	Acquired by Smith + Nephew, Jan 2022, $135M
Engage Therapeutics	Acquired by UCB, Jun 2020, $125M
EngMab	Bought by Celgene, Sep 2016, $625M + $2.4B milestones
Enigma Therapeutics	Acquired by NeuroDiscovery, Feb 2013
enobia pharma	Acquired by Alexion Feb 2012
Enochian Biopharma	Acquired by DanDrit Biotechnology, Feb 2018
Ensure Medical	Acquired by Cordis, Jul 2006, up to $90M
Entasis Therapeutics	Acquired by InnoViva, Jul 2022, $113M; AstraZeneca spinout
Entellus Medical	Acquired by Stryker, Feb 2018, $662M
Enteric Medical	Bought by Boston Scientific, Jun 2002, $300M
Entero Therapeutics	Acquired by Grid.ai in reverse merger, Nov 2025; fka First Wave BioPharma; Merged with ImmunogenX, Mar 2024; Merged with AzurRx, Sep 2021, $229M stock, took name
EnteroMedics	Acquired ReShape Medical, Oct 2017, renamed ReShape Life Sciences
Entrepix	Acquired by Amtech Systems, 2023
Envigo	Acquired by Inotiv, Nov 2021; Swapped assets with Covance to exit preclinical CRO business
Envision Medical	Bought by BMS, Aug 1996
Envoy Therapeutics	Acquired by Takeda, Nov 2012
Enzymatics	Bought by Qiagen, Jan 2015, Colorado facility spun off as ArcherDx
Epic Therapeutics	Acquired by Baxter, Nov 2002, $50M+
EpiCapture	Acquired by Trinity Biotech, Oct 2024, $3M
Epicentre	Acquired by Illumina, Jan 2011
Epicyte Pharmaceutical	Acquired by Biolex May 2004
Epinomics	Acquired by 10X Genomics, Aug 2018
EpiTherapeutics	Bought by Gilead, May 2015, $65M
Epitome Biosystems	Assets acquired by Millipore, 2009
Epitomics	Bought by Abcam, Mar 2012, $155M
EPIX Therapeutics	Bought by Medtronic, Jan 2019, $316M
Epixis	Acquired by VBI Vaccines
Epocal	Acquired by Alere, Feb 2013
Epoch Biosciences	Acquired by Nanogen, Sep 2004
EpsilenBio	Acquired by Chroma Medicine, Nov 2021
Epygenix Therapeutics	Acquired by Harmony Biosciences, Apr 2024
EQRx	Acquired by Revolution Medicines, Nov 2023 for slightly over EQRx cash on hand
Eragen Biosciences	Bought by Luminex 2011
Erbi Biosystems	Acquired by MilliporeSigma, Dec 2022; fka Pharyx
Ercole Biotech	Acquired by AVI Biopharma 2008
EryDel	Acquired by Quince Therapeutics, Oct 2023
EsbaTech	Bought by Alcan
EsoBiotec	Acquired by AstraZeneca, May 2025, $425M + $575M milestones
Esoterix	Bought by LabCorp, May 2005
Esperance Pharmaceuticals	Shut down late 2023; Technology sold to A28 Therapeutics, 2022
Esperion Therapeutics (1)	Acquired by Pfizer early 2004 $1.3B
ESSA Pharma	Acquired by XenoTherapeutics, Oct 2025 (nonprofit)
Essen BioScience	Bought by Sartorius, Apr 2017, $320M; fka Essen Instruments
Estetra	Acquired by Richter, Jun 2024
Estudysite	Acquired by Velocity Clinical, Dec 2020
ETHICAL ONCOLOGY SCIENCE	Acquired by Clovis Oncology, Nov 2013
Euprotein	Acquired by Meridian Bioscience, Apr 2022
Eureka Genomics	Acquired by Affymetrix, May 2015, $14M
Eurofins DiscoverX	Acquired by Eurofins, Jul 2017; fka Discoverx
EUSA Pharma	Acquired by Recordati, Dec 2021, $850M; Spun out of Jazz, Mar 2015; Acquired by Jazz Pharmaceuticals, Apr 2012, $700M
Euthymics Biosciences	Assets acquired by Ethismos Research, Nov 2017
Euticals	Bought by AMRI, May 2016, $358M
ev3	Acquired by Covidien, Jul 2010, $2.6B
Evalve	Owned by Abbot Vascular
Evergreen Medical Technologies	Acquired by Haraeus
Evgen Pharma	Acquired Chronos Therapeutics and changed name to TheraCryf, Mar 2024
Evidera	Acquired by PPD, 2016
Evoke Pharma	Acquired by QOL Medical, Nov 2025
Exalenz Bioscience	Acquired by Meridian Bioscience, Apr 2020
Exalpha Biologicals	Acquired by LifeSpan Biosciences, Jul 2019
Excaliard	Bought by Pfizer 2011
Excelsior Medical	Acquired by ICU Medical, Oct 2015
Excelsyn	Bought by AMRI
Exelead	Acquired by Merck KgaA, Jan 2022, now part of Sigma-Aldrich
Eximias Pharmaceutical	Acquired by YM BioSciences, May 2006
Eximo Medical	Acquired by AngioDynamics, Oct 2019, $46M + $20M milestones
Exiqon	Acquired by Qiagen, Oct 2017
Exocell	Acquired by Ethos Biosciences, Nov 2018
Exonics Therapeutics	Acquired by Vertex, Jun 2019, $245M
Exosome Diagnostics	Acquired by Mdxhealth, Sep 2025, $15M; Acquired by Bio-techne, Aug 2018, $250M + $325M milestones
Expedeon	Acquired by Abcam, Jan 2020; Acquired by SYGNIS, Jun 2017, €11.5M
Explora Biolabs	Acquired by Charles River, Apr 2022, $295M
ExplORer Surgical	Acquired by GHX, Oct 2021
Exploristics	Acquired by MMS, Feb 2025
Expression Analysis	Acquired by Quintiles, Aug 2012
EXPUTEC	Acquired by Korber Group, Jun 2020
Exquiron	Acquired by Aptuit, Apr 2016
Exscientia	Acquired by Recursion Pharmaceuticals, Nov 2024
ExsoMed	Acquired by Acumed, Jul 2022
EyeBio	Acquired by Merck, Jul 2024, $1.3B + $1.7B milestones
Eyevance Pharmaceuticals	Acquired by Santen, Sep 2020
F-star Therapeutics	Website down Dec 2025 - Apr 2026; Privatized Apr 2025; Acquired by invoX Pharma, Mar 2023, $161M
Fabrus	Acquired by Sevion Therapeutics, May 2014
Facet Biotech	Bought by Abbott 2010
Faeth Therapeutics	Acquired by Sensei Biotherapeutics, Feb 2026
Fairhaven Pharmaceuticals	Acquired by Liminal BioSciences, Jul 2020
Falcon Pharmaceuticals	Bought by Sandoz from Alcon Oct 2011
Famy Life Sciences	Acquired by Viatris, Nov 2022
Faraday Pharmaceuticals	Shut down Feb 2026
Fathom Pharma	Acquired by Consegna Pharma, Apr 2022
Faulk Pharmaceuticals	Bought by Panther Biotechnology, Jul 2015, stock plus royalty
Faxitron Bioptics	Acquired by Hologic, Jul 2018, $85M
FazaClo	Acquired by Azur Pharma 2007
Fermentas	Acquired by Thermo Fisher, May 2010, $260M
Ferrokin Biosciences	Bought by Sandoz Jul 2012, $1.525B
Fibrocell Science	Acquired by Castle Creek Pharmaceuticals, Dec 2019; fka Isolagen
Fidelta	sold by Galapagos to Selvita, Nov 2020, $37M
Finox Biotech	Acquired by Gedeon Richter, Jun 2016
Firefly BioWorks	Acquired by abcam, Jan 2015, $28M
FirstString Research	Renamed Xequal May 2022; Acquired by Relief Therapeutics, Jul 2016
Fitzgerald Industries International	Acquired by Biosynth, Aug 2023, $30M; Acquired by Trinity Biotech, 2004
Five Prime Therapeutics	Acquired by Amgen, Apr 2021, $1.9B
Flame Biosciences	Acquired by Leap Therapeutics, Jan 2023
Flaskworks	Acquired by Northwest Biotherapeutics, Sep 2020
Flexion Therapeutics	Acquired by Pacira BioSciences, Nov 2021
Flexus Biosciences	Bought by BMS, Feb 2015, $800M + $450M milestones
FloDesign Sonics	Acquired by MilliporeSigma, Oct 2019
Florida Biotechnologies	Acquired by NAYA Biosciences, Jan 2024, $20M
Flow Forward Medical	Acquired by Artio Medical, Jul 2020
FlowMetric	Acquired by Kcas Bio, Feb 2022
FluoFarma	Acquired by Porsolt, Dec 2015
Fluxion Biosciences	Acquired by Cell Microsystems, Aug 2023
Focal Medical	Acquired by Continuity Biosciences, Jun 2025
Focal Therapeutics	Acquired by Hologic, $125M, Oct 2018
Focus-X Therapeutics	Acquired by Full Life Technologies, Nov 2022, up to $245M
Foguera	Bought by Sandoz Jul 2012, $1.525B
Foldrx Pharmaceuticals	Bought by Pfizer, Sep 2010
Forbius	Acquired by BMS, Aug 2020; fka Armada Pharmaceuticals, fka Formation Biologics
Forendo Pharma	Acquired by Organon, Dec 2021, $954M
Foresight Biotherapeutics	Bought by Shire, Aug 2015, $300M
Forest Laboratories	Bought by Actavis, Jul 2014, $25B
FORMA Therapeutics	Acquired by Novo Nordisk, Oct 2022, $1.1B
Formedix	Acquired by Certara, Oct 2023
Fornix Biosciences	Acquired by skiing company in reverse merger, Dec 2013
ForSight VISION4	Acquired by Roche, Jan 2017
ForSight VISION5	Acquired by Allergan, Aug 2016, $95M
Forte Bio	Folded into Sartorious after purchasing from Danaher, Oct 2019
Forty Seven	Acquired by Gilead, Apr 2020, $4.9B
Forward Clinical Trials	Acquired by Cenexel, Aug 2021
Fournier Pharma	Acquired by Solvay, 2006
Fovea Pharmaceuticals	Acquired by Sanofi Oct 2009
Frame Cancer Therapeutics	Acquired by CureVac, Jun 2022, €32M
Freedom Meditech	Acquired by Trividia Health, Jan 2017
Frontida BioPharm	Acquired by Adare Pharma Solutions, Dec 2021
Frontier Global Sciences	Acquired by eurofins, Sep 2012
Frugi Biotechnology	Acquired by BigHat Biosciences, Mar 2022
FSC Pediatrics	Acquired by Flamel, merged into Avadel Pharmaceuticals Jan 2017
Funxional Therapeutics	Bought by Boehringer Ingelheim, Jul 2012
Furiex Pharmaceuticals	Acquired by Forest Labs, Apr 2014
G1 Therapeutics
G7 Therapeutics	Acquired by Heptares, Nov 2016, $12M
Gadea Pharmaceutical	Acquired by AMRI, 2015, $174M
Gadeta	Closed Feb 2024; Acquired by Clade Therapeutics, Oct 2023
Gala Biotech	Acquired by Catalent Pharma Solutions, ~Jul 2007
Galena Biopharma	Acquired via Reverse Merge by Sellas Life Sciences, Aug 2017
Galil Medical	Acquired by BTG plc, May 2016
Gallus	Bought by Patheon, Aug 2014
Gallus Immunotech	Acquired by Exalpha Biologicals, Jun 2018
Gambro	Acquired by Baxter, Sep 2013
GammaDelta Therapeutics	Acquired by Takeda, Oct 2021
GAMUT Therapeutics	Acquired by SparingVision, Apr 2021
GandTex	Assets Acquired by SmooFi, Oct 2016
Ganymed Pharmaceuticals	Bought by Astellas, Dec 2016, $1.4B
GATC Biotech	Acquired by eurofins, Jun 2017
GATT Technologies	Acquired by Ethicon, May 2022
Gauss Surgical	Acquired by Stryker, Sep 2021
GAVIS PHARMACEUTICALS	Acquired by Lupin
GD Searle	Acquired by Monsanto 1985, Merged into Pharmacia, name retired in 2003 after Pfizer acquisition
GE Healthcare	Acquired by Danaher, Apr 2020, $21.4B, rebranded as Cytiva
Geltex Pharmaceuticals	Bought by Genzyme
Gema Biotech	Acquired by AMEGA biotech, early 1990s
Gemin X	Acquired by Cephalon Mar 2011
Gemini Laboratories	Acquired by Amneal, May 2018
GEMoaB Monoclonals	Being acquired/relocated by consortium, Jun 2021, now part of Avancell
Gemphire Therapeutics	Acquired via Reverse Merger by NeuroBio, Dec 2019
Gen-probe	Acquired by Hologic 2012
Gen9 Bio	Bought by Ginkgo Bioworks, Jan 2017
Genable Technologies	Bought by Spark Therapeutics, Mar 2016, $15M
Genaco Biomedical	Acquired by Qiagen 2006
Genae Associates	Acquired by IQVIA
Genaissance Pharmaceuticals	Acquired by Clinical Data, Jun 2005
GenCell Biosystems	Acquired by BD, Oct 2014
Gene Labs	Bought by GSk 2008
GeneDx (old)	Acquired by Sema4, Jan 2022, $623M
Genelabs Technologies	Acquired by GSK, Oct 2008, $57M
Genelex	Acquired by Invitae, Mar 2020
GeneLogic	Bought by Ocimum, Oct 2007, $10M; bankrupt Dec 2011
Genencor	Bought by DuPont
GenePOC Diagnostics	Acquired by Meridian Bioscience, Apr 2019, $50M + $70M milestones
Generation Bio	Acquired by Xoma, Feb 2026; fka Torus Therapeutics
GeneSeek	Bought by Neogen
Genesoft Pharmaceuticals	Acquired by Genome Therapeutics, Nov 2003
Genetic Systems	Bought by Bristol-Myers, 1986
Genetic Therapy	Bought by Sandoz, Jul 1995, #295M
Genetics Institute	Bought by Wyeth, Sep 1996
GeneTx Biotherapeutics	Acquired by Ultragenyx, Jul 2022, $75M
GeneWEAVE Biosciences	Bought by Roche, Aug 2015, $190M
Genexx	Acquired by Opko Health , Oct 2009
Genhelix	Acquired by mAbxience, Jun 2014
Genia Technologies	Acquired by Roche, Jun 2014
Genibet Biopharmaceuticals	Acquired by Recipharm, Feb 2022
Genkyotex	Acquired by Calliditas, Nov 2020
Genlantis	Acquired by AMSBIO
GenMark Diagnostics	Acquired by Roche, May 2021, $1.85B
GenoLogics	Acquired by Illumina, Sep 2015
GenoMatix	Acquired by Intrexon
Genome Explorations	Acquired by Tesis Biosciences, Feb 2022
Genomic Health	Acquired by Exact Sciences, Nov 2019, $2.8B
Genomic Solutions	Acquired by Digilab
Genomics Collaborative	Acquired by BioServe, 2007
Genoox	Acquired by Qiagen, May 2025, $70M + $10M milestones
Genopis	Acquired by Wacker Feb 2021
Genoptix	Bought by Novartis Jan 2011, sold off Jan 2017, bought by Neogenomics, Dec 2018, $125M + 1 million shares
Genos	Acquired by NantOmics, Apr 2017
Genosity	Bought by Invitae, Apr 2021, $200M
Genpathway	Acquired by Active Motif, Nov 2010
Genpro Research	Acquired by Catalyst Clinical Research, Jul 2023
Gentium	Bought by Jazz Pharmaceuticals, Jan 2014, $1B
Gentris	Bought by Cancer Genetics Jun 2014 ($6.5M)
Gentronix	Acquired by Scantox, Sep 2024
GenturaDx	Bought by Luminex 2012
GenVec	Bought by Intrexon, Jun 2017, $16M in stock
GenWay Biotech	Acquired by Aviva Systems, Feb 2017
Genzyme	Acquired by Sanofi, 2011, $20.1B
Genzyme Genetics	Bought by LabCorp, Dec 2010
Geospiza	Acquired by Perkin Elmer, May 2011, $??
Gideon Pharmaceuticals	Acquired by Elorac Pharmaceuticals, Apr 2016
Glamorous AI	Acquired by X-Chem, Oct 2021
Global Blood Therapeutics	Acquired by Pfizer, Oct 2022, $5.4B
GlobalCare Clinical Trials	Acquired by Covance, Jul 2020
Gloucester Pharma	Bought by Celgene 2009
Gloucester Pharmaceuticals	Acquired by Celgene, Dec 2009, $340M + $300M milestones
GlyCart Biotechnology	Acquired by Roche, Jul 2005
GlycoFi	Bought by Merck, $400M, 2006
GlycoMimetics	Acquired by Crescent Biopharma, Jun 2025
GlycoVaxyn	Acquired by GSK, Feb 2015, $190M
GLyPharma Therapeutic	Acquired by Theracon, Oct 2018
GN Otometrics	Acquired by Natus, Jan 2017
GnuBIO	Bought by Bio-rad
goBalto	Acquired by Oracle, Oct 2018
Good Start Genetics	Acquired by Invitae, Aug 2017
Good Therapeutics	Acquired by Roche, $250M, renamed Bonum Therapeutics
GoodStart Genetics	Acquired by Invitae, Aug 2017
Gotham Therapeutics	Acquired by 858 Therapeutics, Sep 2021
GPC Biotech	Acquired by Agennix, Nov 2009
GQ Bio	Acquired by Pacira BioSciences, Feb 2025; fka GeneQuine Biotherapeutics
GQ Life Sciences	Acquired by Aptean, Oct 2016
Grace Therapeutics (1)	Acquired by Acasti, Aug 2021
Gracell Biotechnologies	Acquired by AstraZeneca, Feb 2024, $1.2B
Graceway Pharmaceuticals	Bought by Medicis out of Bankruptcy
Greenleaf Health	Acquired by Validant, Apr 2021, now part of Eliquent Life Sciences
Greenwich Biosciences	Acquired by Jazz Pharmaceuticals, May 2021
Griffin Laboratories	Acquired by Atos Medical
Grupo Biotoscana	Acquired by Knight Therapeutics, Nov 2019
GSL Biotech	Acquired by Dotmatics
GTP Bioways	Acquired by Olon, 2024
GTx	Acquired by Oncternal via reverse merger ticker, Jun 2019
Guide Therapeutics	Website down Oct 2021 - Dec 2021; Acquired by BEAM Therapeutics, Feb 2021, $120M + $320M Milestones
Guilford Pharmaceuticals	Bought by MGI Pharma, Jul 2005
Gynesonics	Acquired by Hologic, Jan 2025, $350M
Gyroscope Therapeutics	Acquired by Novartis, Dec 2021, $1.5B
Gyrus	Acquired by Olympus, 2008, $2B
H-Immune Therapeutics	Acquired by HiFiBiO, Oct 2018
H&S Technical Services	Acquired by Nipro, 2020
Haemostatix	Acquired by Ergomed, May 2016
Hain Lifescience	Acquired by Bruker, Oct 2018 (80% stake)
Haina Pharmaceutical	Acquired by China Sky One, $428k, Apr 2008
HalioDx	Acquired by Veracyte, Aug 2021
Halo Genomics	Bought by Agilent
Halo Labs	Acquired by Waters, May 2025
Halo Pharma	Acquired by Noramco, Nov 2023; Acquired by Cambrex, Sep 2018, $425M
Hamamatsu Pharma Research	Acquired by CMIC, Oct 2023
Handl Therapeutics	Acquired by UCB, Nov 2020
HansaBioMed	Acquired by Lonza, Apr 2017
Hansen Medical	Bought by Auris Surgical, Apr 2016, $40M
Harbor Therapeutics	Acquired by Crede Capital Group, Jan 2015. Website gone.
Harbour Antibodies	Acquired by Harbour Biomed, Dec 2016
Harpoon Therapeutics	Acquired by Merck, Mar 2024, $680M
Harrisvaccines	Bought by Merck Animal Health, Nov 2015
Hauser Pharmaceutical Services	Acquired by Cedarburg
Hawthorn Pharmaceuticals	Acquired by Pernix Jan 2012
Haystack Sciences	Acquired by insitro, Oct 2020
HCS Pharma	Acquired by Netri, Mar 2025; fka Hippocampus Pharma
HD Biosciences	Acquired by WuXi Apptec, Jan 2016
Healeon Medical	Acquired by Bimini HealthTech, Jun 2020
Health Advances	Bought by Parexel, Jan 2016
Health Decisions	Acquired by Premier Research, Jul 2021
Health-Chem Diagnostics	Acquired by PL Developments, Jul 2017
HealthPoint Bio	Bought by Smith & Nephew
Healthpoint Biotherapeutics	Acquired by Smith & Nephew, Sep 2013, $782M
HeartWare	Bought by Medtronic, Aug 2016, $1.1B
Helio Vision	Bought by Aldeyra Therapeutics, Jan 2019, $10M
Helix Diagnostics	Acquired by Bio-rad, Jul 2001
Hemacare	Acquired by Charles River Labs, Jan 2020, $380M
Hematech	Acquired by Sanford Health, Jan, 2013, became Sanford Applied Biosciences
Hemera Biosciences	Website down Nov 2024 - May 2025; Rights to only product (HMR59) acquired by Janssen, Dec 2020
Hemmo Pharmaceuticals	Acquired by Piramal, Apr 2021, $106M + Milestones
Henogen	Acquired by Novasep, Jul 2009
Heptares Therapeutics	Acquired by Sosei Group, Feb 2015
Hera BioLabs	Acquired by Demeetra, Jan 2026; Spun out from Transposagen, 2016
Hercon Pharmaceuticals	Acquired by Zydus Cadila, 2019
Hexal	Acquired by Sandoz, Jun 2005
HI-Bio	Acquired by Biogen, Jul 2024, $1.15B + $650 Milestones; aka Human Immunology Biosciences
Hi-Tech Pharmacal	Acquired by Akorn, Apr 2014
Hibiskus Biopharma	Acquired by Lodo Therapeutics, Sep 2020
Highline Sciences	Acquired by Tempus, Feb 2022
HighPoint Solutions	Acquired by IQVIA, Oct 2017
HilleVax	Acquired by Xoma, Sep 2025
Hillrom	Acquired by Baxter, Dec 2021, $12.5B
HistoRx	Acquired by Genoptix Sep 2012
HistoTox Labs	Acquired by Inotiv, Apr 2021, $22M
Horizon Discovery	Acquired by Perkin Elmer, Oct 2020, $383M
Horizon Therapeutics	Acquired by Amgen, Oct 2023; fka Horizon Pharmaceuticals
Horizon Therapeutics	Acquired by Amgen, Oct 2023; fka Horizon Pharmaceuticals
Hospira	Acquired by Pfizer, Sep 2015
Hotspur Technologies	Acquired by Teleflex, Jul 2012
HRA Pharma	Acquired by Perrigo, May 2022, $2.1B
Humabs BioMed	Bought by Vir Biotechnology, Aug 2017
Human Genome Sciences	Bought by GSK
HumanZyme	Acquired by Proteintech, Apr 2018
Hybritech	Bought by Lilly, 1986, $400M+
Hygia Health Services	Acquired by Stryker, May 2018
Hyperion Therapeutics	Bought by Horizon Pharma Mar 2015 $1.1B
Hypnion	Acquired by Eli Lilly, Mar 2007
Hyseg Pharmaceuticals	Acquired by ARCA Biopharma, Jan 2009
Ibex Technologies	Acquired by BBI Solutions, Apr 2024
Ibis Biosciences	Acquired by Abbott Jan 2009
iCad inc	Acquired by RadNet, Apr 2025, now part of DeepHealth
Icagen (1)	Acquired by Pfizer Oct 2011, Renamed Neusentis Mar 2012, Icagen name and assets acquired by XRPro Sciences Jul 2015
Icagen (2)	Acquired by Ligand Apr 2020; Purchased Icagen assets from Pfizer
ICBiotec	Acquired by eGenesis, May 2020
Ichorion Therapeutics	Acquired by Cerecor, Sep 2018, $26.6M
iCo Therapeutics	Acquired by Satellos by Reverse Merger, Aug 2021
Icon Bioscience	Acquired by pSivida, rebranded as EyePoint Pharmaceuticals
Iconix Biosciences	Acquired by Entelos, Aug 2007
Icos	Acquired by Eli Lilly, 2006, $2.2B
Icosavax	Acquired by AstraZeneca, Feb 2024, $800M
ICQ Consultants	Acquired by Ellab, Nov 2022
ID Biomedical	Acquired by GSK, Sep 2005, $1.7B
ID Pharma	Acquired by I'rom Group
IDbyDNA	Acquired by Illumina, Jun 2022
Idenix Pharmaceuticals	Bought by Merck, Jun 2014
IDEV Technologies	Bought by Abbott, Jul 2013, $310M
IDM Pharma	Acquired by Takeda
IDRx	Acquired by GSK, Feb 2025
Idun Pharmaceuticals	Acquired by Pfizer Feb 2005, Acquired by Conatus Pharmaceuticals Aug 2010
IFM Therapeutics (1)	Acquired by BMS after less than a year, $300M + $1B milestones. Spinning out some assets into new company with same name
Igenica Biotherapeutics	Assets acquired by Pierre Fabry, May 2017
iGenomX	Acquired by Twist Biosciences, Jun 2021
IGM Biosciences	Acquired by Concentra, Aug 2025; Strategic Alternatives, ended both programs, Jan 2025
Ignyta	Acquired by Roche, Feb 2018; $1.2B
iHear medical	Acquired by InnerScope Hearing Technologies, Nov 2021
Ikaria	Acquired by Mallinckrodt, Apr 2015
iLab Solutions	Assets acquired by Agilent, Aug 2016
ILEX Oncology	Acquired by Genzyme, Dec 2004, $1B in stock
Ilkos Therapeutic	Acquired by Odan Laboratories, Dec 2020
Ilypsa	Bought by Amgen $420M Jun 2007
Imaging Advantage	Acquired by Envision Healthcare, Mar 2017
Imago Biosciences	Acquired by Merck, Jan 2023, $1.35B
Imara	Acquired by Enliven Therapeutics, Oct 2022
imarc	Acquired by Avania, Jun 2021
ImaRx	Assets acquired by newly formed Cerevast Therapeutics in 2009
ImClone	Bought by Lilly, Oct 2008, $6.5B
Imgenex	Acquired by Novus Biologicals Oct 2013
IMGM Laboratories	Acquired by Medicover, Apr 2026
Immco Diagnostics	Acquired by Trinity Biotech, Aug 2013, $33M
ImmPACT Bio	Acquired by Lyell Imunnopharma, Nov 2024; Merged with Kalthera, Jul 2021
Immucor	Acquired by Werfen, Mar 2023, $2B
ImmuMetrix	Bought by CareDx Jun 2014
Immune Design	Bought by Merck, Feb 2019, $300M
Immune Targeting Systems	Acquired by Vaxin, Feb 2015
Immunetics	Acquired by Oxford Immunotec, Oct 2016
Immunetrics	Acquired by Simulations Plus, Jun 2023
Immunex	Bought by Amgen, Jul 2002, $16B
Immunitrack	Acquired by Eli Lilly, Oct 2023
ImmunoCellular Therapeutics	Rebranded as EOM Pharmaceuticals, Nov 2022; Assets bought Aug 2019, $500k
ImmunoGen (2)	Acquired by AbbVie, Feb 2024, $10.1B
Immunomedics	Acquired by Gilead, Oct 2020
Impac Medical Systems	Acquired by Elekta, Jan 2005
Impact Biomedicines	Bought by Celgene, Jan 2018, up to $7B
Impilo Therapeutics (1)	Acquired by CEND Therapeutics, Sep 2020
Impopharma	Acquired by Rubicon Research, Jan 2020
ImThera Medical	Acquired by LivaNova, Dec 2017
Imugen	Acquired by Oxford Immunotec, Jul 2016, $22M
In Vitro ADMET Laboratories	Acquired by Discovery Life Sciences, Dec 2021
In2Bones	Acquired by Conmed, Jun 2022, $145M
Incisive Surgical	Acquired by CooperSurgical, Jan 2019
Incline Therapeutics	Acquired by The Medicines Company, Dec 2012
Indevus	Acquired by Endo Pharmaceuticals 2009
InDex Pharmaceuticals	Acquired by Investors, Jun 2024
Indicia Biotechnology	Acquired by Platine Pharma Services, Jun 2013
IndiPharm	Acquired by private equity to be relaunched as InClinica
IndUS Pharmaceuticals	Bought by Pivot Pharmaceuticals, Nov 2015
Inexia	Acquired by Centessa
InfaCare	Acquired by Mallinckrodt, Sep 2017, $80M + $345M milestones
Infinity Laboratories	Acquired by eurifins, Sep 2024
Inflazome	Acquired by Roche, Sep 2020, $450M
InGen Biosciences	Acquired by Exonhit 2012
Ingenuity Systems	Bought by Qiagen, renamed Ingenuity, folded into Qiagen
Inhibitex	Acquired by BMS 2012, $2.5B
Inhibrx	Acquired by Sanofi, May 2024, $1.7B
Inivata	Acquired by NeoGenomics, May 2021, $390M
Injex Pharma	Bought by Chinese Investor, Jan 2016
Innara Health	Acquired by Cardinal Health, Apr 2022
Innate Immunotherapeutics	Acquired Amplia Therapeutics, took its name
InnAVasc Medical	Acquired by W.L. Gore, Aug 2022
InNeuroCo	Acquired by Integer, Oct 2023
InnFocus	Acquired by Santen, Jul 2016
Innocutis	Acquired by Cipher Pharmaceuticals, Apr 2015
Innogenetics	Acquired by Fujirebio Europe, Sep 2010
InnoPharma	Acquired by Pfizer, Sep 2014, $225M + $135M milestones
Innovalve	Acquired by Edwards, Jul 2024, $300M
Innovative Therapies	Acquired by Cardinal Health, Aug 2014
Innovus Pharmaceuticals	Acquired by Aytu Bioscience, Feb 2020
Inositec	Acquired by Vifor Pharma, Nov 2021, CHF20M
Inova Diagnostics	Acquired by Werfen, 2008
Inova Labs	Bought by ResMed, Jan 2016
Inozyme Pharma	Acquired by Biomarin, Jul 2025, $270M
Inpharmatica	Acquired by Galapagos, Jul 2019
Insight Genetics	Acquired by Oncocyte, Feb 2020
Insight Medical Systems	Acquired by Enovis, Jul 2022
Insight Pharmaceuticals	Acquired by Prestige Brands, Apr 2014, $650M
InSilico Solutions	Acquired by Kiromic, Jul 2021
InSite Vision	Acquired by Sun pharma Sep 2015
Inspire Pharmaceuticals	Acquired by Merck 2011
Instratek	Assets acquired by Stryker, Sep 2016
InstruNor	Acquired by Fluidigm, Feb 2020
InSymbiosis	Acquired by Camargo, Jun 2019
Intabio	Acquired by SCIEX, Jan 2021
Intact Vascular	Acquired by Philips, Aug 2020, $275M
Intarcia Therapeutics	Acquired by i2o Therapeutics, Aug 2023
Intec Pharma	Acquired by Decoy Biosystems via Reverse Merger, Aug 2021
INTEGA Skin Sciences	Acquired by Crescita Therapeutics, Sep 2016
IntegenX	Acquired by Thermo Fisher, Mar 2018
Integrated Diagnostics	Acquired by Biodesix, Jul 2018
Integrated Diagnostics (2)	Acquired by Biodesix, Jul 2018
Integrated Laboratory Systems	Acquired by Inotiv, Jan 2022, $56M
Integrated Proteomics Applications	Acquired by Bruker, Sep 2020
Integrity Bio LyoTip	Acquired by Curia, Jul 2021
Integrity Orthopaedics	Acquired by Smith + Nephew, Jan 2026, $450M
Integromics	Bought by Perkin-Elmer 2017
InteKrin	Owned by Coherus Biosciences
Intellicyt	Acquired by Sartorius, Jun 2016, $90M
Intelligent Biosystems	Acquired by Qiagen, Jun 2012
Intellikine	Bought by Millennium 2011
IntelliSyn R&D	Acquired by X-Chem, Jan 2021
Intendis	Acquired by Bayer 2006, Renamed Bayer Health Care 2012
Interferon Source	Bought by PBL Assay Science
Interius BioTherapeutics	Acquired by Kite, Aug 2025
InterMune	Bought by Roche, Aug 2014, 8.5B
International Point Of Care	Acquired by Fortis Life Sciences, Jul 2023
Interpares Biomedicine	Acquired by Clarified Precision Medicine, Aug 2021
Intersect ENT	Acquired by Medtronic, May 2022, $1.1B
InterX	Acquired by NeoTX, May 2022
Intrafuse	Tech acquired by Conventus Orthopedics, Dec 2019
Intrinsic Bioprobes	Acquired by Thermo Fisher Sep 2011
Intronn	Acquired by VIRxSYS, Sep 2007
Inversago Pharma	Acquired by Novo Nordisk, Sep 2023
Inviragen	Bought by Takeda, May 2013 Announced
Invitae	Acquired by Labcorp, Apr 2024; Chapter 11 Bankruptcy, Feb 2024
Invitrogen	Acquired by Thermo Fisher, Apr 2013, $13.6B
Invuity	Acquired by Stryker, Oct 2018, $190M
Iogyn	Acquired by Boston Scientific, May 2014
Iomai	Bought by Intercell 2008
IOmet Pharma	Acquired by Merck, Jan 2016, $400M
IONTOX	Acquired by LifeNet Health LifeSciences, Aug 2022
iperian	Acquired by Bristol-Myers Squibb, Apr 2014, $175M
IPM Biotech	Acquired by BioAgilytix, Feb 2016
Iquum	Acquired by Roche, Apr 2014
IRIS International	Acquired by Danaher, Sep 2012
IRISYS	Acquired by Recro, Aug 2021
IROC Inocross	Assets acquired by Avedro, Sep 2014
Ironshore Pharmaceuticals	Acquired by Collegium, Sep 2024, $525M; Shut down, Oct 2017, brought back Sep 2018
Ironshore Therapeutics	Acquired by Collegium, Sep 2024
Irvine Pharmaceutical Services	Acquired by Nitto Denko Avecia, Oct 2016
Irvine Scientific	Acquired by Fujifilm, Jun 2018
iScience Interventional	Acquired by Ellex, Jan 2014
Isconova	Acquired by Novavax, Jun 2013
IsoPlexis	Acquired by Berkeley Lights, Mar 2023, $57.8M
Isotechnika	Acquired and merged with Aurinia, Sep 2013
Ista Pharmaceuticals	Bought by Bausch & Lomb - 2012
Italchimici	Acquired by Recordati, May 2016
ITC	Acquired Accumetrics, Rebranded as Accriva Diagnostics
Ivantis	Website down Feb 2023; Acquired by Alcon, Jan 2022, $475M
IVAX Corporation	Acquired by Teva 2006
Ivenix	Acquired by Fresenius Kabi, May 2022, $240M + milestones
Ivera Medical	Bought by 3M, Feb 2015
IVERIC Bio	Acquired by Astellas, Jul 2023, $5.9B; fka Ophthotech
Jade Therapeutics	Acquired by EyeGate Pharma, Mar 2016, stock
Janpix	Acquired by Centessa Pharmaceuticals
Jantibody	Acquired by H-Cyte, Sep 2022
Jecure Therapeutics	Acquired by Genentech, Nov 2018
Jennerex	Acquired by SillaJen, Nov 2013, up to $150M
Jerini	Acquired by Shire, 2008
JHP Pharma	Bought by Par Pharmaceuticals
Jounce Therapeutics	Acquired by Concentra Biosciences, May 2023
Jouvenal	Bought by Warner-Lambert, 1997
JSW Life Sciences	Acquired by QPS, Jan 2012
Jungla	Acquired by Invitae, Jul 2019, $65M
Juniper Pharmaceuticals	Acquired by Catalent, Aug 2018
Juno Therapeutics	Acquired by Celgene, Jan 2018, $9B
Just Biotherapeutics	Acquired by Evotec, Jul 2019, up to $90M
K2M	Acquired by Stryker, Nov 2018
Kadmon	Acquired by Sanofi, Sep 2021
KAI Pharmaceuticals	Bought by Amgen 2012
KAI Research	Acquired by Navitas Life Sciences
Kairos Therapeutics	Acquired by Zymeworks
Kalila Medical	Acquired by Abbott, Feb 2016
Kalon Biotherapeutics	Acquired by Fujifilm Diosynth Dec 2014
KaNDy Therapeutics	Acquired by Bayer, Sep 2020, $425M
Kantar Health	Acquired by Cerner, Apr 2021, rebranded as Cerner Enviza
Kanyos Bio	Acquired by Anokion, Sep 2019
Kapa Biosystems	Bought by Roche, Aug 2015
Kapplex	Acquired by Miroculus, Apr 2016
Karos Pharmaceuticals	Sold to Roivant Sciences, 2017
Karuna Therapeutics	Acquired by BMS, Mar 2024, $12.7B
Kate Therapeutics
Katena Products	Acquired by Corza Medical, Dec 2021
KCR	Acquired by ICON plc, Feb 2024; fka Kiecana Clinical Research
Kedalion Therapeutics	Acquired by Novartis, Jun 2022
Kemwell Biopharma	Bought by Recipharm, Apr 2016, $205M
Kendle	Acquired by INC Research 2011
Kenta Biotech	Assets acquired by Aridis Pharmaceuticals, May 2013
Keosys	Acquired by Banook Group, Jun 2024
Khepri Pharmaceuticals	Acquired by Arris Pharmaceuticals Nov 1995
Kiadis Pharma	Acquired by Sanofi, Oct 2020, $357M
Kinaxo	Bought by Evotec
Kineta	Acquired by TuHURA Biosciences, Jun 2025; Reverse merged into Yumanity, Jun 2022
Kinetic Discovery	Acquired by Exscientia, Nov 2018
Kinetix Pharmaceuticals	Bought by Amgen 2000
King Pharmaceuticals	Bought by Pfizer, Oct 2010, $3.6B
Kinnate Biopharma	Acquired by Xoma, Apr 2024
Kiq	Acquired by Unum Therapeutics, Jul 2020
Kleo Pharmaceuticals	Acquired by Biohaven, Jan 2021
Klotho Neurosciences	Acquired by mining company; fka Anew Medical
KMT Hepatech	Acquired by PhoenixBio, Dec 2017
Knoll Pharmaceutical	Taken over by BASF 1975, sold to Abbott 2002, $6.9B
Knome	Acquired by Tute Genomice, Nov 2015
Koligo Therapeutics	Acquired by Orgenesis, Oct 2020
Kolltan Pharmaceuticals	Bought by Celldex, Nov 2016, $62.5M + $172.5M milestones
KorvaLabs	Acquired by Curative, May 2020
Kos Pharmaceuticals	Acquired by Abbott 2006
Kosan Biosciences	Acquired by BMS 2008
KPL	Acquired by SeraCare, Aug 2013, Stock
Kreatech Diagnostics	Acquired by Leica Biosystems, Jul 2013
Kronos Bio	Acquired by Concentra Biosciences, Jun 2025
KuDOS Pharmaceuticals	Acquired by AstraZeneca, Dec 2005, £120M
Kuur Therapeutics	Acquired by Athenex, May 2021, $70M stock + $115M milestones; fka Cell Medica
KWS BioTest	Acquired by Charles River, Jan 2018, £15M
Kyalin Biosciences	Acquired by Retrophin, Dec 2013
Kymab	Acquired by Sanofi, Apr 2021, $1.45B
Kynos Therapeutics	Acquired by Dr. Falk Pharma, Oct 2024
Kythera Biopharmaceuticals	Bought by Allergan, Oct 2015, $2.1B
La Jolla Pharmaceutical	Acquired by Innoviva, Aug 2022, $149M
Lab901	Bought by Agilent
Labcyte	Acquired by Beckman Coulter, Jan 2019
Labopharm	Bought by Paladin 2011
Labor Dr. Merk	Acquired by Boehringer Ingelheim, Dec 2020
Laboratoires Genevrier	Acquired by IBSA, Aug 2021
Laboratories Delalande	Acquired by Synthélabo, 1991
Labrys Biologics	Bought by Teva, Jun 2014
Lacrimedics	Acquired by Innovia Medical, Nov 202
Lake Region Medical	Bought by Greatbatch, Oct 2015, $1.73B
LakePharma	Acquired by Curia, Jul 2021
Laminar	Acquired by Johnson & Johnson, Nov 2023, $400M
Lancaster Laboratories	Bought by eurofins, Apr 2011, $200M
Landos Biopharma	Acquired by AbbVie, May 2024, $137.5M
Langhua Pharmaceutical	Acquired by Viva Biotech, Aug 2020, $367M
LaNova Medicines	Acquired by Sino Biopharm, Jul 2025
Lanx inc	Acquired by Biomet, Nov 2013, $150M
Laragen	Acquired by Transnetyx, Aug 2023
Lasergen	Acquired by Agilent, Apr 2018, $105M
LAT Pharma	Acquired by NanoAntibiotics, Apr 2016
Laureate Pharma	Acquired by Gallus
Laurus Synthesis	Website down Dec 2025
LAVA Therapeutics	Acquired by Xoma, Nov 2025
Lazarus Effect	Acquired by Medtronic, Sep 2015, $100M
LDR Global	Acquire by Zimmer Biomet, Jun 2016, $1B
LDR Holdings	Bought by Zimmer Biomet, $1B, Jun 2016
LEAD Therapeutics	Acquired by BioMarin Pharmaceuticals, 2010
Lederle Labs	Bought by Wyeth 1994
LemnaGene	Acquired by Biolex 2005
Lenetix	Acquired by Bio-Reference Labs 2010
Lentigen	Acquired by Miltenyi Biotech, Apr 2014
Leonard-Meron Biosciences	Acquired by Citius Pharmaceuticals, Mar 2016
LeukoSite	Acquired by Millennium 1999
Lexent Bio	Acquired by Foundation Medicine, Jun 2020
Libertas Pharma	Acquired by Mayne Pharma, Jul 2013
Libra Medical	Acquired by RQM+, May 2023
Librede	Acquired by Lygos, Jan 2020
Lidco	Acquired by Masimo, Feb 2021
Life Molecular Imaging	Acquired by Lantheus, Jan 2025
Life Technologies	Bought by Thermo-Fisher, Apr 2013, $13.6B
Lifecell	Acquired by KCI, 2008, $1.7B; Sold to Allergan Dec 2016, $2.9B
Lifecode	Acquired by MedGenome, Feb 2016
Lifecode Health	Assets Acquired by MedGenome, Feb 2016
LIFNano Therapeutics	Website hijacked May 2023 - Aug 2023
LigaTrap	Acquired by Chromagenex, Apr 2025
Lightpoint Medical	Acquired by Telix, Nov 2023
LigoCyte Pharmaceuticals	Acquired by Takeda Oct 2012
LimFlow	Acquired by Inari Medical, Nov 2023, $250M + $165M milestones
Lineage Therapeutics	Acquired by Impax, Mar 2015
Lineagen	Acquired by Bionano Genomics, Aug 2020, $9.6M
Link Technologies	Acquired by LGC, Jul 2017
Linkage Biosciences	Acquired by Thermo Fisher, Jul 2017
Lipomics Technologies	Acquired by Metabolon, Aug 2012
Liponex	Acquired by ImaSight in reverse merger, Jun 2008
LipoScience	Bought by LabCorp, Nov 2014, $85.3M
Liposonix	Bought by Medicis
Living Pharma	Acquired by Lentigen, Jul 2017
Lobesity	Assets acquired by 9 Meters Biopharma, Jul 2021, $5M + $45M milestones
Locemia Solutions	Sole product acquired by Eli Lilly, Oct 2015
Lodo Therapeutics	Acquired by Zymergen, May 2021
LogicBio Therapeutics	Acquired by AstraZeneca, Nov 2022, $68M
Lohmann Animal Health International	Acquired by Elanco, Feb 2014
Longboard Pharmaceuticals	Acquired by Lundbeck, Oct 2024; Arena Pharmaceuticals spinout
Loop Genomics	Acquired by Element Biosciences, Feb 2022
Lotus Tissue Repair	Acquired by Shire, Jan 2013, $49.3M + $275M milestones
Lowell Therapeutics	Acquired by AcelRx Pharmaceuticals, Jan 2022
Loxo Oncology	Bought by Eli Lilly, Feb 2019, $8B
LS9	Bought by Renewable Energy Group, Jan 2014
Lubrizol Life Science Health, CDMO Division	Acquired by Agno Pharma, Reverted back to being called Particle Sciences Dec 2023
Lucigen	Acquired by LGC, Feb 2018
LuinaBio	Renamed AcuraBio, Aug 2022
Lumara Health	Bought by Amag, Sep 2014, $675M
Lumena Pharmaceuticals	Bought by Shire, May 2014, $260M + $90M for milestone possibilities
Lumigen	Bought by Beckman-Coulter, Oct 2006
Luminex	Acquired by Diasorin, Apr 2021, $1.8B
LumiraDx	Acquired by Roche, Jul 2024, $295M
LumiThera	Acquired by Alcon, Sep 2025
Lumora	Bought by Erba Diagnostics Sep 2015, Rebranded Erba MDX
Lung Therapeutics	Acquired by Aileron Therapeutics, Oct 2023
Lusochimica	Owned by Menarini
Lutonix	Acquired by C.R. Bard, Dec 2011
Luxcel Biosciences	Acquired by Agilent, Jan 2018
Lynx Therapeutics	Acquired by reverse merger with Solexa, 2005
Lyophilization Services of New England	Acquired by PCI Pharma Services, Dec 2021
Lypro Biosciences	Acquired by Cerenis Therapeutics, Nov 2017
Lysosomal Therapeutics	Acquired by BIAL, Sep 2020, rebranded BIAL Biotech
M8 Pharmaceuticals	Acquired by Acino, Dec 2023
Mablink Bioscience	Acquired by Eli Lilly, Dec 2023
Mabpharm (1)	Acquired by Cipla, Jul 2014
Macroceutics	Acquired by HotSpot Therapeutics, Aug 2019
Macrochem	Acquired by Access Pharmaceuticals, Feb 2009
MacroCyclics	Acquired by Areva, Oct 2011
Macusight	Effectively acquired by Santen, 2008
Magellan Diagnostics	Purchased by Meridian Biosciences, Mar 2016, $66M
Magenta Therapeutics	Acquired by Dianthus, Sep 2023
Magnum Therapeutics	Acquired by Introgen Therapeutics, Oct 2004
Maine Biotechnology Services	Acquired by BBI, Mar 2018
Maine Standards Company	Acquired by LGC, renamed LGC Main Standards, Nov 2015
Makiz	Acquired by Stada, Aug 2007, €125M
Mako Surgical	Acquired by Stryker, Sep 2013, $1.65B
Manchester Pharmaceuticals	Acquired by Retrophin, Mar 2014, $29.5M + $33M milestones
MantleBio	Acquired by Collate, Aug 2025
MAP Pharmaceuticals	Acquired by Allergan 2013
Marcadia Biotech	Acquired by Roche Dec 2010
MarDx	Acquired by Fitzgerald Industries, 2007
Maribo Medico	Acquired by ResMed, Nov 2015
Marinus Pharmaceuticals	Acquired by Immedica, Feb 2025
Marker Gene Technologies	Acquired by Abcam, Mar 2020
Marqmetrix	Acquired by Thermo Fisher, Jun 2023
Martek Biosciences	Bought by DSM
Martindale Pharma	Acquired by Ethypharm, Mar 2017
Mast Therapeutics	Bought by Savara for its public shell, Jan 2017
MaSTherCell	Acquired by Catalent, Feb 2020; Bought by Orgenesis, Mar 2015, $24M in shares
Masy BioServices	Acquired by Alcami, Dec 2021; fka Masy Systems
MateraCor	Acquired by BioVentrix, Jan 2022
Mathys Medical	Acquired by DJO, Jun 2021
Matritech	Assets bought by Matritech 2007
Maverick Therapeutics	Acquired by Takeda, Oct 2021, $525M
Mavupharma	Acquired by AbbVie, Jul 2019
Maxer Endoscopy	Acquired by Erbe Elektromedizin, Apr 2021
Mazor Robotics	Acquired by Medtronic, Dec 2018, $1.7B
MBL International	Acquired by JSR Life Sciences, Mar 2021
MC3 Cardiopulmonary	Acquired by Medtronic, Mar 2024
MD Biosciences	Acquired by MLM Medical Labs
med fusion	Acquired by Quest Diagnostics, Jul 2017
Meda Pharmaceuticals	Acquired by Mylan, Aug 2016
MedAlliance	Acquired by Cordis, Oct 2023, $235M
Medarex	Bought by BMS 2009
MedCision	Assets bought by MedCision, May 2018
Medeor	Acquired by Relmada Therapeutics, Dec 2013
Mederi Medical	Acquired by Restech, Apr 2018
Medevoke	Acquired by MEDiSTRAVA, Jan 2024
Medi-Tate	Acquired by Olympus, May 2021
Medicago	Acquired by Mitsubishi Tanabe, Sep 2013, $357M
Medical Device Usability	Acquired by UL, 2018
Medicis Pharmacal	Bought by Valeant Pharmaceuticals Dec 2012
Medicrea	Acquired by Medtronic, Nov 2020
Medimetrics	Assets acquired by Progenity, Sep 2019
MedImmune	Acquired by AstraZeneca, Apr 2007, $15.6B; folded into AstraZeneca, Feb 2019
Medion Diagnostics	Bought by Grifols?
Medistem	Bought by Intrexon Dec 2013
Medivation	Bought by Pfizer, Oct 2016, $14B
Medivative Technologies	Acquired by Kimball Electronics, Jul 2016
Medivators	Acquired by Cantel Medical, Sep 2015
MedPharmics	Acquired by Velocity Clinical, Sep 2022
MedPlast	Bought Integer Business & Rebranded as Viant Medical, Jul 2018
Medpointe Pharmaceuticals	Acquired by Meda Aug 2007, $767M
MedShape	Acquired by DJO, Apr 2021
MedSource	Acquired by Ergomed, Dec 2020, $18M
Medtech	Acquired by Zimmer Biomet, Jul 2016
MEDTOX	Bought by Labcorp Jul 2012
Medventure	Acquired by Helix Medical, Oct 2012
Meilleur Technologies	Acquired by Lantheus, Jul 2024
MeiRui Pharma	Bought by GSK
Melanovus Oncology	Assets acquired by Cipher Pharmaceuticals, Jan 2015
Melt Pharmaceuticals	Acquired by Harrow Health, Nov 2025; Spun out of Harrow Health/Imprimis Jan 2019
Memory Pharmaceuticals	Acquired by Roche, Nov 2008
Memry	Acquired by Resonetics, Oct 2023
Mera Pharmaceuticals	Bought by a karate business, Aug 2012, presumably for ticker
Meraqi Medical	Acquired by Viant Medical, Sep 2019
Merial	Acquired by Sanofi 2009, swapped to Boehringer Ingelheim Jun 2016
Meridian BioGroup	Acquired by Pace Life Sciences, Aug 2022
Meridian Medical Technologies	Merged into Kindeva, Dec 2022; Acquired by Altaris, Dec 2021
Meridien Research	Acquired by Accel Clinical Research, Jun 2020
Meritage Pharma	Bought by Shire, Feb 2015, $70M +$175 milestones
Mersana Therapeutics	Acquired by Day One Therapeutics, Jan 2026, $285M
Merus Labs	Bought by Norgine, Jul 2017, $342M
Mesa Biotech	Acquired by Thermo Fisher, Mar 2021, $550M
Metabasis	Bought by Ligand
Metabolomics Diagnostics	Acquired by Trinity Biotech, Sep 2024
Metaphore Pharmaceuticals	Acquired by ActivBiotics, Jan 2006
MethylGene	Bought by Mirati Therapeutics Jun 2013
Metrics Contract Services	Acquired by Catalent, Aug 2022, $475M
Metsera	Acquired by Pfizer, Nov 2025, $10B
Metys Pharmaceuticals	Acquired by Novaremed, Sep 2021
MGI Pharma	Acquired by Eisai, Jan 2008, $3.9B
MiaMed	Bought by Amicus Therapeutics, Jul 2016, $6.5M cash/stock + $85M milestones
Michrom	Bought by Bruker, Feb 2011
Microbiology Research Associates	Acquired by private equity, combined into Analytical Lab Group
Microchips Biotech	Acquired by Dare Bioscience Nov 2019; fka microCHIPS inc
MicroConstants	Acquired by BioAgilytix, Aug 2021
MicroDose Therapeutx	Bought by Teva, Jun 2013, $40M + $125 milestones
MicroMed	Acquired by Natus, Jan 2023
MicroMed Laboratories	Acquired by Infinity Laboratories, Jun 2020
Micromet	Bought by Amgen Jan 2012, $1.2B
Microsulis Medical	Acquired by AngioDynamics, 2013
Microtest	Acquired by Accuratus Lab Services, Jul 2014
MicroVention	Now Terumo Neuro
Micrus Endovascular	Bought by J&J, Sep 2010
Middle Peak Medical	Acquired by Symetis, technology moved to Polares Medical
MiddleBrook Pharmaceuticals	Bought by Victory Pharmaceuticals 2011
MIDI Labs	Acquired by Biolog, Jan 2023
Midlothian Labs	Acquired by Hi-Tech Pharmacal, Dec 2007
MIGS	Acquired by DNA2.0, Apr 2016,
Miikana Therapeutics	Acquired by Entremed, Jan 2006
Millennium Pharmaceuticals	Acquired by Takeda, May 2008, $8B, eventually rebranded as Takeda Oncology
Millipede Medical	Bought by Boston Scientific, Feb 2019, $325M
Minaris Regenerative Medicine	Acquired by Altaris, Jan 2025; fka Hitachi Chemical Advanced Therapeutics Solutions; fka PTC Cell Therapy
Minaris Regenerative Medicine	Acquired by Altaris, Jan 2025; fka Hitachi Chemical Advanced Therapeutics Solutions; fka PTC Cell Therapy
Mindset Pharma	Acquired by Otsuka Pharmaceuticals, Oct 2023, $59M
miRagen Therapeutics	Acquired Viridian Therapeutics, Oct 2020, took that name Jan 2021
Mirati Therapeutics	Acquired by BMS, Jan 2024, $4.8B
MirImmune	Acquired by Rxi Pharma, Jan 2017, stock
MiroBio	Acquired by Gilead, Sep 2022
Miroculus	Acquired by Integra Biosciences, Mar 2023
Miromatrix Medical	Acquired by United Healthcare, Dec 2023, $91M
Misonix	Acquired by Bioventus, Oct 2021, $518M
Mitim	Acquired by Recipharm, Feb 2016, $75.5M
Mitobridge	Acquired by Astellas, Nov 2017, $225M + $225M milestones; Formerly Mitokyne
Mitokinin	Acquired by AbbVie, Oct 2023, $110M + $545 milestones
MitoKor	Bought by Micrologix Biotech Apr 2004
Mitosciences	Acquired by Abcam, May 2011, $6M
MJ Geneworks	Acquired by Bio-Rad, Aug 2004, $32M
MMI Genomics	Assets bought by Neogen
Mo Bio Laboratories	Acquired by Qiagen, Jan 2016
Moberg ICU Solutions	Acquired by Natus, Dec 2022
Mobidiag	Acquired by Hologic, Jun 2021, $795M
MoBiTec	Acquired by Calibre Scientific, Jan 2024
Mobius Imaging	Bought by Stryker, Oct 2019, $500M
Mobius Therapeutics	Acquired by Glaukos, Aug 2025
MockV Solutions	Acquired by Maravai LifeSciences, Mar 2020
Modifi Biosciences	Acquired by Merck, Oct 2024, $30M + $1.3B milestones
ModiQuest	Acquired by ImmumoPrecise, Apr 2018
Modis Therapeutics	Bought by Zogenix, Sep 2019, $250M + $150M milestones
Molecular Infusions	Acquired by Surterra Wellness
Molecular Insight Pharmaceuticals	Acquired by Progenics, Jan 2013
Molecular Medicine	Acquired by AGC Biologics, Sep 2021; aka MolMed
Molecular Medicine Bioservices	Acquired by SAFC
Molecular Profiles	Acquired by Columbia Labs, Sep 2013
Molecular Response	Acquired by Bioduro, Mar 2018
MolecularMD	Acquired by ICON plc, Feb 2019
MOLLI Surgical	Acquired by Stryker, Jan 2025
Mologic	Acquired by Gates & Soros and turned into nonprofit
MoMelan Technologies	Acquired by Kinetic Concepts, Nov 2012
Momenta Pharmaceuticals	Acquired by J&J, Oct 2020, $6.5B
Monogram Biosciences	Bought by LabCorp 2009
Montigen Pharmaceuticals	Acquired by SuperGen, Apr 2006, $18M
Montis Pharmaceuticals	Bought by SuperGen, Apr 2006
Morphic Therapeutic	Acquired by Eli Lilly, Aug 2024, $3.2B
Morphochem	Acquired by Deinove, May 2018
Morphogen-IX	Acquired by Centessa Pharmaceuticals
MorphoSys	Acquired by Novartis, Feb 2024, $2.9B
Morphotek	Acquired by Eisai, Apr 2007
Morton Grove Pharmaceuticals	Acquired by Wockhardt, Oct 2007
Motus Therapeutics	Bought by Allergan, Oct 2016, $200M
Movetis	Acquired by Shire, Aug 2010
Mpex Pharmaceuticals	Acquired by Axcan 2011, $17.5M + $195M milestones
MPI Research	Acquired by Charles River Laboratories, Apr 2018, $800M
MultiGEN Diagnostics	Bought by PCLS Apr 2014
Multiplicom	Acquired by Agilent, €68M, Dec 2016
Mural Oncology	Website down Jan 2026 - May 2026; Acquired by Xoma, Aug 2025; Spun out of Alkermes Nov 2023
MVI Health	Acquired by Penumbra, Sep 2018
MVP Laboratories	Acquired by Phibro Animal Health, Jan 2016
MWG Biotech	Owned by Eurofins
Myogen	Acquired by Gilead, Oct 2006, $2.5B
MyoKardia	Acquired by Bristol-Myers Squibb, Oct 2020, $13.1B
Myonexus Therapeutics	Bought by Sarepta, May 2019, $165M
MYR Pharmaceuticals	Acquired by Gilead, Mar 2021, €1.1B + €300M milestones
Myraqa	Acquired by Illumina Jul 2014
Myst Therapeutics	Acquired by Turnstone Biologics, Jan 2021
N-of-One	Acquired by Qiagen, Jan 2019
Nalpropion Pharmaceuticals	Bought by Currax, Sep 2019
Namocell	Acquired by Bio-Techne, Jul 2022
Nanna Therapeutics	Acquired by Astellas, Apr 2020
Nano Science	Acquired by EAG, 2006
Nano3D Biosciences	Assets sold to Greiner Bio-One, May 2018
Nanolabz	Acquired by HIL Applied Medical, Jun 2016
nanoMR	Bought by DNA electronics, Jan 2015, $24M
Nanopareil	Acquired by Gamma Biosciences, Sep 2020
Nanosphere	Acquired by Luminex, Jun 2016
Nanostim	Acquired by St. Jude Medical, Octo 2013
NanoString	Acquired by Bruker, May 2024, $393M; Chapter 11 bankruptcy, Jan 2024
Nanosyn	Website down May 2026; Acquired by Element, Oct 2021
NanoView Biosciences	Acquired by Unchained Labs, May 2022; Merged with Nexgen Arrays, Dec 2016
Narus Biotechnologies	Acquired by Cofactor Genomics, Feb 2016
NAT Diagnostics	Acquired by Becton-Dickinson, May 2020
Natrix Separations	Acquired by Merck KGaA/MilliporeSigma, Aug 2017
Nature Technology	Acquired by Aldevron, Jan 2022
Naurex	Acquired by Allergan, Jul 2015, $560M + milestones
Navigenics	Acquired by Life Technologies 2012
NBE Therapeutics	Acquired by Boehringer Ingelheim, Dec 2020, €1.18B
nContact	Bought by AtriCure $99M, Oct 2015
Negma Labs	Bought by Wockhardt, May 2007, $265M
Nemod Biotherapeutics	Assets bought by Glycotope Biotechnology 2007
Neogene Therapeutics	Acquired by AstraZeneca, Jan 2023, $200M + $120M milestones
NeoGenesis Pharmaceuticals	Assets acquired by Schering-Plough, Jan 2005
Neomend	Acquired by Bard, Oct 2012, $140M
Neon Mind Biosciences	Shell acquired by an energy company, Jan 2023
Neon Therapeutics	Acquired by BioNTech, May 2020, $67M
Neotract	Acquired by Teleflex, Sep 2017, $1.1B
Neovasc	Acquired by Shockwave Medical, Apr 2023, $100M
Neox Clinical Research	Acquired by Emmes, Dec 2020
Nerio Therapeutics	Acquired by Boehringer Ingelheim, Jul 2024, $1.3B
Neuavi	Acquired by Codman Neuro, Apr 2017
Neugenesis	Bought by Intrexon, 2011
NeuMoDx Molecular	Shut down Jun 2024; Fully acquired by Qiagen, Sep 2020
Neuravi	Acquired by J&J, Apr 2017 - Became part of Cerenovus
Neurescence	Acquired by Bruker, Dec 2022
Neuro Kinetics	Acquired by Neurolign, Oct 2019
Neuro3d	Acquired by Evotec, Mar 2007
NeuroCycle Therapeutics	Acquired by Engrail Therapeutics, Feb 2021
Neurogen	Acquired by Ligand Pharmaceuticals 2009
Neuronex	Acquired by Acorda Therapeutics, Dec 2012, $6.8M
NeuroNova	Acquired by Newron, Jun 2012
NeuroRx (2)	Acquired by Clario, Mar 2025
NeuroTherm	Bought by St Jude Medical Aug 2014, $200M
Neurotron	Purchased by Denver International Business Corp, Jan 2019
Neurovance	Acquired by Otsuka Pharmaceuticals, Mar 2017, $100M + $150M milestones; Euthymics spinout
NeuWave Medical	Bought by Ethicon, Mar 2016
New Horizons Clinical Research	Acquired by Velocity Clinical Research, Nov 2020
New River Pharmaceuticals	Acquired by Shire, Apr 2007, $2.6B
NewLink Genetics	Acquired by Lumos Pharma in Reverse Merger, Mar 2020
Nexa Orthopedics	Acquired by Tornier, Feb 2007
Nexcelom Bioscience	Acquired by PerkinElmer, May 2021, $260M
Nexgen Pharma	Acquired by LGM Pharma, Jul 2020
NextBio	Acquired by Illumina, Oct 2013
NextCODE Health	Acquired by WuXi PharmTech, Jan 2015, $65M; rebranded as WuXi NextCODE
NextPhase Medical Devices	Acquired by Arterex, Jun 2023
NextSource Pharma	Acquired by Azurity Pharmaceuticals, Apr 2025
Nextwave Pharmaceuticals	Bought by Pfizer Oct 2012; Sold to Tris Pharma Sep 2018
Nexus Biosystems	Acquired by Brooks, Jul 2011
Nexus Therapeutics	Acquired by Transport Pharmaceuticals, Aug 2006
Nexvet	Acquired by Zoetis, Jul 2017, $85M
Nico	Acquired by Stryker, Sep 2024
Nicolet NeuroCare	Acquired by Natus Medical, Jul 2012, $58M
Nightstar Therapeutics	Acquired by Biogen, Jun 2019, $800M; aka NightstaRx
Nigra	Acquired by Vernalis
Nimbic Systems	Acquired by Mizuho OSI, Sep 2020
Nimble Therapeutics	Acquired by AbbVie, Dec 2024, $200M
NimbleGen	Bought by Roche, renamed Roche Nimblegen, some tech sold to Arrowhead
Nine Continents Medical	Acquired by Coloplast, Oct 2020, $145M
NitroMed	Bought by private equity company, Jan 2009, effectively dissolved; Sole drug sold on to Arbor Pharmaceuticals, 2012
Noden Pharma	Acquired by LXO Group, 2022
Nogra Pharma	Bought by Celgene, Apr 2014, $710M
Noria Therapeutics	Acquired by Bayer, Jun 2021
Norphan Pharmaceuticals	Acquired by Marathon Pharmaceuticals, 2013
Northern Biologics	All products acquired as of Nov 2020
Northern Nanopore Instruments	Acquired by Oxford Nanopore, Nov 2023
Nortis	Acquired by Quris-AI, Oct 2024
Nova Pharmaceuticals	Acquired by Galera Therapeutics, Dec 2024
NovaCardia	Bought by Merck, Jul 2007, $350M
Novacea	Bought by Transcept
Novadaq	Bought by Stryker, Sep 2017
Novalon Pharmaceutical	Acquired by Karo Bio Nov 2000
Novartis Animal Health	Acquired by Lilly
NovaScreen Biosciences	Acquired by Caliper Life Sciences, Oct 2005, $22M
NovaTarg Therapeutics	Acquired by Pano Therapeutics, Apr 2022
Novatract Surgical	Acquired by Caldera Medical, 2016
Novavita Thera	Acquired by Castle Creek Biosciences, Jan 2022
Novella Clinical	Acquired by Quintiles, Sep 2013
Novellus Therapeutics	Acquired by Brooklyn ImmunoTherapeutics, Jul 2021
NOVEX	Acquired by Thermo-Fisher, Aug 1999, stock
Novex Clinical Research	Acquired by BTC Network, Aug 2016
Novira Therapeutics	Bought by J&J, Nov 2015
Novosis	Acquired by Acino, 2006
Novosteo	Acquired by Cortexyme, May 2022
NPS Pharmaceuticals	Acquired by Shire, Jan 2015, $5.2B
NuChem Sciences	Acquired by Sygnature Discovery, Aug 2023
Nucleo Life Sciences	Acquired by CoreRx, May 2021
Nucleus Therapeutics	Acquired by Patrys, Aug 2016
Nucryst	Bought by Smith & Nephew
Nudge Therapeutics	Acquired by Veralox Therapeutics, Jan 2025
Nuevolution	Bought by Amgen May 2019
NuGEN Technologies	Acquired by Tecan, Aug 2018, $54.4M
NuPak Medical	Bought by Katena Products, Jul 2017
NuPathe	Bought by Teva, Jan 2014, $144M
Nura	Acquired by Omeros
NuVera Medical	Acquired by Biosense Websiter, Sep 2021
nVision Medical	Acquired by Boston Scientific, Apr 2018, $275M
NxStage	Acquired by Fresenius Kabi, Feb 2019, $2B
NxThera	Acquired by Boston Scientific, Apr 2018, $306M + $100M milestones
Nycomed	Acquired by Takeda 2011
OBP Medical	Acquired by CooperSurgical, May 2021, $60M
Obsidio	Acquired by Boston Scientific, Aug 2022
Ocata Therapeutics	Acquired by Astellas, Jan 2016, $379M; fka Advanced Cell Technology
Ocean Ridge Biosciences	Acquired by Frontage, Apr 2021
Oceana Therapeutics	Acquired by Salix Pharmaceuticals, Nov 2011, $300M
OcellO	Acquired by Crown Bioscience, May 2021
Ocera Therapeutics	Acquired by Mallinckrodt, Dec 2017, $42M
Ockham	Acquired by Chiltern, Jul 2014
Oclassen Pharmaceuticals	Acquired by Watson Pharmaceuticals, Feb 1997
Octagen	Assets bought by Ipsen, 2008
Octoplus	Acquired by Dr. Reddy's, 2013, $36M
Oculeve	Bought by Allergan, Jul 2015, $125M
Oculex Pharmaceuticals	Acquired by Allergan, Oct 2003
Oculos Clinical Research	Acquired by iuvo BioScience, Jul 2018
Ocuphire Pharma	Acquired Opus Genetics, Oct 2024, took name will focus on gene therapy
Ogeda	Bought by Astellas, May 2017, €500M
Ohm Laboratories	Owned by Ranbaxy, then Sun Pharma
Ohr Pharmaceuticals	Acquired by NeuBase Therapeutics via Reverse Merger, Jul 2019
Okairos	Acquired by GSK, May 2013
Okapi Sciences	Acquired by Aratana Therapeutics, Jan 2014
Ology Bioservices	Acquired by Resilience, Apr 2021
OMBU Bio	Assets acquired by Boca Biolistics, Feb 2015
Omega Pharma	Acquired by Perrigo, Mar 2015
Omni-Tract Surgical	Acquired by Integra LifeSciences, Jan 2009
Omnica	Acquired by StarFish Medical, Nov 2024
OmniGene Bioproducts	Acquired by BioEnergy
OMNILife Sciences	Acquired by Corin Group, Mar 2019
Omniome	Acquired by Pacific Biosciences, Sep 2021, $800M
Omniseq	Acquired by LabCorp, 2021
Omrix Biopharmaceuticals	Bought by Ethicon
Omthera Pharmaceuticals	Bought by AstraZeneca, May 2013, $323M
On-X Life technologies	Acquired by CryoLife, Jan 2016, $130M
Oncoceutics	Acquired by Chimerix, Jan 2021, $78M
Oncodisc	Acquired by Veris Health, Jun 2021
OncoEthix	Acquired by Merck, Dec 2014, $375M
Oncogen	Acquired by BMS, 1986
Oncogene Science	Acquired by Nuclea Biotechnologies
OncoImmune	Acquired by Merck, Nov 2020, $425M
OncoPlexDx	Bought by Nantomics, Oct 2016
Oncos Therapeutics	Acquired by Oncos Therapeutics, Jun 2015
Oncoscope	Assets acquired by SpectraScience, Feb 2016
OncoSynergy	Acquired by Enochian BioSciences, Apr 2016
Oncotest	Acquired by Charles River, Nov 2015, €34M
One Lambda	Acquired by Thermo Fisher, Sep 2012
Onset Dermatologics	Acquired by Valeant Feb 2014
Onspira Therapeutics	Acquired by Altavant Sciences, Jan 2020
Onux medical	Acquired by Bard, Jul 2004
Onyvax	Assets Apparently Acquired
Onyx Pharmaceuticals	Bought by Amgen, Aug 2013, $10.4B
Open Biosystems	Acquired by Thermo-Fisher 2008
Open Monoclonal Technology	Acquired by Ligand, Jan 2016, $178M
Opiant Pharmaceuticals	Acquired by Indivior, Mar 2023, $145M
Optima Neuroscience	Acquired by Tucker-Davis Technologies, Sep 2011
Optime Therapeutics	Acquired by Lippomix
OptiMedica	Acquired by Abbott Aug 2013, $400M
Optimer Pharmaceuticals	Acquired by Cubist Oct 2013
Optimum Processing Inc.	Acquire by Savillex, Nov 2024
OptiNose	Acquired by Paratek, May 2025, $330M
Optivia Biotechnology	Acquired by BioIVT, Jul 2018
Optometrics	Acquired by Dynasil, Mar 2005
Opus Medical	Acquired By ArthroCare, Nov 2004, $130M
OPX Biotechnologies	Acquired by Cargill, Apr 2015
OraPharma	Owned by Valeant
Oraya Therapeutics	Absorbed into Zeiss, Jun 2016
Orbis Biosciences	Acquired by Adare Pharmaceuticals, May 2020
Orchid Cellmark	Acquired by LabCorp Dec 2011
Orexia	Acquired by Centessa
Organon	Bought by Schering-Plough Nov 2007, integrated into Merck post 2009 acquisition
OriCiro Genomics	Acquired by Moderna, Jan 2023, $85M
Oriel Therapeutics	Bought by Sandoz, Jun 2010
Origenix	Acquired by Micrologix Biotech, Sep 2002, $320M
Origimm Biotechnology	Acquired by Sanofi, Dec 2021
Origin BioMed	Assets sold to Knight Therapeutics, Jun 2015
Origo Biopharma	Acquired by Agomab, Oct 2021
Orphan Europe	Acquired by Recordati, Sep 2007
Orphan Technologies	Acquired by Travere Therapeutics (Retrophin), Nov 2020, $90M + $427 Milestones
Orphazyme	Acquired by kemPharm, May 2022, $7.6M
Ortho Clinical Diagnostics	Acquired by Quidel, Dec 2021, $6B
Orthocon	Assets Acquired by Abryx, Apr 2013
OrthogenRx	Acquired by Avanos Medical, Dec 2021, $160M
Orthogonal Biologics	Acquired by Cyrus Biotechnology, Dec 2021
OrthoGrid	Acquired by Zimmer Biomet, Aug 2024
Orthosensor	Acquired by Stryker, Jan 2021
OrthoSpin	Acquired by Depuy Synthes, Dec 2021
Oscine Therapeutics	Acquired by Sana Biotechnology, Oct 2020
Oscor	Acquired by Integer, Dec 2021
OSI Pharmaceuticals	Bought by Astellas
Osiris Therapeutics	Acquired by Smith & Nephew, Apr 2019, $660M
OSO Biopharmaceuticals	Acquired by AMRI, Jul 2014
Osseon	Dissolved, assets acquired by Merit medical, Sep 2014
Ossis	3D-printed orthopedic implants
Osteotech	Acquired by Medtronic Aug 2010
Othera Pharmaceuticals	Acquired by Colby Pharmaceuticals 2012
Ovation Pharmaceuticals	Acquired by Lundbeck 2009
Ovizio Imaging Systems	Acquired by Chemometec, Oct 2024
Ovoca Bio	Acquired, now a copper & silver explorer in Morocco
Owen Mumford	Acquired by Embecta, Mar 2026
Owl Biomedical	Website down Apr 2025 - Jul 2025; Acquired by Miltenyi, Apr 2013
Oxford Immunotec	Acquired by Perkin Elmer, Mar 2021, $591M
Oxgene	Acquired by WuXi AppTec, Mar 2021, $135M
Oxitec	Bought by Intrexon, Aug 2015, $160M
Oxular	Acquired by Regeneron, Jan 2025
Oxxon Therapeutics	Acquired by Oxford Biomedica Mar 2007
Oyster Point Pharmaceuticals	Acquired by Viatris, Jan 2023
PAA Laboratories	Acquired by GE Healthcare, Aug 2011
Pacific Bio-Material Management	Acquired by Brooks Life Sciences, Jul 2017
PacificGMP	Bought by Abzena, Sep 2015, $8.4M
Paddock Labs	Bought by Perrigo, Jul 2011, $540M
Padlock Therapeutics	Acquired by BMS, Mar 2016, $225 + $375 milestone
Paganini Biopharma	Bought by OncoResponse, Nov 2017
Paidion Research	Acquired by Premier Research, May 2021
PAIRimmune	Acquired by Pacific Biomarkers, Jun 2019
Palamedrix	Acquired by SomaLogic, Jul 2022, $35M
Palette Life Sciences	Acquired by Teleflex, Oct 2023, $600M
Paloma Pharmaceuticals	Acquired by Stratus Media, Renamed RestorGenex, Mar 2014
PAN Medical	Bought by Zavation, Sep 2018
Pandion Therapeutics	Acquired by Merck, Feb 2021, $1.85B
Pangenetics	Bought by Abbott
Panoptes Pharma	Acquired by EyeGate Pharmaceuticals, Jan 2021
Panther Biotechnology	Acquired in Reverse Merger by media company, presumably for ticker symbol
Par Pharmaceutical	Acquired by Endo Pharmaceuticals, Sep 2015, $8.05B
Paradigm Diagnostics	Acquired by Exact Sciences, Mar 2020
Paradigm Spine	Acquired by RTI Surgical, Mar 2019
Paragon Bioservices	Acquired by Catalent, May 2019, $1.2B
Paragon BioTeck	Acquired by Bausch + Lomb, Feb 2023
Parallax Medical	Acquired by ArthroCare, Jan 2004, $35M; Sold to NeuroTherm, Jul 2011
Paramit	Acquired by Tecan, Aug 2021
Parat Systems	Acquired by BD, Jul 2022
Parcus Medical	Sold to Medacta Group, Mar 2025; Acquired by Anika Therapeutics, Jan 2020, $35M + $60M milestones
Pardes Biosciences	Acquired by MediPacific, Aug 2023; Product failed Apr 2023, strategic alts
Park Therapeutics	Acquired by Tris Pharma, Apr 2021
Parsagen Diagnostics	Acquired by Qiagen
Partek	Acquired by Illumina, May 2024
Particle Sciences	Acquired by Agno Pharma, Dec 2023; Acquired by Lubrizol
Patagonia Pharmaceuticals	Majority of assets acquired by Timber Pharmaceuticals, 2019
Patch Biosciences	Acquired by Gingko Bioworks, Feb 2024
PathoGenesis	Acquired by Chiron, 2000, $600M
Pathway Medical	Acquired by Bayer, Aug 2011, $125M
Pathway Oncology	Acquired by Virax, Mar 2014
Pattern Genomics	Acquired by Intus Bio, Jun 2023
PaxVax	Acquired by Emergent Biosolutions, Oct 2018, $270M
PCT Cell Therapy	Acquired by Hitachi, Mar 2017, $75M, rebranded as Hitachi Chemical Advanced Therapeutics Solutions
Pearl Therapeutics	Acquired by AstraZeneca Jul 2013, $560M+$450milestones
PegaOne	Centessa Company
Pegasus Biologics	Assets acquired by Synovis Life Technologies, Jul 2009
Pelican Therapeutics	Bought by Heat Biologics, Mar 2017
Peloton Therapeutics	Bought by Merck, May 2019, $1.05B + $1.2B Milestones
Pelvalon	Acquired by Laborie, Oct 2021
Peninsula Pharmaceuticals	Acquired by Ortho-McNeil, Apr 2005
Penn Pharma	Bought by PCI Pharma Services, Jul 2014, $215M
Penwest	Bought by Endo
Peplin	Acquired by Leo Pharma 2009
PeproTech	Acquired by Thermo Fisher, Jan 2022, $1.85B
PepSep	Acquired by Bruker, Feb 2022
Perbio Science	Acquired by Fisher Scientific, Jun 2003
PermeaDerm	Acquired by Stedical Scientific, Aug 2019
Perosphere Pharmaceuticals	Acquired by AMAG Pharmaceuticals, Jan 2019
Perseid Therapeutics	Bought by Astellas May 2011
Perseon Medical	Assets bought by Medlink, Aug 2016, $4M; fka BSD Medical
PerSeptive Biosystems	Acquired by Perkin-Elmer, 1998
Persys Medical	Acquired by Safeguard Medical, Jun 2021
Pervasis	Bought by Shire, Sep 2009
Pervasis Therapeutics	Bought by Shire 2012
Pfenex	Acquired by Ligand, Oct 2020, $437.5M + $78M milestone; Spun out of Dow Chemical 2009
PFS Genomics	Acquired by Exact Sciences, May 2021, $30.6M
Phadia	Acquired by Thermo Fisher, May 2011, $3.5B
PhagoMed	Acquired by BioNTech, Nov 2021
PharmaCell	Acquired by Lonza, May 2017
Pharmacopeia	Acquired by Ligand Pharmaceuticals 2008
Pharmacore	Acquired by Cambrex, Sep 2016, $25M
Pharmacyclics	Bought by AbbVie, $21B May 2015
PharmaFluidics	Acquired by Thermo Fisher, Oct 2021
PharmaForm	Bought by Biotech Investment Group, Relaunched as Formex Jul 2013
PharmaKinetics Laboratories	Acquired by BASi, Jun 2002?
PharmaSphere	Acquired by Marijuna company, Nov 2011
Pharmasset	Bought by Gilead, Nov 2011, $11B
Pharmatech	Acquired by Caris Life Sciences, May 2019
Pharmatek	Acquired by Catalent, Sep 2016
Pharmaterials	Acquired by Quotient Sciences, Nov 2017
Pharmavene	Acquired by Shire, Mar 1997
Pharmion	Acquired by Celgene 2007
Phase Forward	Bought by oracle
Phenix Research Products	Acquired by Thomas Scientific
Phenocell	Acquired by Axol Bioscience, Oct 2024
PhenomeX	Acquired by Bruker, Oct 2023, $108M; fka Berkeley Lights
Phenox	Acquired by Wallaby Medical, Apr 2022
Pherin Pharmaceuticals	Acquired by Vistagen, Feb 2023
Phitonex	Acquired by Thermo Fisher, Jan 2021
PhosImmune	Acquired by Agenus, Dec 2015, up to $45M
Phosphagenics	Renamed Avecho Biotechnology
PHT Corporation	Acquired by ERT, May 2015
PhyNexus	Acquired by Biotage, Jan 2019
Physio-Control	Bought by Stryker, Feb 2016, $1.28B - became Stryker Emergency Care
Phytera	Assets sold to Galileo, Apr 2002
Phytopharm	Acquired by Ixico, Sept 2013
Phyxius Pharma	Assets acquired by Oxygen Therapeutics, Nov 2013, effectively merged
Pikavation	Acquired by Novartis, Mar 2026, $2B; Synnovation psuedo-subsidiary
Pinewood	Bought by Wockhardt, Feb 2013, €150M
Pinnacle Biologics	Bought by Concordia Healthcare Dec 2013
Pinnacle Pharmaceuticals	Acquired by New River Pharmaceuticals, 2011
Pionyr Immunotherapeutics	Acquired by Akena Oncology, Aug 2023; fka Precision Immune
Piramed Pharma	Acquired by Roche, Apr 2008, $160M + $15M milestones
Pisgah Labs	Acquired by IPCA Pharmaceutical, Jan 2018
Pivot Medical	Bought by Stryker, Mar 2014
Platine Pharma Services	Bought by ABL inc, Jul 2014
Plato BioPharma	Acquired by Inotiv, Oct 2021, $15M
Plex Pharmaceuticals	No news 2020-2023; Acquired by Collidion, 2017
Plexxikon	Acquired by Daiichi Sankyo, Feb 2011
PML Microbiologicals	Bought by Bimerieux Dec 2008
Pneumagen	Acquired by NorthLinks Bio, Apr 2026
PneumRx	Acquired by BTG plc, Dec 2014, $475M
POINT Biopharma	Acquired by Eli Lilly, Dec 2023, $1.4B
Pola Pharma	Acquired by Sun Pharma, Jan 2019
Polyganics	Acquired by Collagen Matrix, Oct 2022
Polynoma	Acquired by TransCode Therapeutics, Oct 2025
Polyplus Transfection	Acquired by Sartorious, Sep 2023, €2.4B
Porex Surgical	Acquired by Stryker, Sep 2010
Porocel	Acquired by Evonik, Aug 2020, $210M
PortaScience	Acquired by DCN Dx, Jun 2021
Portola Pharmaceuticals	Acquired by Alexion Pharmaceuticals, Jul 2020, $1.4B
Poseida Therapeutics	Acquired by Roche, Jan 2025, $1.5B; Spinout of Transposagen Biopharmaceuticals
Potentia Pharmaceuticals	Acquired by Apellis Pharmaceuticals, Nov 2014
Potenza Therapeutics	Bought by Astellas, Dec 2018
PowderMed	Acquired by Pfizer 2006
Powervision	Acquired by Alcon, Mar 2019, $285M
PQ Bypass	Acquired by Thermo Fisher, Apr 2021, $17.4B
PRA Health Sciences	Acquired by ICON plc., Jul 2021, $12B
PRAECIS Pharmaceuticals	Acquired by GSK, Dec 2006, $54.8M
Praha Vaccines	Acquired by Novavax, Jun 2020
Praxis Life Sciences	Acquired by Treximo, Mar 2019
preCARDIA	Acquired by Abiomed, Jun 2021
PreCision Dermatology	Acquired Triax Pharmaceuticals, Renamed Onset Dermatologics
Precision Healing	Acquired by Sanara MedTech, Apr 2022
Precision Nanosystems	Acquired by Cytiva, Apr 2024
PreClinOmics	Acquired by Crown Bioscience, Mar 2016
Pregenen	Bought by bluebird bio Jun 2014
PregLem	Acquired by Richter, Oct 2010
Prescient Neuropharma	Acquired and renamed, pivoted to mining
Preventice Solutions	Acquired by Boston Scientific, Jan 2021, $925M + $300M milestones
Prexton Therapeutics	Acquired by Lundbeck, Mar 2018, $123M
Primatope Therapeutics	Acquired by Kiniksa, May 2019
PrimeraDx	Bought by Qiagen, Jun 2014
Primity Bio	Acquired by Caprion Biosciences, Sep 2018
Primorigen Biosciences	Acquired by Nucleus Biologics, Aug 2019
Principia Biopharma	Acquired by Sanofi, Sep 2020
Prionics	Acquired by Thermo Fisher, Mar 2014
Prism Pharmaceuticals	Acquired by Baxter 2011
Prismic Pharmaceuticals	Acquired by FSD Pharma, Jun 2019
Prochon Biotech	Acquired by Histogenics
ProCyte	Acquired by PhotoMedex, Mar 2005
ProEthic Laboratories	Acquired by Kowa, Sep 2008
ProFibrix	Bought by The Medicines Company, Aug 2013, $90M + $140 milestones
ProfoundBio	Acquired by Genmab, May 2024, $1.8B
Progen Pharmaceuticals	Acquired by TBG Diagnostics, Jan 2016, Drug sold off to Zucero Therapeutics Aug 2016
Progenics Pharmaceuticals	Acquired by Lantheus, Jun 2020
Progenika	Bought by Grifols
Prolifaron	Acquired by Alexion, Sep 2000, $41M
Prolor Biotech	Acquired by OPKO, Aug 2013, renamed Opko Biologics
ProMedDx	Acquired by Precision for Medicine, Aug 2019
Promedica International	Acquired by Iuvo BioScience, Jan 2024
Promedior	Acquired by Roche, Feb 2020
Prometheus Biosciences	Acquired by Merck, Jun 2023, $11B; fka Precision IBD, took Prometheus Biosciences name after buying Prometheus Laboratories from Nestle, Jun 2019
Pronostics	Assets acquired by Phadia, Jan 2009
Pronova BioPharma	Acquired by BASF, Jan 2013
Pronovo Biopharma	Bought by BASF, Nov 2012, $844M
Proof Diagnostics	Acquired by Ginkgo Bioworks, Feb 2024; fka Pine Trees Health
Propagenix	Acquired by STEMCELL Technologies, Jan 2024
Propella Therapeutics	Acquired by Astellas, Dec 2023, $175M
Propeller Health	Acquired by ResMed, Dec 2018, $225M
Prosensa	Acquired by BioMarin, Nov 2014, $680M+milestones
Prosidion	Bought by OSI pharmaceuticals, Apr 2005
ProSolus	Acquired by Canoa, Aug 2019
Prosonix	Bought by Circassia, Jun 2015, $158M
Prostrakan	Acquired by Kyowa Hakko Kirin; renamed Kyowa Kirin Apr 2016
Protagen Diagnostics	Acquired by Oncimmune, Mar 2019
Protein Forest	Bought by Cell Biosciences
Protein Sciences	Acquired by Sanofi, Aug 2017, $650M + $100M milestones
ProteinSimple	Bought by biotechne, Aug 2014, $300M
Protenium Clinical Research	Acquired by Eligo Health Research, Jan 2019
Proteolix	Bought by Onyx Pharmaceuticals, Oct 2009, up to $851M
Proteologix	Acquired by J&J May 2024, $850M; No website, Feb 2023 - Nov 2023
Proteom	Acquired by Amura Ltd
Proteon Therapeutics	Acquired by ArTara Therapeutics, Reverse Merger, Jan 2020
Proteona	Acquired by Singleron, Mar 2022
Protez Pharma	Bought by Novartis 2008, Closed 2010
Protherics	Bought by BTG plc, Sep 2008, £218M
Proven Process	Acquired by NextPhase Medical Devices, May 2021
Proven Process Medical Devices	Acquired by NextPhase, May 2021
Provention Bio	Acquired by Sanofi, Apr 2023, $2.9B
Providence Clinical Research	Acquired by Velocity Clinical Research
Provista Diagnostics	Acquired by Todos Medical Apr 2021; Acquired by Ascenda BioSciences, Jun 2019
Proximagen	Acquired by Upsher-Smith, Aug 2012; Originally spun out of King's College London
ProZyme	Acquired by Agilent, Aug 2018
PSMA Therapeutics	Acquired by Bayer, Jun 2021
Psyadon Pharmaceuticals	Acquired by Emalex Biosciences, Aug 2018
PsyCheNomicS	Acquired by Novasite Pharmaceuticals, Jun 2005
Pulmokine	Acquired by XOMA Royalty, Nov 2024; Website hijacked and no news since 2013 as of Jul 2022
Pulsar Vascular	Bought by J&J Jul 2017 - Became part of Cerenovus; Previously acquired by Codman Neuro, Dec 2016
Pulse Systems	Acquired by Heraeus, 2020
Pulvinar Neuro	Acquired by EPI, Mar 2022
Purigen Biosystems	Acquired by Bionano Genomics, Nov 2022
Pursuit Vascular	Acquired by ICU Medical, Nov 2019, $75M
Putney	Acquired by Dechra, Mar 2016
PvP Biologics	Bought by Takeda, Feb 2020, up to $330M
PX' Therapeutics	Acquired by Promise Proteomics, Jul 2019
Q2 Solutions	Fully acquired by IQVIA, Apr 2021
QED Bioscience	Acquired by Leinco Technologies, Sep 2024
Qorvo Biotechnologies	Acquired by Zomedica, Oct 2023
Qpex Biopharma	Acquired by Shionogi, Jun 2023, $140M
Qrumpharma	Acquired by MannKind, Dec 2020
QS Pharma	Acquired by Quotient Clinical, 2017
QSAM Biosciences	Acquired by Telix Pharmaceuticals, May 2024
Quad Technologies	Acquired by Bio-techne, Jun 2018
Quadrants Scientific	Acquired by Infinity Laboratories
Qualer	Acquired by MasterControl, Mar 2025
Qualitis	Acquired by Optima Pharm, Jun 2022
Qualyst	Acquired by BioIVT, Sep 2017
Quanam Medical	Acquired by Boston Scientific, Apr 2001, $8M
Quanta BioDesign	Acquired by Vector Laboratories, Jul 2023
QuantaLife	Acquired by Bio-Rad, Oct 2011, $162M
Quanticel Pharmaceuticals	Acquired by Celgene, $100M +$300M milestones, Apr 2015
Quantigen Biosciences	Acquired by Versiti, Jul 2023
Quantum Pharma	Acquired by Clinigen, Nov 2017
Quartesian	Acquired by Veranex, Jun 2021
QuatRx	Acquired by Shionogi, 2017
Quay Pharma	Acquired by SGS, Renamed SGS Quay Pharma, Jan 2024
Quellis Biosciences	Acquired by Catabasis Pharmaceuticals, Jan 2021
Questcor Pharmaceuticals	Acquired by Mallinckrodt, Aug 2014 $5.8B
Quethera	Bought by Astellas, Aug 2018, up to $109M
Quintara Discovery	Acquired by Frontage, Jul 2021
Quotient Bioresearch	Acquired by Pharmaron, Feb 2016
R-Tech Ueno	Acquired by Sucampo, Aug 2015, $276B
Ra Pharmaceuticals	Bought by UCB, Apr 2020, $2.1B
Radiant Genomics	Acquired by Zymergen, Jan 2018
RadioTherapeutics	Acquired by Boston Scientific, Nov 2001, $150M
Rain Oncology	Acquired by Pathos AI, Jan 2024, $42M; fka Rain Therapeutics
Raindance Technologies	Acquired by Bio-Rad, Jan 2017
Raptor Pharmaceuticals	Acquired by Horizon Pharma, Oct 2016, $800M
Rare Thyroid Therapeutics	Acquired by PledPharma, Oct 2020
RareGen	Acquired by Liquidia, Jun 2020
Raven Biotechnologies	Acquired by MacroGenics Jul 2008
RCP Diagnostics	Acquired by Provista Life Sciences, Dec 2006
ReadCoor	Acquired by 10X Genomics, Oct 2020
ReadyCell	Acquired by MedTech Barcelona, Nov 2024
Realm Therapeutics	Acquired by ESSA Pharma, Jul 2019; fka PuriCore, abandoned all clinical work Sep 2018, seems to be wound care/topical 510(k) products
Reata Pharmaceuticals	Acquired by Biogen, Sep 2023, $7.3B
Rebiotix	Acquired by Ferring, Apr 2018
Rebound Therapeutics	Bought by Integra LIfeSciences, Sep 2019
Receptos	Bought by Celgene, Jul 2015, $7.2B
RedoxTherapies	Acquired by Juno, Jul 2016, $10M + milestones
Redwood Bioscience	Acquired by Catalent, Oct 2014
Reflectance Medical	Acquired by Sotera, Feb 2015
Regentys	Acquired by Generex, Jan 2019
Regulatory Professionals, Inc.	Acquired by Premier Research, Jul 2018
Regulus Pharmaceutical Consulting	Acquired by Clinipace
Regulus Therapeutics	Acquired by Novartis, Jun 2025, $1.7B
Reinnervate	Acquired by ReproCELL, combined with Biopta to become ReproCELL Europe, Jul 2016
Reliable Biopharmaceutical	Bought by VWR Nov 2016
Relievant Medsystems	Acquired by Boston Scientific, Nov 2023, $850M
Relypsa	Bought by Galenica, Jul 2016, $1.5B, became part of Vifor
Rempex Pharmaceuticals	Acquired by The Medicines Company Dec 2013, $140M
ReNAgade Therapeutics	Acquired by Orna Therapeutics, May 2024
Renaissance Pharma	Acquired by Essential Pharma, Apr 2024
Renalys	being Acquired by Chugai, Oct 2025
RenaMed Biologics	Assets sold to Nephrion, 2007
Renovacor	Acquired by Rocket Pharmaceuticals, Dec 2022; Went public via SPAC Sep 2021
Replace Therapeutics	Acquired by Tome Biosciences, Jan 2024, $185M
Reproductive Health Science	Acquired by Perkin-Elmer, Jul 2018
Reprogenetics	Acquired by CooperSurgical, Jun 2016
Repros Therapeutics	Acquired by Allergan, Dec 2017
Research Across America	Acquired by Synexus, Mar 2016
Research Diagnostic, Inc.	Acquired by Fitzgerald Industries, 2005
ReSearch Pharmaceutical Services	Acquired by PRA, renamed RPS Strategic Solutions Division
ReShape Lifesciences	Merged with Vyome Therapeutics, Aug 2025; Acquired via Reverse Merger by Obalon Therapeutics, took this name
ReShape Medical	Acquired by EnteroMedics, Oct 2017
Resolution Bioscience	Acquired by Exact Sciences, Sep 2023; Acquired by Agilent, Apr 2021, $550M
Respicardia	Acquired by Zoll, Apr 2021
Respironics	Bought by Philips, Mar 2008, $5.1B
RespiVert	Acquired by Centocor Jun 2010
Response Genetics	Acquired by Cancer Genetics, Aug 2015
ReSync Bio	Acquired by Benchling 2025
Retrogenix	Acquired by Charles River Labs, Mar 2021
RetroSense Therapeutics	Bought by Allergan, Sep 2016, $60M
Revascular Therapeutics	Acquired by Boston Scientific, Feb 2011
Reveal Biosciences	Acquired by CellCarta, May 2021
Reverie Labs	Acquired by Ginkgo Bioworks, Feb 2024
Reverse Medical Corp	Bought by Covidien, 08/14
ReViral	Acquired by Pfizer, Jun 2022, up to $525M
Revivicor	Acquired by United Therapeutics, 2011, $7.6M
Revolutionary Medical Devices	Acquired by Vyaire, Oct 2017
RF Surgical Systems	Bought by Medtronic, Jul 2015, $235M
RHEINCELL Therapeutics	Acquired by Catalent, Jun 2021
RhoVac	Reverse Merged with Chosa, Jan 2023
Rhythm Xience	Acquired by Acutus Medical, May 2019
Ribonomics	Sold to MBL International
Richcore Lifesciences	Acquired by Laurus Labs, Jan 2021
Riemser Pharma	Acquired by Esteve, Jan 2020
Rigenerand	Acquired by Evotec, Jul 2022, €23M
Rigontec	Bought by Merck, Sep 2017, $150M + $453 Milestones
Rinat	Bought by Pfizer 2006
Rio Grande Neurosciences	Assets sold to Endonovo Therapeutics, Dec 2017, $4.5M
RITA Medical Systems	Bought by AngioDynamics 2007
River Vision Development Corp	Acquired by Horizon Pharma, May 2017, $145M
rMark Bio	Acquired by Within3, Apr 2021
RMC Pharmaceutical Solutions	Acquired by Syner-G BioPharma Group, Jan 2023
RND Group	Acquired by Gener8, Dec 2021
Ro5	Acquired by Juvenescence, Jun 2025
RockStep Solutions	Acquired by Instem, Jul 2025
Rodeo Therapeutics	Acquired by Amgen, Apr 2021, $55M + $666 milestones
Rodin Therapeutics	Acquired by Alkermes, Nov 2019, up to $950M
ROME Therapeutics	Acquired by Pretzel Therapeutics, Jan 2026
Rosetta Inpharmatics	Bought by Merck 2001
Rotation Medical	Bought by Smith & Nephew, Oct 2017
Roush Life Sciences	Assets purchased by Foxx Life Sciences, 2011
Roxane Labs	Acquired from Boehringer-Ingleheim by Hikma, Feb 2016, merged into West-Ward Laboratories
Roxro Pharma	Acquired by Luitpold 2010
Roxwood Medical	Acquired by BTG plc, Oct 2017
RPS Diagnostics	Assets acquired by Quidel, May 2017, $14M, shell merged into Lumos Diagnostics, May 2019
RQX Pharmaceuticals	Acquired by Amgen, Feb 2013, $111M
RTS Life Science	Bought by Brooks Automation Apr 2011
Rubicon Genomics	Acquired by Takara, Jan 2017
Rules-Based Medicine	Acquired by Myriad Genetics, Apr 2011, $80M; rebranded Myriad-RBM
RxDataScience	Acquired by Syneos Health, Oct 2021
S2 Genomics	Acquired by Precision Cell Systems, Sep 2025
Safis Solutions	Acquired by Pharmalex, Apr 2017
SAGE Labs	Acquired by Horizon Discovery, $48M, Sep 2014
Sage Therapeutics	Acquired by Supernus Pharmaceuticals, Jul 2025, $561M + Milestones
Sairiyo Therapeutics	Acquired by PharmaDrug, Feb 2021
Salgomed	Shut down Apr 2022
SalvaRx	Bought by Portage Biotech, Aug 2018
Salzman Group	Acquired by Kalytera, Feb 2021; Residential address May 2021
SAMDI Tech	Acquired by Charles River, Jan 2023, $40M
Sanarus	Acquired by Hologic, 2020
Sanctum Therapeutics	Acquired by Adnexus, Nov 2024
Sandstone Diagnostics	Assets acquired by Labcorp
Sanifit	Acquired by Vifor Pharma, Nov 2021, €205M + €170M milestones
Sanomune	Acquired by Diamedica, Dec 2009
SanReno Therapeutics	Acquired by Novartis, Jan 2024
Santaris Pharma	Bought by Roche, Aug 2014
Santarus	Acquired by Salix Pharmaceuticals, Jan 2014
Sapphire Biotech	Acquired by AXIM Biotechnologies, Jan 2020
Sapphire Therapeutics	Acquired by Helsinn 2009
SARcode	Bought by Shire Mar 2013
Satiogen Pharmaceuticals	Acquired by Mirum Pharmaceuticals, May 2022
Satoris	Bought by Rules-Based Medicine
Savage Laboratories	Was part of Fougera which was acquired by Sandoz, Jul 2012
SB Drug Discovery	Acquired by Sygnature Discovery, Feb 2026; fka Scottish Biomedical
ScalmiBio	Acquired by ALX Oncology, Oct 2021
Scandipharm	Bought by Axcan Pharma, $100M
Scanwell Health	Acquired by BD, Dec 2021
Scendia Biologics	Acquired by Sanara MedTech
Schein Pharmaceutical	Acquired by Watson Pharmaceuticals, Aug 2000, $674M
Schering-Plough	Acquired by Merck, Nov 2009
Schwartz Pharma	Acquired by UCB, 2006, €4.4B
Schwarz Pharma Manufacturing	Acquired by UCB 2006
Scidera Genomics	Bought by Neogen, Jan 2013
Sciele Pharma	Bought by Shionogi
Sciformix	Acquired by LabCorp, Jun 2018
SciGen	Bough by Yifan Pharmaceutical, Aug 2018
Scil Technology	Acquired by Nanohale, Sep 2012, creating subsidiary Formycon
SCIMEDX	Acquired by Sebia, Sep 2024
Scioderm	Bought by Amicus Aug 2015, $229M+$618M milestones
Scios	Bought by JnJ, Feb 2003
SciSafe	Sold for $73M Nov 2024; Acquired by Biolife Solutions, Sep 2020
SCM Pharma	Taken over by Shire, Aug 2014
scPharmaceuticals	Acquired by MannKind, Oct 2025, $296M
Sea Lane Biotechnologies	Assets acquired by i2 Pharmaceuticals, May 2017
SeaGen	Acquired by Pfizer, Dec 2023, $43B
Seahorse Bioscience	Acquired by Agilent, Nov 2015
SeaView Research	Acquired by Quotient Clinical, Feb 2017
Securus Medical	Bought by Boston Scientific, Apr 2018, $40M
Segetis	Assets bought by GFBiochemicals, Feb 2016
SegWay Orthopedics	Acquired by Trice Medical, Feb 2019
Selcia	Acquired by eurofins, Jan 2018
Select ImmunoGenomics	Acquired by GeneCentric Therapeutics, Aug 2019
Selexis	Merged with KBI Bio by parent, May 2023; Purchased by JSR Life Sciences, Jul 2017
Selexys	Bought by Novartis, Nov 2016, $665M
Semba Biosciences	Acquired by Tosoh Biosciences, Oct 2021
Semma Therapeutics	Acquired by Vertex, Sep 2019, $950M
Semprus Biosciences	Acquired by Teleflex Jun 2012
Senorx	Acquired by Bard, May 2010, $200M
Sense Biodetection	Acquired by Sherlock Biosciences, Feb 2023
Sense Proteomics	Acquired by Oxford Gene Technology, Mar 2009
Sensidose	Acquired by Navamedic, Mar 2023
Sensile Medical	Acquired by Gerresheimer, Jul 2019, up to €350M
SentreHEART	Bought by AtriCure, Aug 2019, $300M
Sentrx	Bought by Telerx, Apr 2013
Seqens CDMO North America	Building exploded May 2023; Renamed Seqens CDMO North America; Acquired by Novacap, Jul 2018
SeqRight	Acquired by GE Apr 2012
Sequana Therapeutics	Bought by Arris Pharmaceuticals 1998
Sequenom	Bought by LabCorp, Sep 2016, $371M
Sequenta	Acquired by Adaptive Biotechnologies, Jan 2015
Sequoia Biotech Consulting	Acquired by Syner-G BioPharma Group
SeQure Dx	Acquired by MaxCyte, Jan 2025
Seragon Pharmaceuticals	Acquired by Genentech, Aug 2014 $725M + $1B Milestones; Acquired by JNJ Aug 2013 $650M + $350 Milestones
Serametrix	Acquired by Caprion Biosciences, Apr 2019
Serendex Pharmaceuticals	Bought by Savara Pharmaceuticals, Jun 2016
Serendipity Bio	Acquired by Arbor Biotechnologies
Serenity Pharmaceuticals	Acquired by Acerus, Mar 2022
SERF SAS	Acquired by Stryker, Mar 2024
Serica Technologies	Bought by Allergan
Serimmune	Acquired by Infinity Bio, Jun 2025
Serono Laboratories	Acquired by Merck KGaA, 2006
Serotiny	Acquired by J&J, 2023
Serpex Medical	Acquired by Maverix Medical, Dec 2023
Sestina Bio	Acquired by Inscripta, Jan 2023
Sevion Therapeutics	Acquired Eloxx Pharmaceuticals, Dec 2017, took name
Sexton Biotechnologies	Acquired by BioLife Solutions, Sep 2021
SeylanMED	Acquired by DermBiont, Oct 2020
SFL Regulatory Affairs & Scientific Communication	Acquired by Veristat, Mar 2022
SGM Biotech	Acquired by Mesa Biotech, Apr 2010
SGX Pharma	Acquired by Eli Lilly Jul 2008
Shantha Biotech	Acquired by Sanofi, Jul 2009, $784M
Shenandoah Biotechnology	Acquired by Fujifilm Irvine Scientific, Mar 2022
Sherpa Clinical	Acquired by PCI Pharma Services, Oct 2018
Shire	Bought by Takeda, Jan 2019, $62B
Shutt Medical Technologies	Acquired by CONMED, 1983
Sicor Biotech	Bought by Teva 2004
Sierra Oncology	Acquired by GSK, Jul 2022, $1.9B
SIG Medical	Acquired by Zimmer, Sep 2019
Sigilon Therapeutics	Acquired by Eli Lilly, Aug 2023, $35M + $273.4M milestones
Sigma-Aldrich	Bought by Merck KgAA, Sep 2014, $17B, now part of MilliporeSigma
SignalChem Lifesciences	Acquired by Sino Biological, Oct 2023
Silarx Pharmaceuticals	Acquired by Lannett, Jun 2015
Silene Biotech	Acquired by NanoSurface Biomedical, Sep 2019
Silicon Biosystems	Acquired by Menarini, Sep 2013
Silicon Therapeutics	Acquired by Roivant, Feb 2021, $450M
Silk Road Medical	Acquired by Boston Scientific, Sep 2024, $1.16B
Siloam Biosciences	Acquired by MiCo BioMed, May 2018
Silvergate Pharmaceuticals	Acquired by cutisPharma, Jun 2019
SimplicityBio	Acquired by Precision for Medicine, Mar 2019
Simplify Medical	Acquired by NuVasive, Feb 2021, $150M
Sinclair Research	Acquired by Altasciences, Jan 2022
Sinensis Life Sciences	Acquired by eurofins, Jan 2016
Singular Bio	Acquired by Invitae, Jun 2019
Sirion Biotechnology	Acquired by PerkinElmer, Jun 2021
Sirius Analytical	Acquired by pion, May 2017
Sirna Therapeutics	Bought by Merck 2006, Sold to Alnylam Jan 2012
Sirtris Pharmaceuticals	Acquired by GSK Apr 2008, Subsumed Mar 2013
Sitari Pharmaceuticals	Acquired by GSK, Sep 2019
SiteOne Therapeutics	Acquired by Lilly, Aug 2025, $1B
Siva Therapeutics	Acquired by Sona Nanotech, Mar 2023, $2M + $6.65M milestones
Skeletech	Acquired by MDS, Aug 2005
SkinMedica	Acquired by Allergan Dec 2012 ($350 million)
Skny Pharmaceuticals	Acquired by Mira Pharmaceuticals, May 2025
Skyland Analytics	Acquired by IDBS, Nov 2021
Slate Pharmaceuticals	Bought by Actient Pharmaceuticals Dec 2011
Slayback Pharma	Acquired by Azurity Pharmaceuticals, Sep 2023
Sloning Biotechnology	Bought by MorphoSys, Oct 2010, $26.5M
Small Pharma	Acquired by Cybin, Aug 2023
SmartCells	Bought by Merck Dec 2010
SmartPharm Therapeutics	Acquired by Sorrento Therapeutics, Sep 2020
Smith Therapeutics	Acquired by AZTherapies, Oct 2019
Smiths Medical	Acquired by ICU Medical, Jan 2022, $2.35B
Snapdragon Chemistry	Acquired by Cambrex, Nov 2022
SNBL	Acquired by Altasciences
SNBL CPC	Acquired by Pharmaron, Feb 2017
SOFAR surgical	Acquired by TransEnterix, Sep 2015, $100M
Soin Therapeutics	Acquired by JanOne, Sep 2022
SOLADIS	Acquired by Efor, 2021
Solana Biosciences	Acquired by Inscripta, Sep 2018
Solentim	Acquired by Advanced Instruments, Aug 2021
Solid Form Solutions	Acquired by Avista Pharma, Jan 2018
SoloHill Engineering	Acquired by Pall, Mar 2014
Solstice Neurosciences	Acquired by US World Meds 2010
Solsys Medical	Acquired by Misonix, Sep 2019, $97M stock; fka Soluble Systems
Solta Medical	Acquired by Valeant, $236M Dec 2014
Soluble Therapeutics	Bought by CytoBioscience, Dec 2016
Solvay	Bought by Abbott 2010
Somahlution	Acquired by Marizyme, Sep 2020
Somaxon Pharmaceuticals	Bought by Pernix Mar 2013, Renamed Pernix Sleep
Somerset Pharmaceuticals	Acquired by Mylan, Jul 2008
Somna Therapeutics	Acquired by Restech, Jun 2020
SoniTrack Systems	Acquired by Zimmer Biomet, Jun 2016
SoniVie	Aquired by Boston Scientific, May 2025, $540M
Sonoma Orthopedics	Acquired by Arthrex, Jul 2017
Sonosite	Acquired by FujiFilm, Dec 2011
Sourcia	Acquired by Alira Health, Apr 2022
Southern Cross Diagnostics	Acquired by Novacyt Group
Spark Therapeutics	Acquired by Roche, Dec 2019, $4.8B
Spatial Transcriptomics	Acquired by 10x Genomics, Dec 2018
SpecialTeam	Assets Acquired by Desco, Dec 2013
Specifar Pharmaceuticals	Acquired by Watson Pharmaceuticals, May 2011, $562M
Specific Diagnostics	Acquire by bioMérieux, May 2022
Spectranetics	Acquired by Philips, Aug 2017, $1.9B
Spectrum Laboratories	Bought by Repligen, Aug 2017, $359M
Spectrum Pharmaceuticals	Acquired by Assertio, Apr 2023, $248M
Speedel Pharma	Bought by Novartis, Jul 2008, $880M
Sphinx Pharmaceuticals	Acquired by Eli Lilly Mar 1994
Spinal Dynamics	Acquired by Medtronic, Jun 2002, $270M
Spinal Kinetics	Acquired by Orthofix, Mar 2018, $105M
Spindle Biotech	Acquired by Applied DNA Sciences, Jul 2023, $1.6M
Spinifex Pharmaceuticals	Bought by Novartis, $200M + milestones, Jul 2015
Spinnovation Biologics	Acquired by Sinensis Life Sciences, Oct 2014
Spiral Genetics	Acquired by Omicia, Jan 2017
Spiration	Acquired by Olympus, Jun 2010
Spire Health	Acquired by Wellinks, Sep 2024
Spirogen	Bought by AstraZeneca, Oct 2013
Spirosure	Acquired by Caire, Jun 2020; fka Spirometrix
Spirox	Bought by Stryker, Jul 2017
Spring Science	Platform acquired as they wound down, Mar 2025; fka Spring Discovery
Springborn Laboratories	Acquired by Charles River Labs, Oct 2002
SQN Clinical	Acquired by Veristat, Feb 2021
SSCI	Bought from Aptuit by AMRI, Jan 2015
SSS International Clinical Research	Acquired by Optimapharma Group, Dec 2021
St. Jude Medical	Acquired by Abbott, Jan 2017, $25B
Stage Cell Therapeutics	Bought by Juno Therapeutics, May 2015, €52.5 million
STATKING Clinical Services	Acquired by Genesis Drug Delivery & Development, Jan 2021
Statsols	Aquired by Dotmatics, 2022; aka Statistical Solutions
SteadyMed	Acquired by United Therapeutics, Aug 2018, $75M + $150M milestones
Stealth Biologics	Acquired by Occulo, Apr 2018
Stelios Therapeutics	Acquired by LEXEO Therapeutics, Jul 2021
StelKast	Acquired by Globus Medical, Sep 2019, $24.1M + $4.3M milestones
Stellar Biotechnologies	Acquired/Merged with Edesa Biotech, Jun 2019
Stemcentrx	Bought by AbbVie, Apr 2016, $5.8B +$4B milestones
Stemgent	Acquired by ReproCELL, Sep 2014
StemVax	Acquired by NovAccess Global, Sep 2020; Unknown Modalities, Apr 2024
Stiefel	Acquired by GSK
Stilla Technologies	Acquired by Bio-Rad, Jun 2025, up to $275M
Stimgenics	Acquired by Medtronic, Jan 2020
Strand Diagnostics	Acquired by P4 Diagnostix, Feb 2020
StrataDx	Acquired by Fulgent Genetics, Mar 2026
Stratagene	Acquired by Agilent, Apr 2007, $246M
StrataGent Life Sciences	Acquired by Corium, 2007
Stratatech	Bought by Mallinckrodt, Aug 2017, $76M + $121M milestones
Strategic Diagnostic Antibodies	Acquired by Fitzgerald Industries, 2004
Strativa Pharmaceuticals	Bought by Par Pharmaceutical, Sep 2007
Stratos Genomics	Acquired by Roche, May 2020
Stromedix	Bought by Biogen Idec 2012
Strongbridge Biopharma	Acquired by Xeris, Oct 2021, $267M; fka Cortendo
Stuart Pharmaceuticals	Acquired by Atlas Chemical Industries
StudyKIK	Acquired by Syneos Health, Sep 2021
Sucampo Pharmaceuticals	Acquired by Mallinckrodt, Feb 2018
Sugen	Acquired by Pharmacia & Upjohn, 1999, $650M stock; Shut down 2003
Summit Biosciences	Acquired by Kindeva Drug Delivery, Jan 2024
Sun Biomedical	Acquired Dimerix, Jul 2015, took name
SUN Bioscience	Acquired by Insphero, Nov 2025
Sun Pharm Corp	Acquired by Geltex Pharmaceuticals
Sunesis Pharmaceuticals	Acquired by Viracta Therapeutics, Feb 2021
Suneva Medical	Acquired by Tiger Aesthetics, Oct 2024
Sunstone BioSciences	Acquired by Intelligent Material Solutions, 2010
superDimension	Acquired by Covidien May 2012
Suppremol	Acquired by Baxter, Mar 2015, €225M, part of Baxalta now
Surface Logix	Bought by Nano Terra
Surface Oncology	Acquired by Coherus, Sep 2023, $65M
Surgical Innovation Associates	Acquired by Integra LifeSciences, Dec 2022
Surgical Specialties	Renamed Corza Medical after acquisition/merger
SurgiQuest	Acquired by ConMed, Jan 2016, $265M
SurgRx	Acquired by Ethicon, Aug 2008
Suros Surgical Systems	Bought by Hologic, Jul 2006, $240M
Swift Biosciences	Acquired by Integrated DNA Technologies, Mar 2021
SwiftScale Biologics	Acquired by Resilience, Dec 2021
Swissfillon	Acquired by ten23, Oct 2021
Syapse	Acquired by N-Power Medicine, Jan 2025
Sylics	Acquired by Innoser, Jan 2023
Symbient Product Development	Acquired by Gener8, Feb 2020
Symbiomix Therapeutics	Acquired by Lupin, Oct 2017, $150M
Symetis	Acquired by Boston Scientific, May 2017, $435M
Symmetry medical	Acquired by Tecomet, Dec 2014
Symmetry Surgical	Acquired by Aspen Surgical, Oct 2022
Symphogen	Acquired by Servier, Jun 2020
Synageva BioPharma	Acquired by Alexion, Jun 2015, $8.4B
Synaptic Pharmaceuticals	Acquired by Lundbeck, Nov 2002
Synbiotics	Acquired by Pfizer Dec 2010. Included in Zoetis spinout
SynCo Bio Partners	Acquired by Wacker, May 2018
Syndesi Therapeutics	Acquired by AbbVie, Mar 2022, $130M + $870M milestones
Synergen	Bought by Amgen 1994
Synergetics USA	Acquired by Valeant, Sep 2015, $190M; Neurosurgical portfolio sold to Stryker, Feb 2016
Synergx	Owned by Morphogenesis
Synergy Health	Acquired by Steris, Nov 2015
Synergy Pharmaceuticals	Acquired by Bausch Mar 2019; Bankrupt, Dec 2018, want to accept Bausch bid $200M for assets, auction forthcoming
Synerlab Group	Renamed Meribel Pharma Group, Apr 2025
SynHelix	Website Down Feb 2025 - Jul 2025; Acquired by Univercells, Jan 2022
Synosia Therapeutics	Acquired by Biotie
Synovel Sciences	Bought by Fountain Pharma, Jan 2017
Synpromics	Acquired by AskBio, Aug 2019
Syntagon	Acquired by Ardena, May 2018
Syntax for Science	Acquired by Optimapharm, Nov 2020
Synthes	Acquired by Johnson & Johnson, Jun 2012, $19.7B
Synthorx	Acquired by Sanofi, Jan 2020, $2.5B
Syntimmune	Acquired by Alexion, Nov 2018, $400M + $800M milestones
Syntonix Pharmaceuticals	Acquired by Biogen, Jan 2007
Syrinx Bioanalytics	Acquired by Senexa Life Science, May 2022
Syrrx	Acquired by Takeda, Feb 2005, $270M
Systagenix	Acquired by KCI, Oct 2013, $485M
SyStemix	Acquired by Novartis, Jan 1997
Systems Medicine	Acquired by CTI Jul 2007
T-cell Factory	Bought by Kite Pharma Mar 2015 €20M
Tacere Therapeutics	Bought by Benitec Biopharma Oct 2012
Talaria Therapeutics	Acquired by Esperion Therapeutics, Oct 2000, $7.3M shares
Talent Biotechs	Bought by Kalytera Therapeutics, Mar 2017, $10M + $20M milestones
Taligen Therapeutics	Acquired by Alexion
Talon Therapeutics	Bought by Spectrum Pharmaceuticals Jul 2013
Tamir Biotechnology	Acquired by Orgenesis, Apr 2020
Tandem Laboratories	Bought by LabCorp, 2008
Tandem Life	Acquired by LivaNova, Feb 2018
TangenX	Acquired by Novasep 2006, sold to Repligen, Dec 2016, $39M
Tangshian Yian Biological Engineering	Acquired by Sinovac
Tanox	Acquired by Genentech, Aug 2007, $919M
Tantti	Acquired by Repligen, Jul 2024
TAP Pharmaceuticals	Acquired by Takeda
Tapemark	Acquired by LTS, Aug 2022
Tara Biosystems	Acquired by Valo Health, Apr 2022
Tarbis Farma	Acquired by Hetero Labs, Jan 2019
Targanta	Bought by The Medicines Company
TargEDys	Acquired by Biocodex, Jun 2023
TargeGen	Bought by Sanofi 2010
Target Therapeutics	Bought by Boston Scientific, Jan 1997
Taris Biomedical	Acquired by J&J, Dec 2019
Tarsa Therapeutics	Product rights acquired
Tarus Therapeutics	Acquired by Portage Biotech, Jul 2022
Taueret Laboratories	Acquired by Predictive Technology Group, Mar 2019
Taurus Biosciences	Acquired by Ligand Pharmaceuticals, Sep 2020, $5M
Tavros Therapeutics	Acquired by Vividion Therapeutics, Jan 2025
Taxon Biosciences	Acquired by DuPont, Apr 2015
TearScience	Acquired by J&J, Nov 2017
TEI Biosciences	Bought by Integra Life Sciences, Jun 2015
Telavant	Acquired by Roche from Roivant, Dec 2023
Telesta Therapeutics	Bought by ProMetic, Aug 2016, $34M
Tenaxis Medical	Bought by The Medicines Company, Sep 2013
Tendyne Holdings	Acquired by Abbott, Sep 2015, $225M
TeneoBio	Acquired by Amgen, Oct 2021, $900M; fka OMT Therapeutics
TeneoTwo	Acquired by AstraZeneca, Aug 2022
Tenet Medicines	Acquired by Eliem Therapeutics, Jun 2024
Tensha Therapeutics	Acquired by Roche, Jan 2016, $115M + $420 Milestones
Tepha Medical Devices	Acquired by BD, Jul 2021
TeraImmune	Acquired by Baudax Bio, Jun 2023
Tercica	Bought by Ipsen, Oct 2008
Terns Pharmaceuticals	Acquired by Merck, May 2026, $6.67B
TerraGen Discovery	Acquired by Cubist Aug 2000, $31M stock
Terrain Biosciences	Acquired by Eclipsebio, Jan 2026
Tesaro	Acquired by GSK, Jan 2019, $5.1B
Tetra Therapeutics	Acquired by Shionogi, May 2020; fka Tetra Discovery Partners
TetraGenetics	Acquired by AbCellera, Sep 2021
Tetraphase Pharmaceuticals	Acquired by La Jolla Pharmaceuticals, Jul 2020, $43M
Tetris Pharma	Acquired by Arecor Therapeutics, Aug 2022
Tfarma	Aquired by Enteralia Bioscience, Nov 2024
TGA Sciences	Acquired by Absorption Systems, Dec 2017
Thallion Pharmaceuticals	Bought by Taro Mar 2017; Bought by Bellus Health, Aug 2013
Thar Pharmaceuticals	Acquired by Grünenthal, Nov 2016
The Binding Site	Acquired by Thermo Fisher, Jan 2023, $2.6B
The Medicines Company	Acquired by Novartis, Jan 2020, $9.7B
The Tech Group	Acquired by West Pharma, May 2016
The Weinberg Group	Acquired by ProPharma Group, Jan 2019
Themis Bioscience	Acquired by Merck KgAA/MSD Jun 2020
Theorem Clinical Research	Bought by Chiltern, Sep 2015
Therabron Therapeutics	Bought by Brace Pharma Capital Jan 2015
TheraCell	Acquired by Isto Biologics, Apr 2022
Therachon	Bought by Pfizer, Jul 2019, $340M + $470M milestones
Theragnostics	Acquired by Ariceum Therapeutics, Jun 2023
THERAMetrics	Acquired Relief Therapeutics, Jun 2016, took name
Therapeia	Program Acquired by Telix, Jan 2017
Therapeutic Human Polyclonals	Acquired by Roche, Apr 2007, $56.5M
Therapure Biopharma	Acquired by Resilience, Apr 2021
TheraSense	Acquired by Abbott, Jan 2004, $1.2B
Theravant	Assets acquired by STRATA Skin Sciences
Therics	Acquired by Integra
TherOx	Acquired by Zoll, Jun 2019
Therox Pharmaceuticals	Acquired by OXIS International, Jul 1995
Theseus Pharmaceuticals	Acquired by Concentra Pharmaceuticals, Feb 2024
Thievon-Wright Consulting Group	Acquired by ERG Clinical, Apr 2018
Third Wave Technologies	Acquired by Hologic Jun 2008
Thoratec	Bought by St. Jude Medical, Oct 2015, $3.4B
Thrive Earlier Detection	Acquired by Exact Sciences, Oct 2020, $2.15B
Tiancheng Pharmaceutical	Acquired by Grifols, Mar 2022, $1.27B
Tibotec Therapeutics	Bought by JnJ, now Janssen Therapeutics
Tidal Therapeutics	Acquired by Sanofi, Apr 2021, $160M + $310M milestones
TiGenix	Acquired by Takeda, Jul 2018, $630M
Tilos Therapeutics	Acquired by Merck, Jun 2019, up to $773M
TISSUE SOLUTIONS	Acquired by BioIVT, Jul 2021
Titan Spine	Bought by Medtronic, Jun 2019
Tmunity Therapeutics	Acquired by Kite Pharmaceuticals, Feb 2023
TNI Medical	Acquired by Masimo, Mar 2020
Tobira Therapeutics	Bought by Allergan, Nov 2016, $600M + milestones
Tocris Bioscience	Acquired by Bio-Techne, 2011
Tolero Pharmaceuticals	Rolled in Sumitomo Dainippon Pharma Oncology, Jun 2020; Acquired by Sumitomo Dainippon Pharma, Jan 2017
TomegaVax	Acquired by Vir Biotechnology, Jan 2017
TomoTherapy	Bought by Accuray, Mar 2011, $277M
Tonbo Biosciences	Acquired by Cytek Biosciences, Nov 2021
Tongjitang Chinese Medicines Company	Bought by Winteam Pharmaceutical
Topaz Pharma	Bought by Sanofi Pasteur 2012
Topera Medical	Acquired by Abbott, 2014, renamed Abbott Electrophysiology
Topigen Pharmaceuticals	Acquired by Pharmaxis, 2010
Topokine Therapeutics	Acquired by Allergan, Apr 2016, $85M + milestones
TopoTarget USA	Sold to Apricus Bio, Dec 2011
Topstone Research	Acquired by Veristat, Oct 2018
TORAX Medical	Acquired by Ethicon, Mar 2017
toSense	Acquired by Baxter, Jun 2020
Totient	Acquired by Absci, Jul 2021
Toxikon	Acquired by Labcorp, Dec 2021
Tramontane Therapeutics	Acquired by Kriya Therapeutics, Sep 2023
Transcend Medical	Acquired by Alcon, Feb 2016, up to $740M
Transferra Nanosciences	Acquired by Evonik Jun 2016; fka Northern lipids
Transform Pharmaceuticals	Bought by JnJ 2005
Transition Therapeutics	Bought by Opko, $60M stock, Jul 2016
Transkaryotic Therapies	Acquired by Shire, 2005
Translate Bio	Acquired by Sanofi, Sep 2021, $3.2B; fka RaNa Therapeutics
TransMolecular	Assets Sold to Eisai 2011
Transmotion Medical	Assets acquired by Winco, Jun 2015
TransPharma Medical	Assets acquired by Syneron, Mar 2012
Transport Pharmaceuticals	Purchased by NitricBio, Oct 2009
Travanti Pharma	Acquired by Teikoku Pharma, May 2009
Trevigen	Acquired by Bio-Techne, Sep 2017
Triad Isotopes	Acquired by Jubilant, Jun 2019
Triad Life Sciences	Acquired by Convatec, Mar 2022
Triad Therapeutics	Acquired by Monogram Energy Oct 2009
Triangle Pharmaceuticals	Acquired by Gilead, 2003, $464M
Triangle Research Labs	Acquired by Lonza, Jun 2016
Trianni	Acquired by AbCellera, Nov 2020, $90M
Triax Pharmaceuticals	Acquired by Onset Dermatology
TrichoScience Innovations	Owned by RepliCel Life Sciences
Trigenesis Therapeutics	Acquired by Dr. Reddy's Laboratories
TRIGR Therapeutics	Acquired by Compass Therapeutics, Jun 2021, $50M
Trilliant Surgical	Acquired by DJO, Jan 2021
Trillium Therapeutics	Acquired by Pfizer, Nov 2021, $2.3B
Trimb Healthcare	Acquired by Karo Pharma, Sep 2019
Trinity Pharmaceuticals	Acquired by Chiesi Farmaceutici, 1999
Tripos	Bought by Certara
Trius Therapeutics	Acquired by Cubist Sep 2013
Trophos	Acquired by Roche, Jan 2015, €120M + €350 milestones
Trubion Pharmaceuticals	Acquired by Emergent BioSolutions Aug 2010, $97M
True North Therapeutics	Acquired by Bioverativ, Jun 2017, $400M + $425M milestones; Spinout from iPerian, 2013
Trukera Medical	Acquired by Bausch + Lomb, Jul 2024; fka TearLab
Truvic Medical	Acquired by Imperative Care, Jul 2021
TRx Pharmaceuticals	Acquired by Cerecor, Nov 2017
Tryp Therapeutics	Acquired by Exopharm, May 2024
tte laboratories	Acquired by Transcat
TUBE Pharmaceuticals	Website gone May 2025; Acquired by Oncamatryx, May 2023
Tularik	Bought by Amgen, Mar 2004, $1.3B
Turning Point Therapeutics	Acquired by BMS, Aug 2022, $4.1B; fka TP Therapeutics
Turnstone Biologics	Acquired by Xoma, Oct 2025
Tusk Therapeutics	Acquired by Roche, Sep 2018, $81M + $679M milestones; Team spinning out into new company Black Belt Therapeutics
Tusker Medical	Acquired by Smith & Nephew, Jan 2020
Tute Genomics	Acquired by PierianDx, Oct 2016
Twelve	Bought by Medtronic, Aug 2015, $458M
Twelve Bio	Acquired by Ensoma, Feb 2023
TWi Pharmaceuticals	Acquired by Bora CDMO, Oct 2022
TX3 Services	Acquired by Tricentis, Mar 2022
TxCell	Bought by Sangamo, Oct 2018, $84M
TyrNovo	Bought by Kitov Therapeutics, Jan 2017, $2M + $1.8M stock
TYRX	Acquired by Medtronic, Jan 2014, $160M
U3 pharma	Bought by Daiichi Sankyo, May 2008, $235M; closed 2015
UDL Laboratories	Acquired by Mylan 1996
Ultimovacs	Acquired by Zelluna, Feb 2025
Ultransonix	Acquired by Analogic, Mar 2013, $83M
UmanDiagnostics	Acquired by Quanterix, Jun 2019, $16M cash+$6.5M stock
Unimed Pharmaceuticals Inc	Acquired by Solvay Jun 1999
Universal Cells	Bought by Astellas, Feb 2018, $102.5M (milestone-dependent)
URL Pharma	Bought by Takeda Apr 2012, Bought by Sun Pharma Dec 2012
Urogenix	Acquired by Astellas
Urovant Sciences	Acquired by Sumitomo Dainippon Pharma with four other Roivant companies, Dec 2019, $3B;
US Diagnostics	Bought by Alere, Jul 2015, $60M
US Endoscopy	Acquired by Steris, Jul 2012
US Labs	Bought by Labcorp
UTILITY therapeutics	Acquired by Alembic Pharmaceuticals, Jul 2025
V-Wave	Acquired by Johnson & Johnson, Oct 2024, $600M + $1.1B milestones
Valence Health	Acquired by Evolent Health, Oct 2016
ValenzaBio	Acquired by Acelyrin, Jan 2023
Valeritas	Acquired by Zealand Pharma, Feb 2020, $23M
Valinor Pharma	Acquired by Grunenthal, Jul 2024, $250M
Valitacell	Acquired by Beckman Coulter, Sep 2022
Vallon Pharmaceuticals	Acquired by GRI Bio, Apr 2023
Valocor Therapeutics	Acquired by Dermira, Oct 2011
Valtech Cardio	Acquired by Edwards Lifesciences, Jan 2017, $340M
ValueGene	Acquired by Integrated DNA Technologies, Jun 2016
Vanadis Diagnostics	Bought by PerkinElmer, Jan 2016
Vandalia Research	Assets acquired by Applied DNA Sciences, $1.5M, Sep 2015
Vanrx Pharmasystems	Acquired by Cytiva, Feb 2021
VARIAGENICS	Acquired by Hyseg Pharmaceuticals, Nov 2002, $55.9M
Varian Bio	Acquired by Biodexa, May 2023
Varian Medical Systems	Acquired by Siemens Healthineers, Apr 2021, $16.4B
Vascular Insights	Assets acquired by Merit Medical, Jan 2019
Vascular Solutions	Acquired by Teleflex, Dec 2016
VasoGen	Assets acquired in complex transaction by Intellipharmaceutics, Oct 2009
VasoNova	Acquired by Teleflex Medical
VaxDesign	Acquired by Sanofi Pasteur, Sep 2010, $55M
VaxGen	Acquired by diaDexus, Jul 2010
Vaxil Bio Therapeutics	Acquired by Data Center Company for ticker
Vaxtrials	Acquired by Emmes, Oct 2023
VClinBio	Acquired Cellix and now operating under that name it seems, Jan 2019
VCN Biosciences	Acquired by Synthetic Biologics, Mar 2022
VectivBio	Acquired by Ironwood Pharmaceuticals, May 2023, $1B
Vectura
Vedere Bio	Renamed Vedere Bio II ayfter most assets acquired by Novartis, Oct 2020, $150M + $130M Milestones
Velano Vascular	Acquired by BD, Jul 2021
Velesco Pharmaceutical Services	Acquired by Pace Analytical, Oct 2021
Velocity Medical Solutions	Acquired by Varian Medical, Apr 2014
Velos	Acquired by WCG, Mar 2018
VelosBio	Acquired by Merck, Oct 2020, $2.75B
Velquest	Bought by Accelrys Jan 2012
Veniti	Acquired by Boston Scientific, Aug 2018, $108M + milestones (already owned 25%)
Venn Life Sciences	Acquired by hVIVO, Dec 2019
Ventana	Acquired by Roche, Jan 2008 $3.4B
VentiRx Pharmaceuticals	Apparently acquired by Celgene
Ventyx Biosciences	Acquired by Lilly, Mar 2026, $1.2B
Veran Medical Technologies	Acquired by Olympus, Dec 2020, $340M
VeraSci	Acquired by WCG, Jul 2021; fka Neurocog Trials
Verb Surgical	Acquired by J&J Dec 2019
Verenium	Bought by BASF, Dec 2013
Veridex	Bought by J&J, now Part of Janssen Diagnostics
Verinata Health	Acquired by Illumina, Jan 2013, $350M+
Verisante Technology	Acquired via Reverse Merger and seems to have left life sciences, Apr 2018
Verlyx Pharma	Acquired by Odan Laboratories, Dec 2018; fka Oncozyme Pharma, McGill spinout
Verogen	Acquired by Qiagen, Jan 2023, $150M
VeroPharm	Acquired by Abbott, Dec 2014, $495M
Verrow Pharmaceuticals	Acquired by Ligand Pharmaceuticals, Jan 2018, $2M
Versantis	Acquired by genfit, Sep 2022, CHF40M + CHF65M milestones
Vertera Spine	Bought by NuVasive, Sep 2017
Vertical Bio	Acquired by Pierre Fabre, Sep 2023
Vertiflex	Acquired by Boston Scientific, Jun 2019, $465M
Vertos Medical	Acquired by Stryker, Oct 2024
Vessix Vascular	Acquired by Boston Scientific, Nov 2012, $425M
Vetex Medical	Acquired by Surmodics, Jul 2021, $40M + $10.5M milestones
Vexim	Acquired by Stryker, Feb 2018, $216M
Via Biomedical	Acquired by Heraeus Medical, Sep 2019
ViaCyte	Acquired by Vertex, Nov 2022, $320M
Viagene	Acquired by Chiron, Apr 1995, $95M
Viamet Pharmaceuticals	Acquired by NovaQuest Capital Management, assets put into new company Selenity Therapeutics, Jan 2018
Viasys Healthcare	Acquired by Cardinal Health, May 2007, $1.5B
Viatris (1)	Acquired by Meda, Aug 2005, €750M
Vibalogics	Acquired by Recipharm, Feb 2022
Vibalogics	Acquired by Recipharm, Feb 2022
Vicebio	Acquired by Sanofi, Dec 2025, $1.15B
Vicept Therapeutics	Acquired by Allergan, 2011
Victory Pharma	Assets Acquired by Shionogi
Vicuron Pharmaceuticals	Acquired by Pfizer (2005) then sold to Durata (2010)
Vidara Therapeutics	Acquired by Horizon Pharma, Sep 2014
Viela Bio	Acquired by Horizon Therapeutics, Mar 2021, $3B; MedImmune spinout
Vifor Pharma	Acquired by CSL, Aug 2022, $11.7B
Vigene Biosciences	Acquired by Charles River, Jun 2021, $292M + $57M milestones
Vigil Neuroscience	Acquired by Sanofi, Aug 2025, $600M
Villaris Therapeutics	Acquired by Incyte, Nov 2022, $70M + $1.36B milestones
Vimela Therapeutics	Subsidiary of Alys Pharmaceuticals
Vintage Pharmaceuticals	Acquired by Apax Partners, Sep 2007, now part of Endo
Viracor-IBT	Renamed Viracor Eurofins; Bought by Eurofins, May 2014
Viralytics	Bought by Merck KGaA, Jun 2018, $394M
Virapur	Acquired by Microbiologics, 2017
ViraTherapeutics	Bought by Boehringer Ingelheim, Sep 2018, $244M
Virco	Bought by J&J
Virdante Pharmaceuticals	Assets acquired by Momenta
Viridian Pharma	Acquired by Martindale Pharma, Jul 2016
Viridus Animal Health	Bought by Huvepharma, Mar 2014
ViroCyt	Acquired by Sartorius, Jul 2016, $16M; Spun out of InDevR
ViroMed Laboratories	Acquired by LabCorp, Jun 2001
ViroPharma	Bought by Shire Jan 2014
ViroStat	Acquired by Medix Biochemica, Nov 2023
Viroxis	Acquired by an oil company, folded into Santalis, Jun 2015
Virttu Biologics	Acquired by TNK Therapeutics, Apr 2017
VisEn Medical	Acquired by PerkinElmer, 2010
Visikol	Acquired by Sartorius, Apr 2025
Visterra	Acquired by Otsuka, Sep 2018, $430M
Vitae Pharmaceuticals	Bought by Allergan, Sep 2016, $639M
Vitaeris	Bought by CSL Behring, Jun 2020
Vitalea Science	Acquired by Eckert & Ziegler, Sep 2012, now called Eckert & Ziegler Vitalea Science
VitalMED	Acquired by Kelpac, Jan 2016
Vitrology	Acquired by SGS, May 2012
Vium	Acquired by Recursion Pharma, Jul 2020
VivaBioCell	Acquired by NantCell, Jun 2015
Viventia	Acquired by Eleven Bio, Sep 2016, $30M in stock
Vivo BioSciences	Acquired by LifeNet health, Nov 2016
Vivopath	Acquired by Charles River, Jul 2014
vivoPharm	Acquired by Cancer Genetics, Aug 2017, $12M
VNUS Medical Technologies	Bought by Covidien, May 2009, $440M
Volcano	Bought by Philips, Dec 2014, $1.2B
Volumetric	Acquired by 3D Systems, Oct 2021
Vtesse	Acquired by Sucampo Pharmaceuticals, Apr 2017, $200M; Spunout of Cyden Orphan drug accelerator
Vuja De Sciences	Acquired by Healx, Sep 2025
VWR	Bought by Avantor Sciences, Nov 2017, $6.5B
Vynamic	Acquired by Inizio, Dec 2025
Vyrsa Technologies	Acquired by Nevro, Dec 2023, $40M + $35M milestones
WaferGen Biosystems	Acquired by Takara Bio, Mar 2017, $50M
Wako Diagnostics	Acquired by Fujifilm, Dec 2016
Walk Vascular	Acquired by Abbott, Sep 2021
Warden Bio	Acquired by Kriya Therapeutics, Jan 2022
Warner Chilcott	Acquired by Actavis, Oct 2013
Warner-Lambert	Bought by Pfizer Feb 2000 $90B
Warp Drive Bio	Assets moved into Revolution Medicines, Sep 2018
Watson Pharmaceuticals	Acquired Actavis, Oct 2012, took their name
WCCT Global	Acquired by Altasciences, Feb 2021
WCG Intrinsic Imaging	Acquired by WCG, Jul 2021
WDPrx - Woodfield Pharmaceutical	Acquired by Reliable HealthCare Logistics
WDSrx –Woodfield Distribution	Acquired by Reliable HealthCare Logistics
Whitecap Biosciences	Acquired by Bausch + Lomb, Jan 2025
WIL Research	Bought by Charles River, Apr 2016, $585M
Wilson Therapeutics	Acquired by Alexion, May 2018, $855M
WntResearch	Shell acquired by Opsy
Wolfe Laboratories	Acquired by Pace Analytical, Dec 2017
Woodland Biosciences	Acquired by Ichor Life Sciences, Sep 2021
Wright Medical	Bought by Stryker, Nov 2020, $4.7B
Wyatt Technology	Acquired by Waters, 2023
Wyeth	Bought by Pfizer
X-BODY	Bought by Juno Therapeutics, Jun 2015, $21M + stock + milestones
X-Ceptor	Acquired by Exelixis, Sep 2004, $22.3M
X-spine	Bought by Bacterin, Jul 2015, $73M, combined with Bacterin to become Xtant Medical
Xanthus Pharmaceuticals	Acquired by Antisoma, Jun 2008
Xceleron	Acquired by Pharmaron, Jan 2017
Xcelience	Acquired by Capsugel, Jan 2016
xCella Biosciences	Acquired by Ligand Pharmaceuticals, Sep 2020, $7M
Xcellerex	Acquired by GE Healthcare, May 2012
Xcyte Therapies	Assets sold, shell sold to Cyclacel, Dec 2005
Xell	Acquired by Sartorius, Aug 2021, €50M
Xellia Pharmaceuticals	Acquired by Novo, May 2024
Xendo	Acquired by ProPharma, Jul 2018
Xenios	Acquired by Fresenius, Nov 2016; formed out of merger between novalung & medos, 2013
XenoBiotic Laboratories	Acquired by WuXi Apptec, Oct 2011
XenoGesis	Acquired by Sygnature Discovery, Oct 2020
Xenometrics	Acquired by Citoxlab, Oct 2017
XenoPort	Acquired by Arbor Pharmaceuticals, Jul 2016, $467M
Xenotech	Acquired by BioIVT, Sep 2022; fka Xenotech
Xenotrans	Assets purchased by Revivicor, Jun 2005
Xenova	Acquired by Celtic Pharma
Xeridiem	Acquired by Spetcrum Plastics
Xhale	Acquired by Philips, Aug 2018
XinThera	Acquired by Gilead, May 2023; Residential address Aug 2021
Xinvento	Acquired by Rhythm Pharmaceuticals, Feb 2023, $5M + $206M milestones
Xlumena	Acquired by Boston Scientific Apr 2015, $62.5M
XO1	Bought by J&J, Mar 2015
Xoft	Acquired by Elekta, Oct 2023
Xpress Biologics	Acquired by PolyPlus, Dec 2022
Xtal BioStructures	Acquired by Schrödinger, Jan 2022, $6M
Xybion	Acquired by Instem, Jul 2025
Xybion	Acquired by Instem, Jul 2025
Xybion	Acquired by Instem, Jul 2025
Xybion	Acquired by Instem, Jul 2025
Xycrobe Therapeutics	Acquired by Crown Laboratories, May 2019
Yellow Jersey Therapeutics	Acquired by J&J, Jul 2024, $1.25B
YM Biosciences	Bought by Gilead Dec 2012
Yumanity Therapeutics	Reverse merged with Kineta, Dec 2022
Z-Factor	Centessa Company
Z-Medica	Acquired by Teleflex, Jan 2021, $500M + $25M milestones
Zacharon Pharmaceuticals	Acquired by Biomarin Jan 2013
ZaltanPharma	Acquired by Riemser, Oct 2019
Zars Pharma	Acquired by NuVo Research
Zavante Therapeutics	Bought by Nabriva Therapeutics, Aug 2018, 8.2M shares
ZebiAI Therapeutics	Acquired by Relay Therapeutics, Apr 2021, $85M
Zeltiq	Bought by Allergan, Feb 2017, $2.4B
ZenBio	Acquired by BioIVT, Aug 2024
Zenyth Therapeutics	Acquired by CSL, Nov 2006
Zephyrus Biosciences	Bought by biotechne, Mar 2016; Spun out of Berkeley
Zevacor	Acquired by Sofie Biosciences, Sep 2017
Zevacor Molecular	Acquired by Curium, Mar 2020
Ziarco	Bought by Novartis, Dec 2016
Zikani Therapeutics	Acquired by Eloxx Pharmaceuticals, Apr 2021; fka Macrolide Pharmaceuticals
Zila	Bought by Tolmar, Jul 2009
Zinsser Analytic	Acquired by Gardner Denver
Zipline Medical	Acquired by Stryker, Jul 2018, $9M
Ziylo	Bought by Novo Nordisk, Jul 2018, up to $800M
Zogenix	Acquired by UCB, Mar 2022, $1.9B
Zonare	Bought by Mindray, Jul 2013, $64M
Zosano Pharma	Acquired by Emergex out of Chapter 11 bankruptcy Aug 2022, $1M
zPREDICTA	Acquired by Predictive Oncology, Dec 2021
ZS Pharma	Bought by AstraZeneca Nov 2015, $2.7B
Zycos	Acquired by MGI Pharma, Sep 2004, $50M
Zyga Technology	Acquired by RTI Surgical, Jan 2018
Zylera Pharmaceuticals	Acquired by Cerecor, Nov 2017
Zymenex	Acquired by Chiesi, Aug 2013
Zymetis	Acquired by AE Biofuels 2011
Zymogenetics	Bought by BMS, Sep 2010, $885M
ZyMot fertility	Acquired by CooperSurgical, Jun 2024
Zynerba Pharmaceuticals	Acquired by Harmony Biosciences, Oct 2023, $60M
Zynex Medical	Acquired by Altivera Medical, Mar 2026
ZyStor	Bought by BioMarin, closed